Enabling the elderly person with lower limb amputation through surgery, rehabilitation and long term care by Fortington, Lauren Victoria
 
 
 University of Groningen
Enabling the elderly person with lower limb amputation through surgery, rehabilitation and
long term care
Fortington, Lauren Victoria
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2013
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Fortington, L. V. (2013). Enabling the elderly person with lower limb amputation through surgery,
rehabilitation and long term care. [S.n.].
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 26-12-2020

Enabling the elderly person with lower limb amputation 
through surgery, rehabilitation and long term care 
Publication was supported by donations received from: 
Centrum voor Revalidatie, UMCG 
Research Institute SHARE 
University of Groningen 
University Medical Center, Groningen 
Foundation Beatrixoord North Netherlands 
OIM Foundation (Assen, Netherlands) 
medi Nederland BV 
Bauerfeind Benelux BV 
Cover design: Meg Fortington, Lauren Fortington 
Cover image: Albert Olsson, with thanks to Emma Olsson and family 














Enabling the elderly person with lower limb amputation 
through surgery, rehabilitation and long term care 
Proefschrift 
ter verkrijging van het doctoraat in de 
Medische Wetenschappen 
aan de Rijksuniversiteit Groningen 
op gezag van de 
Rector Magnificus, dr. E. Sterken, 
in het openbaar te verdedigen op 
maandag 8 april 2013 
om 12.45 uur 
door 
Lauren Victoria Fortington 
geboren op 8 mei 1980 
te Melbourne, Australie 
Promotores: Prof. dr. J.H.B. Geertzen 
Prof. dr. P. U. Dijkstra 
Copromotor: Dr. G.M. Rommers 
Beoordelingscommissie: Prof. dr. W.P. Achterberg 
Prof. dr. J.S. Rietman 
Prof. dr. C.J.A.M. Zeebregts 
Sincere thanks is owed to: 
Prof. dr. Jan Geertzen and Prof. dr. Pieter Dijkstra. 
Dr. Clemens Rommers and Prof. dr. Klaas Postema. 
Dr. Joline Bosmans, Dr. Wendy Post, Anne Wind-Kral and Dr. Jaap van Netten. 
Participating patients and clinical staff in the hospitals, nursing homes and general practices of 
Drenthe, Friesland and Groningen. 
If I was to individually thank everyone who deserves to be, these pages would outnumber those 
which follow. To family, friends and colleagues, near to and far from Groningen: thank you. 

Table of contents 
Introduction 9 
Lower limb amputation in Northern Netherlands: unchanged 
incidence from 1991-1992 to 2003-2004 17 
Short and long term mortality rates after lower limb amputation 31 
Determinants of discharge to long term care after lower 
limb amputation 47 
Rehabilitation in long term care for the elderly person with lower 
limb amputation; a mixed methods, descriptive study 55 
Change in health related quality of life in the first 18 months 
after lower limb amputation; a prospective, longitudinal study 77 
Mobility in elderly people with a lower limb amputation: 
a systematic review 91 
Bias in amputation research; impact of subjects missed from 
a prospective study 7 09 
General discussion 123 
English summary 141 






MPUTATION AND PROSTHETICS brings to mind remarkable and extreme 
images: the technology of The Six Million Dollar Man, rebuilt with 
bionic limbs to save the world; Aron Ralston, depicted in the movie 127 
Hours, amputating his own arm to save his life; or the athleticism of Oscar 
Pistorius, the Blade Runner, competing against able-bodied athletes at the 2012 
Olympic Games: While these impressions are indeed outstanding, the reality 
of amputation in the Netherlands, and other developed countries, is a vastly 
different picture. 
Most people undergoing lower limb amputation are over 65 years of age. 1•2 
Chronic peripheral vascular disease or diabetes has resulted in irreversible 
ischemia or a life threatening infection in the lower limb. By the time an 
individual requires surgical intervention for the limb, there is usually serious, 
and systemic, disease present. It is the complications of this (cardiovascular) 
disease that creates one of the main difficulties in rehabilitation for the elderly 
person, rather than the amputation itself. For example, cardiac disease must be 
carefully assessed to avoid adverse events when beginning rehabilitation. 3•4 Other 
common conditions include renal disease requiring dialysis, cerebrovascular 
disease and (vascular) dementia, as well as changes of ageing which lead to 
functional impairment, such as reduced balance and postural control, and vision 
and hearing loss. 
Specialist needs of the elderly person in rehabilitation are well-known. 
Differences in care for the elderly person with amputation are also recognised, 
being the subject of 'best-practice' papers and reviews.5-7 However, very little 
empirical research has been carried out to identify, support or challenge 
what exactly these unique needs are. Despite advances in preventive care, 
medical treatment and peripheral revascularisation procedures, in some cases, 
amputation remains the best option for ending ongoing pain, hospitalisation and 
infection/ischaemia, and ultimately, enabling a person to live. It is the enabling 
of a person that the research presented in this thesis focusses on. How does an 
elderly person, who has recently had their limb amputated, rehabilitate and how 
successful are they? 
* Equally striking and extreme are images of devastation and war: the Haitian earthquake in 2010 
was the largest ever loss of limbs from a natural disaster; military conflict and lasting consequences 
of improvised explosive devices and land mines continue to result in lost (quality of) life, effecting 
individuals, families and their communities. The research in this dissertation is focussed on the 
situation of the Netherlands and similar developed economies. By no means should this be seen to 









Aims of this thesis 
Amputation and prosthetics is a key research line of the Department of 
Rehabilitation Medicine, University Medical Center Groningen. Several projects 
have looked at different aspects of amputation rehabilitation. Beginning with 
"The elderly amputee: rehabilitation and functional outcome"8 and "Prosthetic 
prescription in lower limb amputation"9 the need for more research of the elderly 
population was evident. Mobility outcomes were investigated in "Functional 
outcome after a lower limb amputation"10 finding the timed up-and-go test a 
reliable measure of prosthetic mobility and the one leg balance test a useful 
predictor of mobility. A conclusion of this work was that functional outcomes 
for elderly people with amputation are poor and rehabilitation programmes need 
further research. In "Rehabilitation aspects of amputation" 11 it was also concluded 
that there is a distinct lack of knowledge concerning the elderly population and 
the issue of bias from research in this population was raised. The problem of bias 
was also highlighted in "Movement and balance control in lower limb amputees."12 
The majority of the population included in that research had undergone 
amputation due to trauma or tumor and this limited the ability to generalise 
results to the elderly population with a vascular related cause, despite them being 
the largest population who undergo the procedure. 
Building on this previous work, the research presented in this thesis looks 
at how the elderly person is enabled from the decision to amputate, through 
their rehabilitation and long term care. Specifically, the following questions were 
considered: 
1. What is the incidence of lower limb amputation? What characteristics 
does the population feature? 
2. What role does the long-term care setting play in the rehabilitation and 
care of the elderly person after a lower limb amputation? 
3. What long-term outcomes can the elderly person expect after a lower 
limb amputation? 
12 
Overview of chapters 
Each of the following chapters addresses one or more of the questions above 
with the aim of understanding how, and how well, the elderly person with lower 
limb amputation is enabled from the time of amputation, through rehabilitation 
and into long term care. 
A review of the medical records of all people who underwent a lower limb 
amputation in the Northern Provinces of the Netherlands in 2003 or 2004 forms 
the basis of the first chapters. The population is defined in chapter two where 
the characteristics and incidence rate are presented. Incidence rates and age 
groups are compared to an earlier cohort from the same region to see whether 
the population requiring rehabilitation and long term care has changed. Chapter 
three focusses on the high rates of mortality after amputation, comparing 
outcomes by different subgroups including age, sex and level of amputation. The 
influence of comorbidities, including diabetes, is also considered. 
After amputation, patients undergo a period of rehabilitation with the aim 
of regaining mobility and independence. For the elderly population, traditional 
inpatient rehabilitation programmes can prove too demanding due to the 
presence of physical and cognitive comorbidity. In chapter four, the determinants 
of discharge location following the amputation are considered with a focus on 
the population who are discharged to long term care facilities. The provision 
of rehabilitation in this setting is then described in chapter five. Using a mixed 
methods approach of a facility survey and qualitative interviews, the barriers and 
potential of rehabilitation programmes for people with a lower limb amputation 
are described from the clinicians' perspectives. 
Mobility is thought to be the key to independence and the basis of a higher 
quality of life. These outcomes are the focus of chapters six and seven. Change 
in health related quality of life over 18 months is analysed in a cohort of people 
with first lower limb amputations. The influence of age and walking ability on 
different HRQOL domains are investigated, along with a comparison to population 
norm values. A systematic review of mobility outcomes focussed on the elderly 
person with lower limb amputation is presented in chapter seven with the aim of 
providing a prognosis of mobility for this population. 
Bias, an issue common across all research of elderly people with amputation, 
is explored in chapter eight. The implications of studying a small population, 
which is then further biased by the non-inclusion of elderly people, is described 
using the example of a prospective study of phantom pain in which an obvious 






Finally, chapter nine summarises the findings, presenting the current evidence 
and research directions for rehabilitation and long term care of the elderly person 
with amputation and looks back at the overriding question of "how well is the elderly 
person with lower limb amputation enabled?" 
Definitions 
All chapters keep the elderly person as a central focus of the research. While there 
is no clear biological or chronological age at which someone is 'elderly: many 
countries have accepted a standard use of 65 years. It is around this age that people 
commonly undergo a transition from working to retirement and with this there are 
corresponding lifestyle changes. 13 As a general rule, the age of 65 years has been used 
as elderly through the following chapters. An exception was made in the systematic 
review presented in chapter seven where the age of 60 years was used to maximise 
inclusion of relevant publications. 
Long term care (LTC) refers to the provision of assistance, both medical and non­
mcdical, to people with chronic illness or disability, over a prolonged time. Although 
different terminology has developed to suit different health settings and services, a 
LTC facility can be considered any institution providing rehabilitative, restorative, 
and/or ongoing skilled nursing care to patients or residents in need of assistance. 
In the Netherlands, LTC is frequently provided in a form of nursing home (Dutch: 
verpleeghuis), although the services available differ from other countries, in particular 
the presence of a unique specialist, the Elderly Care Physician. 14 
Lower limb amputation (LLA) is the complete surgical removal of part of the 
limb in the transverse plane. LLA is often termed 'minor' or 'major' in reference to 
the extent of limb loss although there are discrepancies on which levels these terms 
encompass. In this thesis, major LLA is referring to amputations at or proximal to 
the transtibial level. 
14 
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Abstract 
Study design: Historical cohort study of transtibial amputation, knee 
disarticulation and transfemoral amputations resulting from vascular 
disease or infection, with or without diabetes, in 2003-2004, in the three 
Northern provinces of the Netherlands. 
Background: Investigating population changes gives insight into 
effectiveness and need for prevention and rehabilitation services. Incidence 
rates of amputation are highly varied, making it difficult to meaningfully 
compare rates between studies and regions or to compare changes over 
time. 
Objectives: To report the incidence of first transtibial amputation, 
knee disarticulation or transfemoral amputation in 2003-2004 and the 
characteristics of this population, and to compare these outcomes to an 
earlier reported cohort from 1991-1992. 
Methods: Population based incidence rates were calculated per 100,000 
person-years and compared across the two cohorts. 
Results: Incidence of amputation was 8.8 (all-age) and 23.6 (�45 years) per 
100,000 person-years. This was unchanged from the earlier study of 1991-
1992. The relative risk of amputation was 12 times greater for people with 
diabetes than people without. 
Conclusions: Investigation is needed into reasons for the unchanged 
incidence with respect to the provision of services from a range of disciplines 
including vascular surgery, diabetes care and multidisciplinary foot clinics. 
18 
Introduction 
Incidence rates of transtibial amputation, knee disarticulation and transfemoral 
amputation are highly variable. In a recent systematic review it was reported that 
the rate of major amputation is between 3.6 and 68.4 per 100,000 person-years. 1 
"-
Variations in incidence may occur not only because the actual rates differ but also 
because of differences in research methodology. These differences include: how 
the population is defined - minimum age cut-off; the level of amputation - (non) 
inclusion of partial foot amputations; and the method for identifying inclusion 
of cases - retrospective versus prospective collection from surgical records or 
national databases. 2 These differences make it difficult to meaningfully compare 
rates between studies and regions or to compare changes over time. 
Studies which have reported long-term changes in incidence of amputation 
show a general trend towards a decreasing rate. 3-9 Most studies focus on 
amputations in people with diabetes.1 For the Netherlands, a reduction from 550 
to 363 amputations per 100,000 people with diabetes was reported. 10 Whether 
this decline is consistent in people without diabetes is unknown. 
Investigating population changes can give insight into whether preventative, 
intervention and rehabilitation services are being provided effectively and to the 
right population. In order to look at changes in amputation for people with and 
without diabetes, while avoiding the limitations in comparing rates across studies, 
we replicated an earlier study in the Northern provinces of the Netherlands.11 In 
addition, using the same methodology as that study, we reviewed the medical 
records directly, gaining deeper insight into individual factors than are available 
in the national database in which pre-amputation history is not available and side 
of amputation is not stated. 
The aim of this study was to report the incidence of first transtibial 
amputation, knee disarticulation or transfemoral amputation in 2003-2004 and 
the characteristics of this population, and to compare these outcomes to an 
earlier cohort from 1991-1992. 11 
Methods 
Data collection 
The medical ethics committee of the University Medical Center Groningen ruled 
that a formal application and approval was not required for a retrospective 











The study was conducted in all 14 hospitals of the three Northern provinces 
of the Netherlands: Groningen, Friesland and Drenthe. This region had a total 
population of approximately 1. 7 million people in the study period of 1 January 
2003 to 31 December 2004. 12 
Data collection was matched to the previous study. 1 1 The population included 
from the previous study was modified and data were re-analysed, focussing only 
on transtibial level and above. Each hospital compiled a list of people who had a 
transtibial amputation, knee disarticulation or transfemoral amputation in 2003 
or 2004. People who had an amputation at any of these levels before 1 January 
2003 were excluded. People with a previous amputation distal to and including 
ankle disarticulation, were included. Where multiple amputations occurred 
within the study period ( either re-amputation to a higher level or a bilateral 
amputation), cases were counted once, and the highest level of amputation is 
presented. Amputations that were the result of trauma, cancer, complex regional 
pain syndrome or congenital causes were excluded, thus leaving a cohort with 
amputation resulting from vascular disease or infection, with or without Diabetes 
Mellitus. Medical records for all cases were reviewed between August 2010 and 
June 2011 .  The years 2003 and 2004 were chosen as major changes in the way 
that data are recorded in the Netherlands occurred from 2005 onwards. This 
presented concerns on the reliability of data from later years that would not have 
enabled the direct comparison to our earlier cohort. 
Analysis 
The original dataset was obtained from the authors of the 1991-1992 study for 
analyses. 11 Population data were obtained from the Central Bureau of Statistics 
(CBS), 12 including the number of people residing in each province, and their age 
and sex. There are no large ethnic groups in the region requiring separate 
analyses. The population structure in our region did not change substantially 
from 1991-1992 to 2003-2004, with 2% more people aged � 45, and 0.7% more 
people aged � 75 years, 12 so actual (crude) incidence rates are presented for 
comparison of the two time periods. Age-adjusted rates were checked and 
showed no differing results, and thus, they are not presented. 
The population with diabetes was estimated from prevalence rates obtained 
from the CBS for the years 2003 and 2004 separately. These prevalence rates are 
only available for the population aged � 45 years. The majority of the population 
aged < 45 years is not considered to be at high risk of amputation resulting from 
vascular disease or diabetes (although admittedly, there are exceptions). 
Therefore, it was reasonable to exclude these younger cases from the denominator 
in calculating incidence of those with diabetes. The population without diabetes 
20 
was calculated by subtracting the estimated population with diabetes from the 
total population for each year. A total population incidence rate is also presented, 
for comparison to other studies. Population-based incidence rates were calculated 
per 100,000 person-years, for the different age and sex categories, with a Poisson 
distribution assumed for calculation of the 95% confidence interval (c1). 
Age was compared using t-tests and categorical variables and incidence rates 
were compared with :x2 tests. Statistical significance for all analyses was set at 
0.05. Analyses were performed using Microsoft Excel 2003, PASW Statistics 18 
and Confidence Interval Analysis version 2.2 (Trevor Bryant, University of 
Southampton). 
Results 
Three hundred and forty two people underwent a transtibial amputation, knee 
disarticulation or transfemoral amputation due to vascular disease, infection or 
diabetes, in 2003 or 2004. Forty three people were excluded as they had 
undergone amputation proximal to the ankle before the study period. This 
resulted in 299 people, the majority of which were men (60%), with a mean age of 
74.0 years (table 1) . 
The population characteristics from 2003-2004 showed no major differences 
to 1991-1992. A significant difference in age between men and women within 
each time period remained consistent: in 1991-1992 men were 4 years younger 
than women (73.1 years compared to 77.2 years, p=0.004) and in 2003-2004 men 
were 5 years younger than women (77.0 years compared to 72.0, p<0.001). 
1 99 1 -1 992 2003-2004 Table 1 :  Characteristics 
n=285 n=299* of people with first 
Levelt major lower l imb 
Transtibial 48 ( 1 37) 49 ( 1 46) amputation  in 1 99 1 -
Knee disarticulation 1 0  (27) 9 (27) 1 992 and 2003-2004. 
Transfemoral 36 ( 1 03) 34 ( 1 00) 
Bilateral 6 ( 1 8) 9 (25) 
Sex 
Men 59 ( 1 68) 60 ( 1 78) 
Women 41 (1 1 7) 40 ( 1 2 1 )  
Age 
All 74.8 (1 1 .8) 74.0 (1 1 .2) 
Men* 73.1 ( 1 1 .5) 72.0 (1 0.6) 
Women* 77.2 ( 1 1 .8) 77.0 (1 1 .5) 
Diabetes so ( 1 49) 
*not all variables sum to total due to missing data. t % (n) presented for all variables except 
for age which is mean (sd); :l=Comparison of age by gender: men compared to women in 1 991-
1 992 p=0.004; men compared to women in 2003-2004 p<0.001 . 
2 1  
The 2003-2004 incidence for the all-age population was 8.8 per 100,000 
person-years and for the population aged 2::45 it was 23.6 per 100,000 person­
years (table 2) . Incidence was higher in the older age groups. The incidence for 
the total population, as well as by sex and by age, showed no significant changes 
from 1991-1992 to 2003-2004 (figure 1) . The oldest group (2::75 years) had a 
reduced incidence of almost 12 per 100,000 person-years (from 80.4 to 68.8, 
p=0.150). 
Diabetes was diagnosed in 50% of people with amputation in the period 
2003-2004. The ratio of transfemoral and knee disarticulations to transtibial 
amputations in people without diabetes is 2: 1, whereas the ratio in people with 
diabetes is 1:1 (p=0.017) (table 3). Women with diabetes were 3.1 years younger 
than women without diabetes (p=0.095). Men were significantly younger than 
women both in people with diabetes (71.4 years compared to 76.4 years, p=0.003) 
and without diabetes (73.0 years compared to 79.5 years, p<0.001). 
For people aged 2::45 years with diabetes, the incidence of amputation was 
150.9 per 100,000 person-years, a relative risk 12.3 (95% CI: 9.7;15.4) times 
higher than people without diabetes (table 4). 
Table  2: 1991-1 992 2003-2004 
p* 
Comparison of Incidence (95% CW Incidence (95% CW 
incidence rates for All age 8.9 ( 7.9 ; 9.9) 8.8 ( 7.8 ; 9.8) 0.467 
first major lower ;?: 45 years 24.8 (21.9 ; 27.8) 23.6 (20.9 ; 26.4) 0.552 
limb amputation ;?: 65 years 52.2 (45.8 ; 59.3) 47.4 (41 .6 ; 53.8) 0.292 
in 1991-1992 and 
;?: 75 years 80.4 (68.3 ; 94.0) 68.8 (58.5 ; 80.4) 0. 1 50 
2003-2004. 
Men ;?: 45 32.2 (27.5 ; 37.4) 29.9 (26.3 ; 33.7) 0.530 
Men ;?: 65 72.0 (60.3 ; 85.3) 63.5 (53.2 ; 75.2) 0.303 
Men ;?: 75 106.8 (84.3 ; 133.5) 88.6 (69.6 ; 1 1 1.2) 0.218 
Women ;?: 45 19.5 (16. 1  ; 23.3) 17.9 ( 15.2 ; 2 1 .0) 0.603 
Women ;?: 65 38.5 (3 1 .4 ; 46.7) 35.7 (29.2 ; 43.2) 0.591 
Women ;?: 75 65.1 (5 1.7 ; 80.9) 57.6 (46.0 ; 7 1.2) 0.432 
*p is x2 comparison of 2003-04 to 1992-92 for each sex and age group; t incidence 
per 100,000 people-years with Poisson rate distribution for calculation of 95% Cl 
22 
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Figure shows change in incidence from 1991-1992 to 2003-2004 by age groups. P values are presented from x2 
comparison of 2003-2004 to 1992-1992 shown in table 2. 
Table 3: Diabetes No diabetes p 
Characteristics of 
n* 50 ( 1 49) 50 ( 1 47) 
people with lower Levelt 
limb amputation Transtibial 55 (82) 42 (61 ) 0.01 7 
aged �45 years Knee disart. 8 ( 1 2) 1 0  ( 1 5) 
with and without Transfemoral 26 (39) 42 (62) 
diabetes. Bilateral 1 0  (1 5) 6 (9) 
Sex 
Men 55 (82) 65 (95) 0.059 
Women 45 (67) 35 (52) 
Age 
All 73.7 (1 0.3) 75.3 ( 1 0.9) 0.204 
Men* 7 1 .4 (1 0.4) 73.0 ( 1 0.4) 0.361 
Women* 76.4 (9.5) 79.5 ( 1 0.5) 0.095 
*% (n) presented for all variables except for age which is mean (sd) 
tcomparison of age by gender: men versus women with diabetes p=0.003; 
men versus women without diabetes p<0.001.for age which is mean (sd); 
=!=Comparison of age by gender: men compared to women in 1991-1992 
p=0.004; men compared to women in 2003-2004 p<0.001. 
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Table 4: Inc idence of people with fi rst lower l imb a m putation 
aged �45 years, with a nd without diabetes. 
Incidence* Diabetes No diabetes RR (95% CI) 
All 
2: 45 years 1 50.9 ( 1 27.6 ; 1 77.2) 1 2.3 (1 0.4 ; 1 4.5) 1 2.3 (9.7 ; 1 5.4) 
2: 65 years 1 96.5 (1 62.4 ; 235.8) 27.6 (23.0 ; 33.0) 7.1  (5.5 ; 9.1 ) 
2: 75 years 287.1 (227.7 ; 357.3) 38.4 (30.3 ; 47.9) 7.5 (5.5 ; 1 0.2) 
45 - 64 years 83.1 (57.2 ; 1 1 6.7) 3.2 (2. 1 ; 4.8) 26.0 ( 1 5. 1  ; 43.3) 
65 - 74 years 1 1 4.6 (80.2 ; 1 58.6) 1 8.2 (1 3.2 ; 24.4) 6.3 (4.0 ; 9.8) 
Men 
2: 45 years 1 70.9 ( 1 35.9 ; 2 1 2. 1 )  1 7. 1  ( 1 3.8 ; 20.9) 1 0.0 (7.4 ; 1 3.4) 
2: 65 years 242.9 ( 1 84.9 ; 3 1 3.3) 35.8 (28.2 ; 44.8) 6.8 (4.8 ; 9.5) 
2: 75 years 357.2 (250.2 ; 494.5) 5 1 .7 (36.6 ; 71 .0) 6.9 (4.4 ; 1 0.9) 
45 - 64 years 97. 1 (61 .5 ; 1 45.6) 4.8 (2.9 ; 7.5) 20. 1 ( 1 0.9 ; 36.9) 
65 - 74 years 1 54.8 (98.1 ; 232.2) 33.3 (23.5 ; 45.7) 4.6 (2.8 ; 7.8) 
Women 
2: 45 years 1 30.5 ( 10 1 .2 ; 1 65.8) 8.2 (6.1 ; 1 0.7) 1 6.0 ( 1 1 . 1  ; 23.0) 
2: 65 years 1 62.9 (1 23.4 ; 2 1 1 . 1 )  1 6. 1  ( 1 1 .8 ;  21 .4) 1 0. 1  (6.9 ; 1 4.8) 
2: 75 years 247.4 (1 79.7 ; 332. 1 )  3 1 .6 (22.7 ; 42.9) 7.8 (5.1 ; 1 1 .9) 
45 - 64 years 61 .2 (29.4 ; 1 1 2.6) 1 .3 (0.4 ; 3.0) 47.3 ( 1 6.2 ; 1 38.3) 
65 - 74 years 78.5 (41 .8 ; 1 34.2) 4.7 ( 1 .7 ; 1 0.3) 1 6.7 (6.3 ; 43.8) 
:f: incidence per 100,000 people-years; RR = Relative Risk 
Discussion 
Taken as a single time point, the amputation incidence of 23.6 per 100,000 
person-years aged �45 years can be considered as moderate, falling in the middle 
of other population studies that have been presented in two systematic reviews. 1 •13 
Although the rate has declined slightly over time, the lack of any statistically 
significant reduction in the incidence of amputations in our population is of 
concern and supports a need to investigate the adequacy of multidisciplinary 
prevention programmes and interventions to save limbs. Whilst there are others 
who report no change in amputation rates, 14•15 most research supports an overall 
trend towards a significantly declining incidence. 3-9 
Reasons for unchanged amputation rates must be carefully considered in 
order to build effective care strategies. It was expected that there would be a 
shift towards an older age for people undergoing their first amputation as more 
interventions aim to prevent or delay the procedure. Although this has been 
reported in other populations, 14 there was no change to the mean age at the 
time of first amputation in our region. The oldest group of patients appeared to 
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have a reduced incidence yet the overall rate remained unchanged. A possible 
explanation is the surgeon and patient chose not to pursue amputation as 
a treatment in the older population or people may have already undergone 
amputation at a younger age. A decision on when to amputate is made through 
the combined efforts of medical staff and the patients own situation and wishes. 
Exploration of the individual motivations behind these decisions could offer 
insight into some of the differences in incidence rates over time and across 
different regions. 
In Europe throughout the l 990's, the frequency and quality of 
multidisciplinary foot care continued to increase16 and there was a concerted 
effort made to reduce diabetes related amputations through the St Vincent's 
Declaration. A study conducted in a separate region of the Netherlands, showed 
that referral of patients at risk to multidisciplinary foot clinics, at least up until 
the year 2000, was very low. 17 These results, together with our findings of no 
change to incidence in the time period, support a need to investigate the 
provision of vascular services and foot clinics in more depth. 
Diabetes was diagnosed in 50% of the 2003-2004 cohort. The RR of 
amputation was 12 times greater in people with a diagnosis of diabetes than the 
risk of amputation in people without diabetes. This risk is higher than reports 
from other Western economies including Germany, the United States, Finland 
and Sweden where RR is reported as approximately 7 -10 times greater for people 
with diabetes. 6•18•19 Those studies had similar populations to ours based on the 
inclusion criteria. Therefore, it appears that for people with diabetes in the 
Northern Netherlands, the R R  of amputation proximal to the ankle might be 
slightly higher than in comparable Western regions. Regrettably, there was no 
data concerning diabetes available from the 1991-1992 study and so the impact of 
this important diagnosis on our unchanged incidence rate cannot be determined. 
A nationwide study in the Netherlands demonstrated a decreased rate for 
diabetes-related amputation from 1991-2000. 10 If this reduction is consistent for 
our region specifically, then we need to look at why the changes are not being 
reflected in the overall incidence rate, specifically for amputations due to 
peripheral arterial disease. 
The current study was limited to the Northern provinces of the Netherlands, 
enabling direct comparison to the earlier cohort. However, there are known to be 
considerable regional variations in incidence rates of LLA. 1 •20•21 In addition, in 
order to match the methodology of the previous study, data presented is now 
somewhat outdated from 2003-2004, before a major change to the recording of 
this data was implemented. Both of these points - the region and timing of data 
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collection - should be taken into account in generalizing the results. 
Retrospective identification of LLA poses the inevitable chance of having missed 
cases. The incidence rates should therefore be considered as potentially 
underestimated, although any additional cases would not have an effect on our 
main outcome of no change over time. Our findings in relation to diabetes should 
also be considered as an underestimation as data were recorded from medical 
files, some of which had limited or missing information, particularly to 
distinguish between diabetes type 1 and diabetes type 2. All physicians are 
encouraged to carefully document this diagnosis to enable differentiation 
between the two in future work. 
Our results were suggestive that a small decrease in incidence had 
occurred but without statistical confirmation, which is possibly due to the 
small amputation population size. A repeat study with a recent cohort should 
be performed, with recognition that the data collection procedures in the 
Netherlands have changed. This study would aim to evaluate if the lack of change 
in incidence was due to chance, a slower implementation of changes in care and 
prevention, or if indeed we need to seriously consider the services being provided 
to people with vascular disease and diabetic foot problems. 
Conclusions 
Our findings of an unchanged incidence need to be investigated further with 
respect to the provision of services from a range of disciplines including vascular 
surgery, diabetes care and multidisciplinary foot clinics. The risk of LLA in people 
with diabetes in 2003-2004 was high but should be confirmed through a follow 
up study. Finding effective methods for reducing the rate of amputation is 
imperative with diabetes and general population ageing presenting an increased 
number of people at risk. 
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Supplementary table 1 :  
Population data for calculation of incidence rates. 
1 991 - 1992 2003-2004 
n e,erson-'t_ears crude rate n e,erson-'t_ears crude rate 
All age 285 3200788 8.9 299 3392903 8.8 
� 45 years 278 1 1 23095 24.8 296 1 256654 23.6 
� 65 years 235 4500 1 1 52.2 239 5041 35 47.4 
� 75 years 1 58 1 96529 80.4 1 59 231 060 68.8 
Men � 45 1 68 522063 32.2 1 78 591 75 1 29.9 
Men � 65 1 33 1 84730 72.0 1 35 2 1 2644 63.5 
Men � 75 77 72083 1 06.8 74 83538 88.6 
Women � 45 1 1 7 601 032 1 9.5 1 2 1 664903 1 7.9 
Women � 65 1 02 265281 38.5 1 04 291 491  35.7 
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Abstract 
Objective: to determine mortality rates after a first lower limb amputation 
in the Northern Netherlands and to explore the rates for different 
subpopulations. 
Design: historical cohort study. 
Methods: medical records were reviewed for people who underwent a first 
amputation, at or proximal to transtibial level, in 2003 or 2004, in one of 14 
hospitals from an area of 1.7 million people. 
Results: 299 people were included. 269 cases (90%) had a confirmed status 
(alive or dead) at follow-up, although the date of death was missing in 16 (5%). 
Median time to death was 20.3 months (95% Cl: 13.1 ;27.5). 30-day mortality 
was 22%, 1 -year mortality was 44% and 5-year mortality was 77%. Significant 
differences in median survival were seen for age groups; people aged 85+ 
surviving 8.8 months, younger groups were all over 20 months (p=0.028). 
Significant differences were also seen for age-level combined (p=0.041 ); of 
particular note, people with unilateral transfemoral amputation aged 75-84 
years had significantly longer survival times (22.2 months) than younger (3.4 
months) and older (2.1 months) groups. No differences in survival for people 
with/without diabetes were seen. 
Conclusions: There was a high rate of 30-day mortality. Variation in median 
survival time was most apparent by age groups. 
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Introduction 
Mortality rates after lower limb amputation (LLA) are notoriously high. This is 
attributed to the population consisting of old and medically frail people at the 
time of undergoing a major surgical procedure. Older age, proximal amputation 
levels and comorbidity, particularly renal disease, are all associated with a 
higher rate of mortality after amputation.1-4 Despite this acceptance of a high 
risk of mortality after LLA, reported rates are wide-ranging. Differences are 
largely explained by variation in inclusion criteria. As an example, 1 year after 
amputation, mortality rates as low as 22% have been reported in a population 
that included partial foot amputation. 5 Focussing only on transtibial and more 
proximal levels, mortality rates can reach as high as 52% at 1 year.6•7 Additional 
factors, such as the inclusion of only people undergoing their first amputation 
or also subsequent amputations, different causes of amputation, or the source 
used for death registration can also influence these rates. Unfortunately, this 
information is not always clear, limiting our ability to make valid comparisons 
across studies. 
With treatment options for wound care and at-risk limbs continually 
changing8 the mortality risk and profile of people with LLA is also likely to differ. 
From the perspective of planning and providing rehabilitation services, the 
characteristics of the population surviving to different time points can provide 
valuable insight. Understanding the timing and reasons for mortality after 
amputation in different subgroups may also help to identify specific risk factors 
and open new ideas for pre- and post-operative care. The aims of this study were 
to ?etermine 30-day, I -year, and 5-year mortality rates after a first amputation, 
at or proximal to transtibial level in our region. Differences by population 
characteristics including level of amputation, age groups and diabetes status are 
explored, along with major comorbidities, medical and surgical history, and 
admission and discharge settings. 
Methods 
The medical ethics committee of the University Medical Centre Groningen ruled 
that a formal approval was not required for this retrospective medical record 
review. 
Setting and population 
The study was conducted in all 14 hospitals of the three Northern provinces 
of the Netherlands: Groningen, Friesland and Drenthe. This region had a total 
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population of approximately 1. 7 million people in the inclusion period, with 
around 14% aged over 65 years in the study period.9 
Each hospital compiled a list of all people who had an amputation at a 
transtibial level or proximal, in 2003 or 2004. Changes to recording of data were 
instigated in 2005 which affected the reliability of data in the years following. 
With this in mind, and to allow for a sufficient follow up time, the period 1 
January 2003 to 31 December 2004 was chosen. The incidence of amputation in 
this setting was reported previously at 8.8 per 100,00 person-years. 10 
Medical records for all cases were reviewed between August 2010 and June 
2011. People who had undergone amputation at transtibial level or proximal, 
on either limb, before 1 January 2003 were excluded. People with a previous 
amputation distal to, and including, ankle disarticulation were included. Where 
multiple amputations occurred within the study period ( either re-amputation to a 
higher level or a bilateral amputation), the first amputation was used to calculate 
time to death. Amputations that were the result of trauma, cancer, complex 
regional pain syndrome or congenital causes were excluded, thus leaving a cohort 
with amputation resulting from vascular disease, infection and/ or diabetes. 
Amputation date, side and level (unilateral TT, unilateral proximal (KD or TF), 
or bilateral) were recorded for the study period, as well as any amputations 
performed in the years following. 
Variables 
The primary dependent variable was time to death. The date of death was 
recorded from hospital records, or the general practitioners were contacted for an 
updated status (alive or date of death) in August 2011. 
Characteristics of the population included as independent variables were: age; 
sex; marital status ( dichotomised as partner or alone (includes single, widowed, 
divorced)); the living situation prior to admission for amputation (home, 
nursing home, other); discharge destination (home, inpatient rehabilitation 
centre, nursing home, supported residential home, other hospital, or died before 
discharge); and smoking history (ever, never). Medical diagnoses were based on a 
list of items from the Charlson Comorbidity Index (ICD9 codes stated). The most 
frequent diagnoses were presented under combined groups of: Cardiac disease -
myocardiac infarct ( 410, 411), congestive heart failure (398, 402, 428), or history 
of coronary artery bypass graft; Cerebrovascular disease (430-433, 435); Lung 
disease (491 - 493); Renal disease (403, 404, 580-586); and Diabetes Mellitus 
(250). 
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Where a diagnosis was unclear, details (including medications) were noted 
and discussed with a medical specialist for clarification. In addition, it was 
noted if a patient had diabetes type I or type II and whether they were receiving 
dialysis. Surgical history was recorded and included previous peripheral 
vascular procedures (e.g. bypass or angioplasty) as well as any previous minor 
amputations. 
Time to death, in months, was calculated from the date of the first 
amputation. The last confirmed date of contact with medical care (hospital or 
general practitioner) was recorded for censored data. People who had bilateral 
or re-amputations were combined to one category, multiple major amputation, 
with the underlying notion that these cases had undergone multiple hospital 
admissions, anaesthesia and surgery, probably giving them a different mortality 
risk than people with single amputations. This categorisation procedure was 
chosen to enable sufficient numbers in each group for analyses. 
Statistical analysis 
To consider differences in mortality for the different population characteristics, 
data were first explored for a Cox hazard model. However, the hazard ratios were 
not proportional over time, and thus assumptions for using this model were not 
met. Instead, survival was analysed using Kaplan-Meier curves and stratified Log 
Rank tests to check for differences across independent and combined categories 
of sex, age, level of amputation and diagnosis of diabetes. Missing data were 
right censored at the last confirmed contact date; missing data were not imputed. 
Characteristics of the population who died at 30-days, I -year and 5-year were 
compared to those who survived using x,2 tests for categorical variables and t-test 
for age (normal distribution). Variables with P<0. I were included in logistic 
regression models (stepwise backward logistic regression) with 30-day, I -year 
and 5-year mortality (yes or no) as the dependent variable. Discharge destination 
is presented for descriptive purposes but not included in model due to overlap 
with the category 'death before discharge: Statistical significance for analyses 
was 0.05 (two-sided). Analyses were performed using Microsoft Excel 2003 and 
SPSS 20. 
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Table 1: Characteristics of included population, with comparison of 
people with diabetes and people without diabetes. 
Variable (n) Included Diabetes No diabetes pa 
Level (298) n % n % n % 
Transtibial 146 (49) 83 (56) 63 (42) .020 
Knee disarticulation 27 (9) 12 (8) 15 ( 10) 
Transfemoral 101 (34) 39 (26) 62 (42) 
Bilateral 24 (8) 15 ( 10) 9 (6) 
Sex (299) 
Men 178 (60) 83 (55) 95 (64) . 138 
Women 121 (40) 67 (45) 54 (36) 
Ageb (299) mean (sd) mean (sd) mean (sd) 
Al l 74.1 (1 1 .2) 73.4 ( 10.5) 74.7 ( 1 1 .8) .355 
Men 72.1 ( 10.6) 71 .1  ( 1 0.8) 72.9 (10.4) .266 
Women 77.0 ( 1 1.5) 76.4 (9.5) 77.7 ( 13.6) .5 15 
Admitted from (276) n % n % n % 
Home 177 (64) 90 (65) 87 (64) .829 
Care 99 (36) 49 (35) so (37) 
Living situation (239) 
Alone 139 (58) 79 (64) 60 (52) .050 
Partner 100 (42) 44 (36) 56 (48) 
Discharged to (294) 
Home 42 ( 1 4) 24 ( 1 6) 18 ( 12) .371 
I npatient rehabilitation 40 ( 14) 1 9  ( 1 3) 21 ( 1 4) 
Care 156 (53) 82 (55) 74 (51) 
Died before d ischarge 56 ( 19) 23 ( 1 6) 33 (23) 
Medical history (299) 
Cardiac disease 1 1 4 (38) 57 (50) 57 (50) .964 
Cerebrovascular disease 44 ( 15) 22 ( 1 5) 22 ( 15) 1.000 
Chronic lung disease 66 (22) 30 (20) 36 (24) .403 
Renal disease 59 (20) 39 (26) 20 (13) .006 
Smoking (228) 
Ever 137 (60) 56 (68) 81 (52) .016 
Never 91  (40) 52 (33) 39 (48) 
Surgical history 299) 
Peripheral vase. procedure 150 (50) 68 (45) 82 (55) .093 
� 1 minor amp pre-major 46 ( 1 6) 48 (32) 14 (9) <.001 
> 1 major (either l imb') 68 (23) 36 (24) 32 (22) .35 1  
Variable (n) = number of valid observations fo r  the stated variable; medical and surgical history were yes 
or not recorded so calculations are based on whole population of 299. a p is x2 of people with diabetes 
compared to people without diabetes; bcomparison of age by gender: with diabetes men versus women 




Of 338 cases of LLA identified, 299 were due to a vascular, infection and/ or 
diabetes related cause and were included for analysis (table 1). The majority of 
cases were men (60%), the mean age was 74.1 years and TTA was most frequent 
(49%). Most people were admitted from home (64%), with many living alone 
(58%). Discharge to care was most common (53%), with 19% not surviving to be 
discharged from the hospital. 
Diabetes was diagnosed in 50% of the population. People with diabetes 
had twice as many TTA (56%) than TFA (26%), significantly different to people 
without diabetes (TTA and TFA both 42%; P=.020). Renal disease was more 
prevalent in people with diabetes (26%) than people without (13%, P=.005), 
with no differences seen between these groups for other diagnoses. Previous 
minor amputations were significantly more likely for people with diabetes 
(32%) than people without diabetes (9%, P<.001), whereas frequency of vascular 
reconstructive procedures was similar in the two groups ( 45% in diabetes 
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Based on information presented in table 2, diabetes n = 143 total, 120 died; non-diabetes n 
= 140 total 111 died. Median (se) survival for people with diabetes = 25.0 (5.8) months, non­
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Table 2: Cumulative % of people who died at key time points, and median 
survival estimates (months). 
% dead Survival (months) 
N• (event) 30-day 1 -year 5-year Median se 95% (1 pb 
All 299 2 1 6  2 2  44 77 20.3 3.7 ( 1 3.1 ; 27.5) 
Level 
Uni lateral Transtibial 1 30 1 00 1 7  3 5  7 5  27.8 3.0 (22.0 ; 33.6) .495 
Uni lateral Transfemoral 83 61 27 54 77 1 0.6 4.8 ( 1 .2 ;  1 9.9) 
Multiple Major 66 53 23 45 80 1 6.3 6.8 (2.9 ; 29.7) 
Sex 
Men 1 67 1 30 22 43 76 2 1 . 1 4. 1 ( 1 3.0 ; 29. 1 )  .885 
Women 1 1 6 85 2 1  42 76 25.0 7.3 ( 1 0.8 ; 39.2) 
Age 
< 65 years 59 38 1 9  38 65 26.7 9.9 (7.3 ; 46.0) .028 
65-74 years 77 61 24 45 74 2 1 .3 7 . 1  (7.5 ; 35.2) 
75-84 years 1 03 82 1 5  38 81  25.0 4.1 ( 1 7.0 ; 33. 1 )  
85+ years 44 34 35 56 85 8.8 6.6 (0.0 ; 2 1 .6) 
Diabetes 
No 1 40 1 02 22 45 75 20.7 5.0 ( 1 0.9 ; 30.5) .969 
Yes 1 43 1 1 3  20 41  77 25.0 5.8 ( 1 3.6 ; 36.4) 
Age and Level 
Un i lateral Transtibial 
< 65 years 22 1 4  1 4  24 60 30.8 1 0.1  ( 1 1 .0 ;  50.5) .041 
65-74 years 32 22 1 6  30 7 1  41 .2 1 1 .2 ( 1 9.2 ; 63.2) 
75-84 years 5 1  46 1 2  36 82 26.6 2.7 (2 1 .4 ; 3 1 .9) 
85+ years 25 18 34 45 78 1 2.6 1 3.5 (0.0 ; 39.0) 
Un i lateral Transfemoral 
< 65 years 1 3  1 0  3 1  62 77 8.2 4.9 (0.0 ; 1 7.9) 
65-74 years 26 23 32 64 80 3.4 1 .8 (0.0 ; 6.9) 
75-84 years 3 1  1 8  1 4  35 70 22.2 2 1 .7 (0.0 ; 64.7) 
85+ years 1 3  1 0  45 67 89 2.1 1 .0 (0.0 ; 4. 1 ) 
Multiple Major 
< 65 years 20 1 3  2 1  36 68 37.9 2 1 .4 (0.0 ; 79.9) 
65-74 years 1 9  1 6  27 44 72 30.8 27.3 (0.0 ; 84.4) 
75-84 years 2 1  1 8  24 47 94 1 2.8 1 0.5 (0.0 ; 33.4) 
85+ years 6 6 1 7  67 1 00 8.6 5.8 (0.0 ; 1 9.9) 
a N is total number in category, (event) is number with confirmed death. Not all categories add to 281 due to 
missing data; b P is log rank between categories for median survival time 
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Table 3: Characteristics of population who died at 30-days, 1-year and 5-years 
Varia61e (nJ total 30 days p• 1 year p• S year p• 
Level (266) n %  n %  n %  
Unilateral n 1 30 32 (25) . 1 94 55 (42) .024 1 01 (78) .758 
Unilateral KD/TF 70 30 (36) 51 (61 ) 67 (81 ) 
Multiple major 66 20 (30) 33 (50) 54 (82) 
Sex (283) 
Men 1 67 47 (28) .599 81 (49) .594 1 3 1  (78) .725 
Women 1 1 6 36 (31 )  60 (52) 93 (80) 
Ageb (283) mean (sd) mean (sd) mean (sd) mean (sd) 
Died 74.1 (1 1 .2) 75.8 (1 1 .4) .043 75.3 (1 0.8) .01 5 75.0 (1 0.6) <.001 
Alive 65.7 (1 2.9) 72.8 (1 1 . 1 )  72. 1  (1 1 .5) 68.8 (1 2.2) 
Admitted from (262) n %  n %  n %  
Home 1 72 41 (24) .045 76 (44) .01 5  1 28 (74) .022 
Care 90 32 (36) 54 (60) 78 (87) 
Living situation (226) 
Alone 94 24 (28) .677 44 (47) .981 75 (80) .399 
Partner 1 32 37 (26) 62 (47) 99 (75) 
Discharged to (278) 
Home 41 6 (1 5) <.001 14 (34) .01 0 26 (63) <.001 
Inpatient rehab 37 1 (3) 6 (1 6) 20 (54) 
Care 1 44 24 (1 7) 62 (43) 1 1 9 (83) 
Died before 56 50 (89) 
Medical history (299) 
Diabetes 1 43 37 (26) . 1 97 66 (46) .21 2 1 1 3 (79) .956 
No 1 40 46 (33) 75 (54) 1 1 1  (79) 
Cardiac disease 1 04 33 (32) .499 61 (59) .024 91 (88) .008 
No 1 79 50 (28) 80 (45) 1 33 (74) 
Cerebrovasc. disease 42 1 9  (45) .01 4  2 8  (67) .01 8 36 (86) .257 
No 241 64 (27) 1 1 3  (47) 1 88 (78) 
Lung disease 61 17 (28) .777 31 (51 ) .861 52 (85) .1 86 
No 222 66 (30) 1 1 0  (50) 1 72 (78) 
Renal disease 58 19 (33) .520 38 (66) .007 54 (93) .003 
No 225 64 (28) 1 03 (46) 1 70 (76) 
Smoking (21 8) 
Ever 1 31 43 (33) .234 65 (50) .598 1 02 (78) .883 
Never 87 22 (25) 40 (46) 67 (77) 
Surgical history (299) 
Peripheral vase. proc 1 41 35 (25) .097 63 (45) .085 1 1 0 (78) .639 
None 1 42 48 (34) 78 (55) 1 1 4 (80) 
:2: 1 minor amp. 61 13 (21 ) . 1 20 24 (39) .065 49 (80) .799 
Variable (n) = number of valid observations for the stated variable; medical and surgical history were yes or not 
recorded so calculations are based on whole population of 299; a P isx2 with survivors and non-survivors; bt-test 
for age with survivors and non-survivors; not al l  variables add to 299 (population total) due to missing data. 
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Table 4: Final logistic 
B (se) p OR 95% Cl 
regression models for 
variables associated 30-day death -1.20 (0. 17) 
with 30-day, 1 -year Cerebrovascular disease 0.85 (0.35) .016 2.34 1 .17 ; 4.68 
and 5-year death. Age (centred at 70 years) 0.02 (0.0 1 ) .070 1.02 1 .00 ; 1 .05 
1-year death -0.43 (0. 1 8) 
Renal disease 1 .26 (0.35) <.001 3.53 1 .79 ; 6.96 
Age (centred at 70 years) 0.04 (0.01) .002 1.04 1 .02 ; 1 .07 
Cerebrovascular disease 0.93 (0.38) .013 2.55 1 .2 1 ; 5.34 
Minor amputation (pre-major) -0.70 (0.32) .030 0.50 0.27 ; 0.93 
5-year death 0.79 (0. 1 9) 
Renal disease 1 .68 (0.56) .003 5.35 1 .79 ; 1 6.0 
Age (centred at 70 years) 0.05 (0.01) <.00 1 1 .05 1 .02 ; 1.08 
Admitted from care 0.62 (0.37) .099 1 .90 0.89 ; 3.85 
Final model fit from backward stepwise LR presented. OR =odds ratio 
Nagelkerke R square 30-day=.050; 1-year=.143; 5 year =. 159 
Mortal ity 
Mortality data were unable to be found for 30 (10%) people. Fourteen could 
not be traced at all following their discharge from hospital and 16 were not 
known by the general practitioner listed in their file. These cases, with unknown 
status, were older than people with a confirmed status (known=73.6 (11.0) 
years, unknown=78.0 (12.1) years, P=.044), with no significant differences in sex 
(P=.095) or level of amputation (P=.088). Although death could be confirmed, 
the date was missing for 16 (5%) people. 
The median time to death was 20.3 months (95% CI: 13.1 ; 27.5) (table 2) . 
For people with unilateral TTA, time to death was longer at 27.8 months (22.0 ; 
33.6), and for TFA shorter at 10.6 months (1.2 ; 19.9) (median survival time by 
level, p=0.495). Significant differences between median survival time were seen 
by age groups. People aged 85+ years survived a median 8.8 months, while the 
remaining younger age groups all survived 20+ months, P=.028). Combining age 
and level, people with unilateral TFA aged 75-84 years had significantly longer 
survival times (22.2 months) than younger (3.4 months) and older (2.1 months) 
people with TFA. No differences were seen for people with or without diabetes 
(figure 1) . 
Twenty-two percent of the population died within 30-days. Factor 
significantly associated with 30-day mortality were age, location admitted 
from, previous peripheral vascular procedure and cerebrovascular 
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disease (table 3) .  The odds of death within 30-days were 2.3 times greater for 
those with cerebrovascular disease compared to those without (95% CI: 1.17; 4.68, 
P=.016) (table 4) . 
After one year, 44% of the population had died. Variables associated with 
mortality were age, location admitted from, previous peripheral vascular 
procedure or previous minor amputation and a diagnosis of cerebrovascular, 
renal or cardiac disease. People with renal disease had 3.53 times greater odds 
of death at one year than people without (95% CI: 1.79; 6.96, P<.001) and 
cerebrovascular disease 2.5 times greater odds of dying than people without (95% 
CI: 1.21; 5.34, P=.013). The five-year mortality rate was 77%, with renal disease 
presenting 5.35 times greater odds of dying (1.79 ; 16.0, P=.003). 
Discussion 
Against a background of changing treatment options for limb salvage, we aimed 
to review the effect this has on mortality rates for the population who go on 
to have a transtibial or proximal amputation. The mortality rates reported in 
this study demonstrated the frailty of the population, with 22% of people dying 
within 30 days. It has been suggested that LLA in people with vascular disease 
might be performed as pain relief at the end stages of care. 6 Our results, with a 
high post-operative mortality, are in line with that suggestion. Equivalent rates 
have been reported in Scandinavian studies with 19-30% of people dying in the 
first month after LLA, 1•6•7 while in other, comparable western populations this 
is reported to be much lower, around 10%.3.4·1 1•14 Investigation of underlying 
influences from health services, surgical decisions and patient motivations 
behind decisions to amputate might help to explain some of the differences in 
post-operative mortality rates between studies. As an example, a poorer mortality 
outcome has been found when there are in-hospital delays in decision making. 15 
Similarly, the health seeking behaviours of different populations should be 
explored for their influence on time to presentation for treatment. 
For those who survive the post-operative period, mortality outcomes were 
more consistent with other studies. After 1 year, 44% of the population had died, 
falling mid-range of results in literature at 30-50%. 1•6•12• 13•16 The 77% mortality rate 
at 5 years was higher than previous findings of 56-70%.4•13•14 Direct comparisons 
of these mortality outcomes are problematic owing to the differences in 
populations and reporting. However, the rates do serve to highlight the variability 
in outcomes from reporting different populations and emphasise a need to 
carefully review the included population before applying results in clinical, 
research or other contexts. 
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Diabetes remains the leading cause of major lower limb amputation. 17 The 
disease process differs from other vascular-related causes and tends to result 
in transtibial or distal amputation levels. With this, the influence of diabetes 
on survival has been described as time-dependent, with short term rates being 
the same or better than people without diabetes but worse in the long term.2•3 
Other authors, including the current work, have found no difference in mortality 
rates for people with diabetes compared to people without diabetes at any time 
point. 6•18 These conflicting findings between studies of diabetes and mortality, 
may again arise from population differences, such as inclusion of non-vascular 
amputations or people undergoing (partial) foot amputation.5 Outcomes 
should ideally be reported separately for both the underlying cause and level of 
amputation (in addition to diabetes status), to avoid the bias resultant from non­
vascular and mixed-level populations. In the case of a first amputation proximal 
to the ankle, resulting from a vascular or infection related cause only, there was 
no influence of diabetes diagnosis on mortality rates. 
Survival is generally described with negative wording, such as 'dismal.' 1 3•19 Yet, 
considering the population as frail and elderly, perhaps a more positive angle 
should be stressed; almost one quarter of our cohort survived to 5 years. There 
should be a focus on finding determinants of survivors to enable rehabilitation 
and long term care services for this group to be well planned. Specifically, 
investigation of people who survived the post-operative period but died 
within one first year, in our case 22% of the population, could lend support to 
rehabilitation programmes aimed at enhancing quality of life during this short 
time. The most important influence on mortality at 30-days was the presence of 
cerebrovascular disease, with renal disease having most influence after 1 and 5 
years. Unfortunately, no other clear determinants of the I-year survivors could be 
found but further investigation of this group is suggested, as they are potentially 
an important population from both surgical and rehabilitation perspectives. 
Complementary to investigating determinants of survival, pre-operative care 
and the timing of amputation should be looked at for its influence on differing 
mortality rates. Less than 50% of our cohort received pre-amputation vascular 
intervention. In the last decade, there have been increasing possibilities for 
limb-salvage by means of both endovascular and surgical techniques.8 It remains 
unclear what effect these interventions may have on the population who go 
on to have an amputation. Along this line, the timing of amputation on both 
mortality and functional outcomes is also of interest. This includes consideration 
of patients who might benefit from having an earlier amputation or foregoing 
amputation entirely and choosing a palliative direction for care. 20 
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A strength of this study design was the population-based setting, which 
covered a wide geographic region. Although the sample of people with 
amputation can be considered of a moderate size, some of the findings from 
subgroup analyses may have been due to insufficient power to detect differences. 
Additionally, data were retrieved directly from the medical files, giving insight 
to information not available in our national database.21 However, a retrospective 
study presents inevitable limitations, and also includes the problem of missing 
data. Specifically, detailed information on the severity of disease and cause 
of death were not reliably available but would provide important additional 
information. Only comorbidities and items that were listed in the medical files 
were recorded and therefore our results may have underestimated the prevalence 
of some of these. An important example is smoking, which was infrequently 
recorded despite its known influence on post-amputation healing and the need 
for revision surgeries. 14 We could not differentiate the cause beyond 'vascular or 
infection related' although the underlying disease processes of diagnoses differ, 
particularly with respect to chronic or acute limb ischaemia. 
Cases that had undergone multiple major amputations were combined to 
one group for analyses, although the mortality risk may differ for people with 
bilateral amputation compared to those who had a re-amputation of the one 
limb. However, in our national database, no differentiation between left- or right­
sided amputations can be made and future work will necessitate this 'multiple­
major' categorisation. Unfortunately, 10% of cases could not be traced following 
discharge from the hospital and a further 5% had a confirmed status but no date 
of death could be traced. As reported in results, unknown cases were older than 
confirmed cases with no significant differences in sex or level of amputation 
seen. Mortality rates were presented as a proportion of known cases, and we 
expect that these estimates would not be largely affected by the unknown cases, if 
anything we may have underestimated mortality rates. 
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Introduction 
Rehabilitation after lower limb amputation (LLA) in long term care (LTC) 
has many positive outcomes, with up to 57% of the population successfully 
discharged within 12 months. 1 After LLA, it is important that rehabilitation begins 
without delay, particularly for older adults, who experience a rapid decline in 
physical conditioning.2 Knowing who will be discharged to a LTC setting enables 
planning to begin immediately, even before surgery. Research from the United 
States and Finland has shown that being- older, being female, living alone and 
having transfemoral amputation increases the chance of discharge to LTc,3-5 The 
aim of this study was to investigate determinants of discharge to LTC after LLA in a 
Dutch setting. 
Methods 
Medical records of all people who underwent a first transtibial (TTA), knee 
disarticulation (Ko) or transfemoral amputation (TFA) due to vascular disease, 
infection or diabetes mellitus between 1 January 2003 and 31 December 2004, 
were reviewed as part of a study on incidence of amputation. The primary 
dependent variable was discharge destination, recorded as LTC or other (home, 
inpatient rehabilitation, supported residential home, other hospital). Independent 
variables included were age, sex, level (unilateral TTA, unilateral proximal (KD 
or TFA), or multiple major amputations), living alone (includes single, widowed, 
divorced) or with a partner, living situation before amputation (care or home) 
and comorbidities (yes, no: diabetes mellitus, cardiac (myocardial infarct, 
cerebrovascular disease, or coronary artery bypass graft), lung disease, or renal 
disease). Variables with p<0. l in bivariate analyses, were included in a logistic 
regression analysis (backward stepwise logistic regression) . 
Results 
Two hundred ninety-nine people with a first amputation were initially included. 
Fifty-six (19%) died before discharge from hospital and were excluded from 
further analyses. The mean age of the population discharged (n=243) was 
74.0± 11.4 years, 146 (60%) were men, 114 (47%) underwent unilateral TTA and 
70 (29%) unilateral TFA or KD. 5 cases had missing data for discharge location. 
Bivariate analyses according to discharge location showed that sex, age and living 
with a partner were all significantly associated with discharge location ( table 
1). Logistic regression analyses showed that older people were more likely to 
be discharged to LTC (� (standard error) 0.053 (0.014); odds ratio = 1.05, 95% 



















Table 1: Long term care Other p 
Determinants 
of discharge to % (n)* 55 ( 1 30) 45 ( 1 08) 
long term care Sex 
after lower limb Women 25 (60) 1 5  (35) 0.03 1 
amputation 
Men 29 (70) 3 1  (73) 
Age 
Mean (sd) 76.5 (9.4) 70.8 (1 2.6) <0.001 
Before amputation 
Lived with partner 25 (48) 30 (58) 0.038 
Lived alone 27 (53) 1 8  (35) 
Level of amputation 
Uni lateral TT 24 (57) 23 (54) 0. 1 39 
Uni lateral TF or KD 1 9  (44) 1 0  (24) 
Multiple major 1 2  (27) 1 2  (28) 
Admitted from 
Home 3 1  (70) 3 1  (71 ) 0.243 
Care 22 (49) 1 6  (36) 
Comorbidities 
Diabetes 3 1  (73) 22 (52) 0.21 8  
Cardiac disease 23 (55) 1 5  (35) 0.1 1 7  
Lung disease 1 4  (34) 1 0  (23) 0.382 
Kidney disease 1 1  (27) 7 (1 7) 0.320 
Characteristics were compared by discharge location (LTC or other) using x2 for 
categorical variables and t-test for age (normal distribution). Variables with p 
< 0.1 were included in a logistic regression model (stepwise backward LR) with 
discharge location as the dependent variable. Statistical significance was set at 
p<0.05 and analyses were performed in SPSS Statistics 20. TT = transtibial, KD = knee 
disarticulation, TF = transfemoral. *not all categories sum to their respective totals 
due to missing data. 
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Discussion 
Older age was the sole factor associated with discharge to LTC. Rehabilitation 
after LLA can take place in a number of settings, but most previous research has 
focussed on inpatient rehabilitation programmes. This setting yields the best 
outcomes in terms of longer survival, a greater chance of receiving a prosthesis, 
greater mobility, being more likely to return to independent living, greater 
medical stability, fewer subsequent amputations and better quality of life.4•6-8 
However, inpatient rehabilitation programmes operate at an intensive level of 
training, which a large proportion of the LLA population is unable to manage 
because of older age and comorbidity. Research of rehabilitation in LTC is gaining 
increasing interest, 1 because it may offer a suitable option for the older LLA 
population. 
It is likely that differences in the model of care provided accounted for the 
different findings in this study from those in the literature. Studies on discharge 
destination are mainly limited to U.S. settings, where a much smaller percentage 
of people were discharged to LTC (18.5-21 %,5•9 vs 55% in the Netherlands). 
No association between amputation level and discharge to LTC4•5 was found in 
the current study. In addition to differences in care models, inclusion of people 
with partial foot amputations in those studies might have contributed to the 
importance of amputation level on discharge, partial foot amputation being a 
less-aggressive procedure performed more frequently in a younger and somewhat 
healthier population. 
This study covered a large regional population of all people undergoing LLA 
over a 2-year period, and findings can be generalised to the Dutch setting, but 
given that the design was a retrospective cross-sectional review, prospective, 
longitudinal studies should be undertaken to confirm the results. In the 
Netherlands, older adults can expect to be discharged to LTC after amputation. 
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Objectives: To describe the current set up, barriers and potential for 
providing rehabilitation to people with lower limb amputation in a long 
term care setting. 
Design: Survey and interviews 
Subjects/Participants: Elderly care physicians, physiotherapists 
Methods: In 2011, clinicians from 34 long term care facilities participated in 
a semi-structured interview covering rehabilitation and daily care, personal 
skills and training, team work and communication, discharge processes. 
Results: Each facility sees only a small proportion of people with amputation 
(maximum of 3.6% of all admissions). This limited number of patients 
appeared the main barrier in providing care, as it is difficult for clinicians 
to maintain knowledge and resources are spread widely. Two main areas of 
improvement were suggested by participants: [a] use of guidelines in care 
and [b] collaboration with specialised team members. 
Conclusion: The spread of patients across many centres makes it difficult 
for professionals working in long term care to obtain skills and knowledge 
for care of people with amputation. A designated facility for amputation 
rehabilitation is presented as a solution but also smaller clinical changes are 
suggested, including improvements in communication and training. 
Introduction 
After a lower limb amputation (LLA), many people enter a rehabilitation 
programme with the aim of learning how to manage changes in physical, 
psychological and social functioning. Rehabilitation can take place in a number 
of settings. People who are enrolled for specialised inpatient rehabilitation 
programmes tend to have better outcomes than those who receive rehabilitation 
in other settings such as home or nursing care. These outcomes include longer 
survival, a higher chance of receiving a prosthesis, improved mobility, being 
more likely to return to independent living, greater medical stability, a lower 
number of subsequent amputations or a higher quality of life.1-5 Inpatient 
rehabilitation programmes are generally targeted toward a population who are 
able to manage an intensive level of training. However, LLA frequently has an 
underlying cause of peripheral vascular disease or diabetes mellitus with most 
people over the age of 65 years. 6•7 Additional comorbidities and changes from 
ageing often result in cognitive and cardiovascular problems that impact a 
person's ability to meet the demands required for participation in high intensity 
rehabilitation. A lower intensity programme, undertaken in a long term care 
(LTC) setting, might offer a reasonable alternative from traditional inpatient 
programmes for elderly people with LLA. 
Admission to a LTC facility after LLA is common in the Netherlands with 
55% of all people who survive the acute hospital phase discharged to this 
setting. 8 As many as 65% return home within one year of admittance for 
amputation rehabilitation.9 The average length of rehabilitation is 81.5 days, 
which is longer than patients with other pathology including stroke (69.1 days) 
and elective orthopedic surgery (40.6 days).10 Around 150 people undergo 
vascular related amputations per year in the Northern Netherlands.1 1 However, 
with more than 34 LTC facilities in the region, very few patients with LLA are 
seen at any one facility. This leads to questions concerning the clinicians' ability 
to maintain adequate skills and knowledge in treatment of this population.12 
Given the large proportion of patients with LLA discharged to this setting, 
the relatively long length of stay and the high costs associated with providing 
their care, it is surprising that so little is known about the actual rehabilitation 
treatment provided. For example, what are the rehabilitation aims and 
expectations on admission? What type of training is provided and with what 
frequency? Do clinicians have the relevant expertise for treating someone with 
LLA? With an increasing expectation to provide evidence based care, this lack of 
information is insupportable. As a starting point, the rehabilitation programme 






















exploration. The aim of this study was to describe the current set up, barriers 
and potential for providing care to people with LLA in a LTC setting. 
Methods 
The Medical Ethics Committee of the University Medical Center Groningen 
determined that formal approval was not required for this study conducted with 
health professionals and LTC administrative data. 
Setting 
There are 34 LTC facilities ((specialist) nursing homes) with a geriatric 
rehabilitation unit in the 3 northern provinces of the Netherlands. The area has 
a population of around 1. 7 million people of which 17% are over the age of 65 
years.13 Elderly Care Physicians (ECP) are a specialisation in the Netherlands 
responsible for the treatment and support of elderly and chronically ill in 
LTC. The project was introduced through presentations at the ECP regional 
professional meetings and in their association newsletter, as well as meetings 
with the ECP and physiotherapists (PT) in their workplace. 
Design 
A mixed methods design was used. Part one of the study involved a 
questionnaire sent to all LTC facilities in December 2009. The questionnaire 
asked how many admissions the facility had in total, how many people were 
admitted with LLA, and the characteristics of this population (sex, date of birth, 
reason for and level of amputation). The period surveyed was from 1 January 
2008 to 31 December 2009. A reminder letter to return the survey was sent in 
early 2010 to all non respondents. Descriptive data are presented. 
Part two involved interviews with the ECPs and PTS in 2011. A series of 
open questions was developed based around 5 key themes: rehabilitation 
and daily care procedures; personal skills and training; communication; the 
multidisciplinary team; and care after discharge. Themes were developed in 
discussion with rehabilitation physicians and ECP over the most common issues 
encountered in clinical practice. Participants were encouraged to respond with 
their own line of thinking on each theme, with prompts given where needed 
(see Appendix A). The interviewer (Aw) was a qualified ECP who was undergoing 
training to become a rehabilitation physician. The interview procedure was 
piloted with rehabilitation physicians from our centre, to ensure there was clear 
understanding of the questions and continuity of the interview. Participants 
were chosen using research-based recruitment,14 from the survey responses 
concerning LTC admission numbers and location. This strategy was designed 
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to include nursing homes with relatively frequent admissions with amputation 
and others with infrequent admissions, as well as an even geographical 
representation across the three provinces. The interviewer contacted each 
professional, explained the project in full and asked if they were able and willing 
to participate. All those approached gave consent. After 3 facilities per region (9 
interviews with ECPs, 9 interviews with PTs), no new information or topics were 
being discussed and data saturation was deemed complete. As such, no further 
interviews took place. Interviews were completed throughout 2011, with an ECP 
and PT from the same facility, separately. The interviews lasted approximately 60 
minutes and were conducted in the participant's workplace during their regular 
work hours. 
Analysis 
The interviews were recorded on tape and transcribed verbatim. Identifying 
information was replaced with descriptors to ensure anonymity for participants. 
Interview transcripts were read by two investigators (LF and GR), to familiarise 
themselves with the data. A coding book was developed by one investigator 
(LF) (using a constant comparison approach) and tested by a second (GR) on a 
full transcript. Discrepancies were discussed; these mainly concerned overlap 
between the codes. Three interviews were then coded in full, independently, 
and inter-coder agreement was reviewed for consistency.14 No substantial 
differences were apparent and the remaining transcripts were coded in full by 
LF and reviewed by GR. Data were then arranged in a matrix according to their 
codes and linked to the different themes. Two investigators (JG and PD), who 
did not participate in the initial coding, reviewed these themes and the data, 
adding their interpretations. A native English speaker (LF) translated all quotes 
presented in results together with a native Dutch speaker (PD) to ensure context 
and nuances were maintained. 
Results 
Survey of facilities 
Seventeen (52%) LTC facilities responded to the survey, reporting on 90 people 
admitted after LLA in a two-year period. Fifty-nine (66%) of the admissions 
were men and 82 (91%) amputations resulted from a vascular cause. The median 
age at admission was 77 years (IQR :  14 years; range 46-100 years). Individual 
facilities admitted between 0 and 19 people in the 2 year period surveyed, which 























19 people participated, 9 ECPs and 10 PTs (one facility had two PTS participate 
together). Participants had a mean age of 44 years (sd=8), worked 30 hours 
per week (sd=7), and had 12 years of experience (sd=8). Seven participants had 
undergone postgraduate training in LLA rehabilitation and prosthetics. The 
main findings from the interviews are presented below, under the subtitles of 
the key themes investigated. 'Teamwork' and 'communication' were combined 
due to overlap in the results and an additional theme 'elderly person with 
amputation' is presented. The results are presented using the words and 
perspective of the participants. 
Elderly person with amputation 
Independent return to home is the main goal of admission to rehabilitation 
in LTC. Patients would otherwise be directed immediately to a long-stay ward. 
Clinicians are aware that rehabilitation outcomes are dependent on many 
factors including the availability of family and home care. People also need a 
high level of intrinsic motivation. If a patient can return home independent 
in transfers and household walking, rehabilitation is considered successful. 
However, most independent people still need substantial help with, for example, 
putting on their prosthesis. 
The expectations of rehabilitation from patients and their families often 
exceed their likely potential. People have little understanding of the physical 
capacity that is required to walk with a prosthesis or the cognitive capacity for 
understanding how to use it safely. However, realising the difficulties they face 
may be part of accepting their LLA. 
"People often have very high expectations. They have their operation and think 
they can just get a prosthesis and walk again. And sometimes it is not going 
to succeed or it is not what they hoped for. So that is difficult. It is a difficult 
conversation." [PHYSIOTHERAPIST) 
In contrast to younger patients, older patients with LLA tend to present 
with a more complex range of comorbidities. Clinicians acknowledge that an 
older patient's life experience can bring value to their rehabilitation. Treatment 
is approached from an open perspective, giving attention to what the patient 
wants to happen. Essentially, you have to look at the person, not their missing 
limb. 
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"The main difference is that in this population there are more things at play. 
The high biological age often has consequences, such as deconditioning, older 
people move less and then even more so after the amputation. You often see 
people are immobile for a long period beforehand. So their whole fitness level 
is much lower. Then there are still other diseases and disorders, and a poor 
psychosocial network. If people live alone and need a prosthesis to go home, 
that's somewhat complex." [PHYs10THERAP1sTJ 
Rehabilitation and daily care 
Although some clinicians describe the older person with LLA as being no 
different from other patients in LTC, differences in treatment were evident. 
The intensity of care, both in time and energy, was a major discussion point. 
Facilities are funded to provide 4 hours of treatment to each patient per week. 
This time is for all treatment: medical, physiotherapy and also other para­
medical treatment. There is no strict adherence to the time allocations, nor is 
there pressure from management staff to adhere; some patient groups simply 
need more time, some less. It was felt that the person with LLA requires more 
time, particularly in the beginning phases of care. The PT alone takes up most or 
all of the 4 hours, in stump management, strengthening exercises and so forth. 
The application of standard protocols or care plans is hampered by both 
the amputation population and by frequently changing clinicians (table 1). The 
population differs too greatly in their presentation, particularly the range of 
comorbidities and cognitive abilities, to apply protocols. However, a basic set of 
guidelines from which to work would be useful. It should be flexible, enabling 
independent choices for individual patients. One example where protocols 
are not used is clinimetric measures. They are used for other conditions, 
particularly stroke. The reliability of performing the tests with a prosthesis was 
questioned, but also the overall value for a patient's treatment or care was not 
seen. 
Personal skills and training 
The ECPs/PTS described knowledge as being more important than any specific 
skill. Attendance at a training course in prosthetics and amputation was a stand 
out factor for gaining this knowledge. The people who had participated in a 
course for amputation rehabilitation have confidence in what they are doing, 





















Table 1 :  Ba rriers in provision of amputation rehab i l itation 





"(Amputation rehabilitation) is based a lot on clinical intuition. We have to 
wait a bit and just see what happens." [PHYSIOTHERAPIST] 
"We need a much stricter protocol. Then we could take admission 
and discharge measurements, yes, I think that would actually be 
very good. But again it takes time and I think the current quality 
of rehabilitation depends on the fact we only see three or four 
(amputation) patients per year. That's not many; perhaps if we saw more 
patients, we would be more inclined to change." [ELDERLY CARE PHYSICIAN] 
Lack of involvement 
and special isation from 
multid iscipl i nary team 
members 
"Better training of clinicians in the department is needed. 
This is actually very important; it's what I really miss. Things 
are often missed simply because people don't know, for 
example how the liner should be fitted or how the prosthesis 
should sit. Yes, these things mostly, these are things that 
quite often go wrong." [PHYSIOTHERAPIST] 
Case mix - lack 
of patients with 
amputation seen 
in each faci l ity 
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"Well, for us, what is very clear in the nursing home is that the 
rehabilitation physician and physiotherapist take care of someone with 
an amputation. We (elderly care physicians) take care of the wound." 
[ELDERLY CARE PHYSICIAN] 
"I would like better cooperation with occupational therapy. I don't mean to 
say that it is their fault, but working together as a team we could better assess 
what is necessary for someone to go home, use of a wheelchair and also 
the prosthesis, and we could better streamline their care." [PHYSIOTHERAPIST] 
"I'd like to see more patients with amputation. I would really like to 
encourage more to come here. With experience, we get more experienced." 
[ELDERLY CARE PHYSICIAN] 
"I'd like to see better training of the nurses, but then you run into the 
problem of seeing so few patients (with amputation), simply because 
there is only 5 or 6 per year, and with the varying nursing staff, it's 
just a question of which patients they happen to see." [PHYSIOTHERAPIST] 
"Well the best thing really would be if you could have a little section where 
the care is very specialised, because every time (there is an amputation 
admission) we spend quite a lot of time teaching others how to care for 
those (patients) in the right way. It costs a lot of energy, but there are just 
too few people with amputation admitted here." [PHYSIOTHERAPIST] 
control, technical aspects of prostheses, etc), frequently helping colleagues with 
problems. Patients may even be referred to a particular centre because of this 
knowledge and experience. 
General skills that are important in treatment of people with amputation 
included geriatric assessment skills and specifically, assessment of patients from 
a 'geriatric' viewpoint. Assessment should include questions about the patient's 
wishes, the home situation and function prior to amputation. Thinking from a 
functional perspective was emphasised, so not always focussing on what might 
be technically correct but rather what is important or needed for the patient. For 
example, the ability to perform independent transfers and walking to get from 
A to B is more important than how well they do it. Patience is a vital skill, as 
this population need intensive care for their rehabilitation training, which can 
continue for a long time. Skills in working as a team are needed, with colleagues 
frequently discussing situations and problem solving together. 
To maintain knowledge and skills it is important that people with 
amputation are seen on a regular basis. Participants found it difficult to answer 
the question "what is the minimum number of patients needed per year to 
maintain skills and knowledge?" and responses ranged from unknown, 2, 5 and 
up to 20 per year or even weekly. Seeing more patients with amputation might 
help to maintain the working partnerships with other ( external) professionals. 
The problem of too few patients was consistent throughout all facilities with 
no major differences seen in the responses given throughout the interviews by 
clinicians working where relatively more or less people are admitted with LLA. 
Teamwork and communication 
The PTS have a key role in the care of people with amputation. They take charge 
of decisions concerning amputation rehabilitation. In particular, they act to refer 
patients in a timely manner to an appropriate professional, such as the surgeon 
or wound care specialist. This 'signalling role' occurs naturally as they spend the 
most time with the patients. The ECP is responsible for medical care, directing 
family meetings and external communication, including discussion with other 
medical specialists, the general practitioner (at admission and discharge) or the 
surgeon (rarely, as needed e.g. wound healing problems) .  Some ECPs describe 
wound care as the limit of their 'amputation role' and beyond that they are 
responsible only for medical management. They were quick to refer any and all 
amputation issues to the rehabilitation physician or PT. This was also apparent in 
the interviews, with amputation questions answered with 'you can better ask the 
PT: Other ECPS tried to ensure they have a wider range of amputation knowledge, 
























The role of the rehabilitation physician varies from having all decisions 
and issues concerning the LLA referred directly to them and the LTC facility 
wanting more direct face time, to the feeling that the ECP can manage most 
issues themselves and questioning how much value for money having a more 
intense presence from the rehabilitation physician would give. Other allied 
health professionals are available onsite in the LTC. Occupational therapists have 
only a small role in the care of people with amputation, covering wheelchair 
prescriptions and a home visit before discharge. Social workers, psychologists, 
dieticians, and other therapists are consulted if needed but the general feeling is 
that there is a lack of knowledge about amputation and most care falls back on to 
the PT. 
There is a weekly multidisciplinary team meeting in all facilities with patients 
discussed regularly. The rehabilitation physician and prosthetist attend fortnightly 
or monthly clinics. Most discussion occurs between these structured meetings. A 
feature of communication was the informal nature of relationships and flexibility 
from team members. The PTs and ECPs freely approach each other at any time 
enabling prompt resolutions to problems. The whole team goes out of their way 
to assist others, with training, advice or flexibility in care such as the prosthetist 
dropping by the nursing home before or after work. 
Many of the nursing professionals work part-time or shift work. Knowledge 
may be passed on, e.g. a nurse is instructed by the PT in bandaging or safe­
transfers, but that person may not encounter the patient again. This is one of 
the main differences from inpatient rehabilitation, where an entire unit may 
be dedicated to LLA with all nursing, medical and paramedical professionals 
'specialised' in the condition. 
Care after discharge 
The general practitioner, rehabilitation physician and prosthetist are the key 
contacts for patients after discharge. Some patients continue in the LTC in 
outpatient care. Others are referred to community PT. The relationship with 
external clinicians is good with referrals and handover back and forth. External 
health providers are generally chosen by locality. Some people had concerns over 
not knowing about the community PT's skills or interest areas and that once a 
patient is discharged they would not hear anything more. Having the option to 
bring patients back 2-3 months after discharge would be good to 'top-up' their 
rehabilitation. In other disciplines, particularly stroke, there is more coordination 
in the community setting, but there are too few people with LLA for this to work. 
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Discussion 
This study aimed to provide an overview of the current treatment for people with 
LLA admitted to LTC in the Northern Netherlands to identify the barriers and 
potential for providing evidence based care in this setting. Internationally, there 
is an increasing need to find cost-effective rehabilitation options for people with 
amputation with different approaches of current interest and importance. Dutch 
LTC differs from other systems, in particular the medical specialisation of ECPs 
and presence of onsite multidisciplinary rehabilitation teams offering geriatric­
tailored treatment. The influence of rehabilitation setting on outcomes has been 
investigated in reference to other conditions in older people, mostly orthopaedic 
disorders and stroke. The clinicians interviewed recognised that treatment for 
these other conditions, particularly stroke, is stronger with better planning and 
coordination of care. Outcomes of amputation rehabilitation have mainly been 
looked at from the perspective of traditional inpatient care. Two recent studies 
showed that good outcomes from LTC can be achieved, particularly in terms of 
independent discharge to home, with rates of 57-65% within one year, greater 
pre-amputation function being a key factor for success. 12•1 5  Despite these positive 
outcomes, it appears that the current rehabilitation process in LTC is largely 
unsustainable, certainly within the Dutch setting, with the burden of care falling 
largely to PTS. 
Two key areas to improve stood out: [a] the need for use of guidelines in 
care and [b] a wider collaboration with specialised team members. There were 
no protocols or guidelines in use for people with amputation in LTC, which was 
attributed to the highly variable nature of the patients presentation. However, 
the idea of having some guidance was very much supported. Guidelines for 
management of people with amputation are available16 and these guidelines 
should be reviewed for their applicability to the LTC setting. Rehabilitation after 
LLA benefits from a multidisciplinary team. 16 The set up of Dutch LTC with an 
onsite multidisciplinary team enables comprehensive provision of a range of 
services specific for the geriatric population. Despite this team available, PTS 
work largely in isolation concerning issues related to patients with amputation, 
with referral to rehabilitation physician and prosthetist when necessary. The PTS 
find it quicker and easier to do something themselves, for example, they take 
charge of bandaging the limb rather than re-training nursing staff with each 
new amputation admission. Other potentially valuable professions, in particular 
nursing and occupational therapy, lacked knowledge of rehabilitation for people 
with amputation. Nurses can provide essential support between PT sessions 
























The tendency for the PT to take on a substantial amount of the responsibility is 
perhaps one of the reasons why the 'intensity' of care was described so strongly 
for this condition. 
The issues raised make it difficult to provide efficient care to people with 
amputation in the LTC setting. One solution would be to designate an amputation 
rehabilitation facility in each province. This would offer advantages such as 
an increased number of patients with amputation, more specialisation by 
professionals, and stronger relationships with external colleagues. However, the 
aversion of people to travel away from their local area may prevent this success, 
particularly if applied to a larger geographical setting. Other small changes can 
be readily implemented, for example annual training for the PTS and the set up 
of a partnership with a larger rehabilitation centre. This training and formalised 
access to support from a specialist can address weaknesses in the PT's skills 
and knowledge. It will not reduce the burden in care provision but provide 
the tools for them to better manage. Finding methods to capitalise on other 
multidisciplinary team members available in LTC should be a priority. 
The high expectations of the patient and family were one of the only 
negative aspects described. Early involvement of the rehabilitation physician 
is recommended, including pre-operative consultation where appropriate. 16 
Although a successful outcome cannot be reliably predicted, the rehabilitation 
physician has the experience to provide education and advice to the patient about 
likely outcomes and what to expect from the rehabilitation process. 
We investigated centres with many and few amputation admissions expecting 
to see differences in the issues raised. Surprisingly, this was not the case, with 
all more or less in agreement. We suspect this is because even those centres 
with relatively more amputation admissions still only see one patient every few 
weeks or months, so the problem of having too few patients remains. The issues 
described by participants were remarkably similar across the different facilities 
with data saturation reached after 18 interviews. We hope this will provide some 
positive and interesting discussion points for the clinicians involved in enabling 
changes in the near future. 
Some limitations of the study need consideration. The response to the survey 
was low at only 50%. Nevertheless, it provided the insight we needed to ensure 
that facilities which admitted a larger and smaller number of people with LLA 
were included for interviews. The study was conducted in Dutch LTC settings, 
which offers onsite multidisciplinary rehabilitation. This approach differs from 
other developed countries limiting generalisation to other settings. Finally, there 
was a potential for bias introduced by the interviewer who was a rehabilitation 
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specialist in training but also a former ECP. Given the descriptive nature of the 
questions we do not believe this connection provided any substantial influence 
over the participant's responses. 
Conclusions 
This study shows that although current care of people with amputation is 
associated with good outcomes it is, to a large extent, dependent on the problem 
solving abilities, energy and empathy of the individual clinicians involved. With 
funding agents requiring greater evidence and accountability in decision making, 
the current care appears unsustainable. Each LTC facility sees a relatively small 
proportion of people with amputation. This spread of patients across many 
centres makes it difficult for professionals to obtain and maintain skills and 
knowledge for care. A designated LTC facility for amputation rehabilitation is 
presented as a solution but also smaller clinical changes are suggested, including 
improvements in communication and training. 
Acknowledgements 
We thank al l  participating professionals for their time and efforts in completion of surveys and interviews. We 
also thank Froukje Boersma for her involvement in development of the study, and Koen Esselink for his help 
























(1) Czerniecki JM, Turner AP, Will iams RM, et al. The effect of rehabilitation in a comprehensive inpatient 
rehabilitation unit on mobility outcome after dysvascular lower extremity amputation. Arch Phys Med Rehabil 
2012;93:1384-1391. 
(2) Kurichi JE, Small DS, Bates BE, et al. Possible incremental benefits of specialized rehabilitation bed units 
among veterans after lower extremity amputation. Med Care 2009;47:457-465. 
(3) Stineman MG, Kwong PL, Ku richi JE, et al. The effectiveness of inpatient rehabilitation in the acute 
postoperative phase of care after transtibial or transfemoral amputation: study of an integrated health care 
delivery system. Arch Phys Med Rehabil 2008;89:1863-1 872. 
(4) Dillingham TR, Pezzin LE. Rehabil itation Setting and Associated Mortality and Medical Stability Among 
Persons With Amputations. Arch Phys Med Rehabil 2008;89:1038-1045. 
(5) Pezzin LE, Dillingham TR, MacKenzie EJ. Rehabilitation and the long-term outcomes of persons with trauma­
related amputations. Arch Phys Med Rehabil 2000;81 :292-300. 
(6) Moxey PW, Gogalniceanu P, H inchl iffe RJ, et al. Lower extremity amputations--a review of global variability 
in incidence. Di abet Med 201 1 ;28:1 144-1 153. 
(7) Ephraim PL, Dillingham TR, Sector M, et al. Epidemiology of limb loss and congenital limb deficiency: a 
review of the literature. Arch Phys Med Rehabil 2003;84:747-761 .  
(8) Fortington LV, Dijkstra PU, Geertzen JHB. Determinants o f  discharge to  long term care after lower limb 
amputation. J Am Ger Soc 2013; 61: 298-299. 
(9) Spruit- van Eijk M, van der Linde H, Bu ijck B, et al. Geriatric Rehabilitation of lower limb amputees: a 
multicenter study. Disabil Rehabil 2012;34:145-150. 
(10) Peerenboom PBG. Rehabilitation in the AWBZ (general act on exceptional medical expenses) (Dutch: 
Revalidatie in de AWBZ: Omvang, aard en intensiteit). 2008. Available online at: http://www.vumc.nl/, accessed 
March 2012. 
(1 1 )  Fortington LV, RommersGM, van Netten SJJ, eta I. Lower limbamputation in Northern Netherlands; unchanged 
incidence from 1991 -1 992 to 2003 2004. Prosthet Orthot Int. Early on line DOI: 1 0.1177/0309364612469385 
( 12) Spruit- van Eijk M, van der Linde H, Bu ijck B, et al. Predicting prosthetic use in elderly patients after major 
lower limb amputation. Prosthet Orthot Int 2012;36:45-52. 
(13) Central Bureau of Statistics, Netherlands. [database on the Internet] Accessed March, 2012. Available at: 
http://www.cbs.nl. 
(14) Hennick M, Hutter I ,  Bailey A. Qualitative research methods. London: SAGE Publ ications; 201 1 .  
(15) Hershkovitz A ,  Dudkiewicz I ,  B ri l l  S. Rehabilitation outcome of  post-acute lower limb geriatric amputees. 
Disabil Rehabil 2012  June [Epub ahead of print] 
(16) Netherlands Society of Physical and Rehabil itation Medicine. Draft guidelines in amputation and lower 
extremity prosthetics (Dutch: Conceptrichtlijn amputatie en prothesiologie onderste extremiteit). VRA - Dutch 
Association of Rehabil itation Physicians; 2011. Available on line at www.cbo.nl, accessed August 2011. 
(17) Spil iotopoulou G, Atwal A. Is occupational therapy practice for older adults with lower limb amputations 
evidence-based? A systematic review. Prosthet Orthot Int 2012;36:7-14. 
68 
Appendix A: Interview guide 
Describe the aims of the interview and ask if there are questions 
Remind participants that their responses are given in  confidence and wi l l  be anonymous. 
Ask permission to record interview. 
Demographic data 
Personal detai ls - age, sex, etc 
Working deta i ls - years in present position, hours worked, etc 
Specia lisation - tra in ing and additional relevant information 
TOPIC 1: Personal ski l ls and training 
Are there any special ski l ls needed for treatment of elderly people with amputation? 
Descriptions. 
Have you and where did you learn these skil ls? 
Do you feel that you have sufficiently mastered these skil ls? Have you followed any extra 
training? 
How many patients do you think you need to treat to maintain these ski l ls? 
TOPIC 2: Rehabil itation and dai ly care 
Who is involved in rehab? What are their tasks? Who is responsibi le for the patient's treatment? 
Do you thin k  there are arguments for special treatment of the elderly with LLA? Or  not? 
Do you use treatment protocols I guidelines? 
What is the frequency of therapy? Who determines the frequency? 
Are patients encouraged to use a prosthesis? Who decides whether the patient wi l l  be fitted 
with a prosthesis? Who prescribes? 
How involved are the nursing / care staff in the rehab? Examples - wound care, bandaging, 
compression, stump inspection, donning and doffing prosthesis, transfer tra in ing. 
What do you see as the main goals of rehab for people with LLA in  this setting? 
Do you use outcome measurements? Berg balance scale, sit-up-and-go, Barthel index. 
What resources are available for rehab of people with LLA? What is missing? Do you have a wish 
list? 
TOPIC 3: Communication 
How does the team communicate over patient's rehab? Consu lts, writing, phone, email, in 
person? 
How is the relationship with physio and ECP? Other team members? Professional or  personal? 
Are there any problems in  communication? With patient, nursing, family . . .  
What happens i f  there are problems? Would you l ike t o  see anything d ifferent? 
TOPIC 4: Team work / collaboration (external to LTC team) 
Who else is involved in the rehab of the person with LLA? 
What is the role of the general practitioner when their patient is admitted for rehab? Are they 
involved? 
How is the cooperation/communication between yourself and other team members? 
TOPIC 5: Discharge / and fol low up 
What / who determines when the patient can be discharged? 
Where is discharge paperwork/ letter distributed? 
Are there any problems / difficulties with discharge process? 
Who is responsible for fol low-up care if p roblems arise after discharge? Does the patient know 
who to contact with questions or problems? 
Concluding 
Do you have other issues /suggestions related to the care of the elderly patient with amputation, 
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Abstract 
Objective: To describe changes in health related qual ity of life in people 
with lower l imb amputation from time of amputation to 18 months, with 
consideration of the influence of age and walking distance. A comparison of 
quality of life in people with amputation to Dutch population norm values 
is also made. 
Design: Multicentre, longitudinal study 
Subjects: Al l  people undergoing first amputation: 1 06 were referred, 82 
were included (mean (sd) age 67.8 years (1 3.0), 67% men) .  35 remained in 
the study at 1 8  months. 
Methods: Dutch language RAND-36 questionnaire was completed at time 
of amputation, 6 and 1 8  months after amputation. 
Results: A significant improvement with time was seen in physical function, 
social function, pain, vitality, perceived change in health (all p<0.001 ) .  
People over 65 years had a poorer outcome compared to people <65 years 
on ly for physical function (p<0.001 ). Walking distance was associated with 
improved scores in social function (p=0.047) . 
Conclusions: Quality of life improved significantly in 5 of 7 domains 
investigated; most change occurred in the fi rst 6 months. Physical function 
remained wel l below population norm values. Different domains may be 
affected in different ways for older and younger age groups; the source and 
reasoning needs investigation. 
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Introduction 
Lower limb amputation (LLA) results in not only a permanent physical change to 
an individual, but also has an impact on psychological and social well being. The 
changes can affect a range of aspects that contribute to a persons health related 
quality of life (HRQOL). 1-2 HRQOL is an important indicator of overall health. 
Research of people with LLA reflects the growing attention toward HRQOL with 
increasing use as an outcome measure. 3 
HRQOL in people with LLA is generally lower than population norm values 
or control subjects4•5 particularly in physical components.6-9 HRQOL after LLA 
may improve over time; higher scores being reported by individuals with 
a longer duration of time since amputation.10•1 1  However, most studies of 
HRQOL after LLA have been cross sectional in design and include a majority of 
subjects who have lived with their amputation for at least 2 years.4-7,1 1-13 There 
remains a gap concerning the post-operative response and adjustment early 
after amputation. 3•14•1 5  Longitudinal studies, extending beyond the post-acute 
period, are needed to substantiate or refute previous cross-sectional findings. 
Walking distance is thought to play a key role in independence and HRQOL 
for people with LLA. 13 An ability to walk 500m was previously proposed as a 
minimum walking distance needed for independent living.16 It is assumed that 
this independence is associated with having a positive effect on psychosocial 
aspects of HRQOL. However, how the influence of walking distance might change 
over time, and which specific aspects of HRQOL are affected, remain unknown. 
Learning to walk with a prosthesis is a laborious task, requiring cognitive 
ability, conditioning and balance. LLA is most frequently performed in elderly 
people due to chronic peripheral vascular disease or diabetes mellitus. 17 The 
co-morbidities prevalent in this population make regaining walking an even 
more difficult task. There are additional physical, psychological and social co­
morbidities associated with both the underlying cause of the amputation, such 
as cardiovascular disease, contractures and infection, and with ageing, including 
arthritis, social isolation, and a reduced capacity for learning. Walking ability 
in the elderly population is highly varied. 18 The elderly person with vascular 
LLA faces a different set of challenges on HRQOL compared to younger people or 
people with other causes of amputation but it is not clear if there is an association 
between age and HRQOL. 
The aim of this study was to describe changes in HRQOL in people with LLA 
from time of amputation to 18 months, with consideration to the influence of 
age and walking distance. Finally, a comparison of HRQOL in people with LLA to 
Dutch population norm values is made. 
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Methods 
Vascular surgeons from all hospitals of the 3 Northern provinces of the 
Netherlands were requested to refer people undergoing amputation to this 
multicentre, longitudinal study from 1 November 2003 to 30 April 2008. Included 
were people: aged �18years; undergoing primary lower limb amputation 
(transtibial, knee-disarticulation, transfemoral); underwent amputation due 
to vascular disease, infection, or diabetes. Excluded were people who: had a 
previous major amputation on ipsilateral limb; were unable to read/write Dutch, 
were unwell or showed signs of clinical dementia which prevented completion of 
questionnaires; or were recruited >Sdays after the amputation due to the risk of 
recall bias. 
The study protocol was approved by the medical ethics committees of 
participating hospitals. All participants gave informed consent. 
Data collection 
Questionnaires were completed 1-2 days before amputation. In acute cases, this 
was not possible, and patients were included up to 5 days after the operation. 
Questionnaires were sent to participants again at 6 and 18 months post­
amputation. Patients were included up to 1 May 2007; some patients had a 
maximum follow up time of 1 year due to the study end date. 
Outcome measures 
Baseline assessment included characteristics (sex, date of birth) and amputation 
details (date, level, side, cause) . Baseline and post-operatively, the primary 
outcome measure was the Dutch-language RAND-36. 19 This is a self-reported 
questionnaire, similar to the SF-36, taking approximately 10 minutes to complete. 
Nine domains contributing to HRQOL are addressed: physical function, role 
limitation physical, social function, role limitation emotional, mental health, 
pain, vitality, general health, and perceived change in health. Scores range from 
0 (worst reported health) to 100 (best reported health) . The RAND-36 is valid for 
the Dutch population.20 Participants also answered a (non-validated) question on 
walking distance, choosing between: 'unable to walk: '< 1 00m walking: '1 00m to 
500m walking: '500m to 1km walking' or '> 1km walking'. These categories were 
recoded for analysis as non-walker, <500m or �S00m walking distance. 
A study of the Northern Dutch population provided norm values for the 
RAND-36. 19 The authors were contacted for their original dataset, enabling 
different age groups to be compared. A minimum age cut off of 30 years in the 




Descriptive results are presented with mean and standard deviation (sd) for 
continuous variables and number and percentage for categorical variables. 
Differences between characteristics of groups were compared using independent 
sample t-test for age (2 groups), one way ANOVA for age and baseline domain 
scores (3 groups) and x2 for categorical variables. 
Changes over time for each domain of the HRQOL were evaluated using 
multilevel models. These models have not been widely used in amputation 
outcome research so far. Multilevel analyses are frequently used for longitudinal 
data, since they also take the correlation between repeated measures within 
individuals into account. In this type of analyses, a linear regression model 
is estimated for each individual, together with the variability between all 
individuals. 21 
A random effects model with unstructured covariance was used, with 
individuals as the highest level and different time points as the lowest level. Age 
was centred at 65 years. In case of significant time effect, predictors (age and 
walking distance) were added stepwise in the model. Interaction effects for time 
with age were explored. Walking distance was not analysed in respect to the 
domain physical function due to substantial overlap of the constructs; the level of 
amputation was instead considered. 
To test for differences in HRQOL scores at 18-months, the means of the norm 
values were compared to the 95% confidence interval of LLA population. For each 
domain, if the mean norm score fell outside this range, the LLA population was 
considered as significantly different. 
Significance for all analyses was set at 0.05 (two-sided) and were performed 
with PASW Statistics 18, mixed models. 
Results 
From 106 referred patients, 82 (77%) were included (figure 1). Ten patients were 
excluded because they were referred too late (>5 days) and 14 patients because 
they had a previous ipsilateral LLA. Excluded patients were slightly younger than 
included patients (not significant) and more likely to have had a transfemoral 
amputation (p=0.001, table I). For 7 patients, the study period ended before their 







� Figure 1 :  I nclusion, drop out, death and walking abi l ity of participants at each time point. 
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By 18 months, 21  patients had dropped out of the study. They had a median 
age 10.3 years older than those who stayed in (not significant) (table 1) . Reported 
reasons for drop out were worsening of co-morbidities or patients were no 
longer interested in participating because they experienced few or no problems. 
Nineteen patients died before their 18-month follow up, 17 ( 90%) of which were 
men (p=0.038). There were no significant differences in age (p=0.076) or level 
(p=0.744) between patients who stayed in the study, died or dropped out. 
The domains, role-limitation emotional and role-limitation physical, were not 
included for analysis. The responses in these domains were frequently missing, 
dichotomised and were not interpretable. 
There were no statistically significant differences in HRQOL domain scores at 
time of amputation between patients who stayed in the study, died or dropped 
out (table 1). In addition, there were no significant differences in domain scores 
at amputation when comparing by sex or level of amputation or comparing 
between people who completed the questionnaire pre-operatively (n=59) with 
those who completed the questionnaire post-operatively (n=23) (data not 
presented). 
Walking distance across each time point is shown in figure 1. All patients 
reported that they were able to walk at least 500m before their amputation. In 
the first 6 months, 26 (32% of all participants; 57% of remaining participants) 
Table 1: Characteristics of patients by category at time of amputation: included 
versus excluded patients; and patients who stayed in study, died or dropped out. 
I ncluded Excluded p* Stayed in  Died Dropped out p* 
n (%) 82 24 42 (5 1 )  1 9  (23) 21  (26) 
Age, mean (sd) 67.8 (1 3.0) 64.7 ( 1 0.1 ) 0.292 64.6 ( 14.2) 7 1 .4 (8.2) 70.8 ( 1 3.0) 0.076 
Men, n (%) 55 (67) 16 (67) 0.577 27 (64) 1 7  (90) 1 1  (52) O.Q38 
Level, n (%) 
Proximal 30 (37) 18 (75) 0.001 16 (38) 8 (29) 6 (42) 0.744 
Distal 52 (63) 6 (25) 26 (62) 1 1  (71 )  1 5  (58) 
RAND-36, mean (sd) 
Physical function 8.9 ( 1 2.8) - 1 0.6 ( 14.3) 5.6 (8.7) 7.9 ( 1 1 .9) 0.398 
Social functioning 34.7 (31 .7) - 29.6 (26.9) 50.0 (37.5) 32.1 (34.6) 0. 1 01 
Mental health 70.7 (20.0) 68.2 ( 18.8) 72.0 (26.2) 75.7 ( 1 3 .7) 0.505 
Pain  26.2 (26.8) 26.4 (29.5) 25.5 (25.5) 26.5 (21 .5) 0.928 
Vitality 47. 1 (23.7) - 47. 1 (23.2) 48.8 (25. 1 )  45.4 (24.7) 0.992 
General health 60.5 (20.8) - 63.0 (21 .8) 60.0 ( 1 4.9) 54.3 (23.8) 0.41 0 
Change in health 24.3 (25.3) - 26.8 (27.6) 1 8.8 (21 .4) 23.2 (22.9) 0.555 
*x2 for level and sex; age compared using t-test (for included versus excluded); one way ANOVA for age and 
domain scores by end status. 
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declined in walking distance. From 6 to 18 months, walking distance was stable 
or improved for the majority of participants, with two people declining to a non­
walking status. 
A statistically significant improvement in mean score from amputation to 
6 months and from amputation to 18 months is seen in 5 of the 7 domains 
evaluated (physical function, social function, vitality, pain and perceived change 
in health, all p<0.001) (table 2). Mental health and general health were consistent 
across all time points. 
Table 2: Change in HROOL over time, accord ing to wal king abi l ity and age 
I ndependent (3 se 95% CI p 
Physical function* Constant 12.0 1.7 8.5 ; 15.5 
Proximal level -7.7 2.7 - 13.1 ; -2.2 0.007 
6 months 21 .4 3.8 13.8 ; 29.0 <0.001 
1 8  months 22.6 4.2 14.2 ; 31 .1  <0.001 
Age -0.4 0. 1 -0.6 ; -0.2 <0.001 
Social functiont Constant 12.5 8.6 -5.3 ; 30.3 
6 months 37.7 6.0 19.0 ; 56.3 0.007 
18 months 38.6 5.9 26.2 ; 5 1 .0 <0.001 
< 500 m 20.7 8.4 3.5 ; 38.0 0.020 
� 500 m 29.6 9.3 9.3 ; 49.8 0.008 
Mental health=!= Constant 70.7 2.3 66.2 ; 75.2 
6 months 2.2 3.7 -5. 1 ; 9.5 0.553 
18 months 5.8 4.0 -2.1 ; 13.6 0.148 
Pain=!= Constant 26.2 3.2 19.8 ; 32.6 
6 months 47.8 5.2 37.4 ; 58.2 <0.001 
18 months 42.8 5.3 32.2 ; 53.4 <0.001 
Vitality=!= Constant 47.4 2.8 41 .8 ;  53.0 
6 months 18.8 3.6 1 1.5 ;  26. 1 <0.001 
18 months 17.7 3.8 9.5 ; 25.9 <0.001 
General health=!= Constant 60.6 2.5 55.3 ; 65.5 
6 months 3.9 3.5 -3.2 ; 1 1 .0 0.273 
18 months -1 .4 3.5 -8.5 ; 5.7 0.689 
Change in health=!= Constant 24.3 3.0 18.3 ; 30.3 
6 months so.a 5.2 39.5 ; 60.5 <0.001 
18 months 42.2 5.6 30.9 ; 53.5 <0.001 
*Constant is people aged 65, time of amputation, transtibial level. Walking ability was 
not analysed in respect to physical function due to substantial overlap of the constructs, 
instead the level of amputation was included. Proximal level refers to people with knee 
disarticulation or transfemoral level amputation; se: standard error; Cl: confidence 
interval. tConstant is people who did not walk, time of amputation; =!=Constant is time of 
amputation 
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An ability to walk gave significantly improved scores in social function 
(p=0.047). Age was significant factor on HRQOL for physical function (p=0.001) 
(figure 2 and figure 3). Physical function was also influenced by level of 
amputation, people with a knee disarticulation or transfemoral amputation 
reporting significantly lower scores (-7.7, p=0.007). 
Eighteen months after their amputation, people with LLA had significantly 
poorer HRQOL scores compared to norm values in three domains and better 
scores in perceived change in health (table 3). Mental health, vitality and general 
health showed no significant differences between people with LLA and norm 
values. Physical function had the largest difference between mean scores, 43.7 less 
for people with LLA than norm values. 
The difference in mean scores seen for the all-age population was not 
statistically significant for social function and pain when considering the age­
specific values for people 65 years and over. 
Figure 2: Change in physical function over time 
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Solid line shows change in physical function over time for a 65 year old with transtibial amputation. 
Error bars represent 95% confidence interval of the mean. For each year over 65 years of age scores 
are: ·0.4; For each year under 65 years, scores are: + 0.4 (p < 0.001 ); For a knee disarticulation or 
transfemoral amputation scores are: -7.7 (p=0.007); As example: dashed line represents a 70 year old, 
with transfemoral amputation. 
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Figure 3: change in HRQOL domain scores over time 
Social function 
Change in social function score 
over time for non-walker with 
transtibial amputation; error 
bars represent 95% confidence 
interval of mean; For cases with 
walk ability < 500m scores are: 
+ 20.7 (p = 0.020); For cases 
with walk ability >500m scores 
are: + 29.6 (p = 0.008) 
Mental health* 
*Change in domain score over 
time, error bars represent 95% 
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Table 3: Mean (sd) RAND-36 domain scores at 18 months for people with lower 1-...1 
limb amputation compared with population norm values. 
All age groups 2:: 65 years < 65 years 
LLA 95% (1 Population LLA 95% (1 Population LLA 95% (1 Population 
{n=35} of LLA {n=804} {n= 1 5} of LLA {n=1 70} {n=20} of LLA {n=634} 
Physical function 34.7 (25.8) 25.5; 43.9 78.4 (25.2) * 30.0 (24. 1 ) 23. 1 ; 5 1 .6 62.5 (28. 1 ) *  37.4 (26.9) 1 7.9 ; 42. 1 82.6 (22.6) * 
Social function 73.2 (26.3) 64.4; 82.0 85.2 (22.4) * 75.9 (23.2) 59.1 ; 83.4 80.8 (25.7) 7 1 .3 (28.7) 63.3 ; 88.5 86.4 (21 .3) 
Mental health 76.5 ( 1 5.3) 7 1 . 1 ;  8 1 .9 76.7 ( 1 8.5) 76.4 ( 1 5.2) 67.6 ; 85.6 75.5 ( 1 7.3) 76.6 ( 1 5.7) 69.5 ; 83.3 77.0 ( 1 8.8) 
Pain  69.3 (24.6) 60.8; 77.8 78.8 (25.9) * 68.9 (25.9) 54.9 ; 84.2 73.3 (28.7) 69.6 (24.5) 58.2 ; 79.7 80.3 (25.0) * 
Vitality 64.5 ( 1 7. 1 )  58.5; 70.5 66.8 (20.3) 66.8 ( 1 7.8) 52.7 ; 73.8 63.9 (2 1 .8) 63.3 ( 1 7.0) 59.4 ; 74.3 67.5 ( 1 9.8) 
General health 64.7 ( 1 6.0) 59. 1 ;  70.3 69.4 (23.1 ) 68.2 ( 1 4.7) 54.1 ; 7 1 .4 59.7 (23.7) 62.8 ( 1 6.7) 60.8 ; 75.5 7 1 .9 (22.2) 
Change in health 66.4 (28. 1 )  56.7; 76. 1 5 1 .2 ( 1 8.5) * 68.8 (24. 1 )  5 1 .3 ;  78.7 46.9 ( 1 9.2) * 65.0 (30.8) 55.3 ; 82.2 52.4 ( 1 8. 1 )  * 
*population mean falls outside 95% confidence interval of lower limb amputation (LLA) population at 1 8  months; 
The sample from which the norm values were derived consisted of: 
Minimum age of 30 used to correspond with our youngest included patient at 30.9 years: 
All ages: n = 804, 35% men, median (IQR) = 50 years (38 to 63). 
2: 65 years: n = 1 70, 37% men, median (IQR) = 71 years (68 to 76). 
< 65 years: n = 634, 34% men, median (IQR)= 45 years (36 to 53). 
Discussion 
The results of this study showed that substantial improvements in HRQOL can be 
achieved after LLA. HRQOL scores were reflective of the difficult situation faced 
at the time of amputation; only mental health and general health scoring over 
50 (out of 100). However, for people who survive, significant improvements 
are gained across the differing domains, with most change evident in the first 
6 months. While realising that it is not always clear who will survive the post­
operative period, for those who do their situation can improve substantially 
within a relatively short time frame. With the exception of physical function, 
domain scores differed little from the population norm values after 6-18 months. 
Previously, this positive change could only be inferred from cross-sectional 
studies that show people with longer time since amputation report higher 
HRQOL than those with more recent amputation. 10•1 1 The impact of time has been 
considered in relation to depression, anxiety, problems with sex and relationships, 
and body image, with findings suggestive that these aspects become evident only 
after 6 to 24 months. 1•22•23 However, those studies were all conducted in relatively 
young populations with LLA, with a mean age less than 60 years. The population 
investigated can have an important impact on the outcomes. In general, older 
people with LLA have different coping strategies, resilience and goals.24 During 
the first year after amputation, people with vascular-related LLA may undergo 
less change than people with traumatic LLA.25 Although HRQOL shows changes 
over time, the contrasting findings from this and other studies, specifically in 
reference to which aspects are changing and when, needs further investigation. 
The increase in HRQOL over time for this population may occur as the 
amputation signals the end of a long period of pain, infection, immobility and 
hospitalisation. After surgery and a period of rehabilitation, many patients are 
able to return home, possibly with greater mobility than prior to the amputation. 
Events leading up to the amputation may have had an important influence on 
the baseline scores, such as the number of previous procedures or the duration 
of hospitalisation. These events were unable to be evaluated in the current study. 
The improvement in scores may also occur from a response shift, reported in 
LLA populations previously. 1•1 1 •26 After experiencing an event such as amputation, 
expectations and importance of different aspects of HRQOL are altered.27 Any 
given score at the time of amputation may not have the same meaning for an 
individual 6 or 18 months later. The importance given to a specific domain may 
also change; for example, social function may be considered less important 
compared to physical function at the time of amputation, increasing or 
decreasing in its relative importance over time. The influence that a response shift 
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may have on longitudinal patient reported HRQOL scores, particularly in elderly 
patients, is unclear28 and it may result in an over- or under-estimation of HRQOL. 
Physical function for all participants remained very poor, especially in 
comparison to norm values. The low scores observed at the time of amputation 
were in accordance with those previously reported using the RAND-36 for 1 6  
patients with vascular LLA.29 Unfortunately, important details from that study 
are missing (time since amputation, level of amputation) so further comparison 
is not possible. Physical function scores 1 8  months after LLA were lower than 
observed in other studies using the RAND-36. However, those studies had highly 
selected populations of people who walk with a prosthesis, 13 a high proportion of 
people with LLA due to trauma and who were of working age. 7 Those populations 
are generally healthier than a population with vascular-related LLA so it was not 
surprising that participants in the current study had poorer physical scores. 
Despite the low physical function, other domains were comparable to 
population norm values. The idea that mobility enables independence and this 
in turn translates to a higher HRQOL 1 1 • 1 3 • 1 6• 30 was not seen in this population, with 
only social function improving with walking ability. A walking distance of more 
or less than 500m was the most important determinant of HRQOL in a study 
investigating phantom pain and other determinants of HRQOL. 1 3  The majority 
of that population were prosthetic users and only half had amputation due to a 
vascular-related cause. Our population consisted only of people with vascular­
related LLA, not all of whom walked. One explanation might be that HRQOL is 
linked to walking distance only when focussing on a population who actually 
walk, the inclusion of non-walking participants negating this link. We did not 
have enough non-walking participants to look at this idea with more certainty. 
With the exception of physical function, there were no significant differences 
between age groups over time seen in the regression equations. However, 
comparing age-specific domain scores to norm values suggests there are indeed 
differences in how older and younger people perceive HRQOL after LLA. For 
example, social function for the all-age group differed significantly from norm 
values, but when these results are broken into age-specific groups the differences 
were no longer apparent. The importance of a social network has been reported 
for people with LLA previously12 but it also might be linked to age-appropriate 
comparisons. Age is thought to be an important determinant of many outcomes 
after LLA, for example walking ability, yet few studies have looked specifically 
at different age groups, particularly elderly people. 18 It seems there may be 
important age-specific variation in HRQOL after LLA that warrant further 
attention. Looking at the influence of time on HRQOL, age should be explored 
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further as it may translate to different time-dependent HRQOL outcomes that can 
be targeted during rehabilitation and long-term care. 
The lack of differences by age and walking ability seen in the regression model 
may also be accounted for by the small sample size (although for a longitudinal 
study of LLA, the sample size can be considered relatively large). 
The elderly person with vascular LLA is often excluded from research 
due to limitations from study designs such as selection bias and recruitment 
settings. 3•5•6•13 Investigations of HRQOL, which include the elderly person with 
vascular LLA, could not only increase sample size, but enable results to be more 
widely generalised. 
The influence of time, age and walking ability on HRQOL were considered. 
Previously investigated determinants of HRQOL in patients with amputation have 
included sex, amputation level and cause, phantom pain, stump pain, phantom 
sensations, sexual satisfaction, depression and social setting. 3 Our findings 
concerning time, walking ability and age should be considered knowing that a 
range of other factors might also play a role with research of HRQOL in people 
with LLA still very much in its infancy. 
To incorporate a representative sample of all people undergoing vascular 
related amputations, there were minimal exclusion criteria. However, a 
substantial number of patients were still missed from the study and selection 
bias was evident; the expected population for the region being 6 years older 
with a mean (sd) age of 74.0 (11.2) years31 (current study with 67.8 (13.0) years), 
with 46% of amputations being transfemoral/knee disarticulations ( compared 
to 37% in current study). Participants were referred from hospitals across three 
provinces, and potential differences in pre- and post-amputation care may also 
have had an impact on HRQOL. 
For longitudinal data, a multilevel model gives unbiased results if there 
is missing at random. 32 In our data, the baseline characteristics did not differ 
significantly by status (stayed in study, dropped out or died), indicating that in 
the beginning all patients had similar risk of drop-out ( due to death or other 
reasons) . However, quality of life is likely to be related to the probability of 
dropping out due to morbidity or death. We are aware that the assumption of 
missing at random might be not true in our data. The sample size of our study, 
however, is too small to do more sophisticated analyses. In a post-hoc analysis 
of data of the 35 participants who remained in the study at 18 months, a similar 









improvement in HRQOL was not attributable to patients with a poorer health 
status dropping out or dying. 
The RAND-36 is a generic health status questionnaire. Therefore, results can 
be compared across different populations, both healthy and with pathology. 
However, use of a generic measure does not identify issues that are of specific 
importance for the LLA population. Use of the R AND-36 along with an 
amputation specific measure, for example, the Trinity Amputation and Prosthesis 
Experience Scales10 is encouraged. This combination will allow comparison to 
other populations whilst still highlighting problems that are specific for people 
with LLA. 
The population of elderly patients with vascular-related LLA may have found 
some of the questions of the RAND-36 limiting as the questionnaire is considered 
as potentially burdensome for the elderly population.20 In particular, the 
domains role-limitation emotional and role-limitation physical were unable to be 
evaluated due to substantial number of missing responses and floor/ceiling effects, 
which made the results non-interpretable. A Veteran's version of the RAND-36 has 
been developed33 and might be a better alternative for future investigations. 
Concl us ions 
In this longitudinal study, we report a significant improvement in many aspects 
of HRQOL after LLA, with most change evident in the first 6 months. Use of 
multilevel analysis incorporated results from all patients, including those who 
later dropped out of the study or died. For elderly patients, physical function 
was rated very poorly but the remaining domains of HRQOL did not differ or 
were better than norm values. Younger patients differed from the norm values in 
physical function and pain. The ability to walk was linked only to social function, 
the distance walked did not matter. Time, age and walking distance are just three 
of many factors to be considered when evaluating HRQOL after LLA. 
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Abstract 
Background: Elderly people with a lower limb amputation impose a heavy 
burden on health resources, requiring extensive rehabilitation and long 
term care. Mobility is key to regaining independence. However, the impact 
of multiple comorbidities in this patient group can make regaining mobility 
a particularly challenging task. An evidence based prognosis for mobility is 
needed for rehabilitation and long term care planning. This systematic review 
summarises the prosthetic and non-prosthetic mobility outcomes achieved 
by elderly people with a lower limb amputation, to determine whether an 
accurate prognosis for mobility can be made. 
Methods: MEDLINE, EMBASE and c1NAHL were searched for studies published 
prior to May 201 0  in English ,  German, Dutch or French, using keywords 
and synonyms for elderly, mobility, rehabilitation and amputation. Mobility 
focussed on actual movement (moving from one place to another) and was 
limited to long term measurements, 6 months after amputation or 3 months 
after discharge from rehabilitation.  
Results: The fifteen included studies featured a diversity of objective 
outcome measures and mobility grades which proved difficult to compare 
meaningfully. In general, studies which included selected populations of 
prosthetic walkers showed that advanced prosthetic mobility skills can be 
achieved by the elderly person with a lower limb amputation, including 
outdoor/ community walking. Studies which included all subjects undergoing 
a lower limb amputation reported that less than half of the elderly population 
achieved a household level of prosthetic mobility. 
Results:The predominant findings from the included studies were incomplete 
reporting of study populations and poor reporting of the reliability of the 
mobility measures used. Therefore, the strength of conclusions from this 
review was limited and the prognosis for mobility in elderly people after lower 
limb amputation remains unclear. Further research into mobility outcomes of 
this population is needed to provide evidence that enables more informed 
choices in rehabilitation and long term care needs. 
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Introduction 
Major lower limb amputation (LLA) is a frequently performed procedure in 
elderly people requiring extensive rehabilitation and long term care. Most LLA are 
in people older than 60 years with vascular disease and/ or diabetes1 and many 
people are discharged to nursing homes for their post-acute or long term care.2•3 
Population ageing and increasing rates of diabetes suggest that elderly people with 
LLA will remain an important subgroup and will continue to place a significant 
burden on health resources and long term care facilities. 
The specific presentation of elderly persons with LLA, with multiple physical, 
psychological, cognitive, and social comorbidities, imposes unique challenges 
to ongoing care. Patients are often systemically unwell with their related 
comorbidities, for example, cardiovascular disease or end-stage renal disease.4- 6 
In addition, there are comorbidities experienced by the wider elderly population, 
physiological changes from ageing, and complications from immobilisation 
through attempts to save the limb, such as deconditioning and contractures.4-6 
Post amputation, there is a relatively short life expectancy with 50% survival after 
2 years.7•8 Together, the combination of comorbidity and mortality imposes some 
pressure on determining a prognosis and choosing the right course of action for 
rehabilitation and/or long term care.4•6 
Mobility is a key component of independent living, enabling the performance 
of activities of daily living. For people with LLA, mobility provides independence 
and a higher quality of life,9•10 and can mean the difference between returning to 
home or remaining in a long term care facility. Rehabilitation of mobility after 
LLA focusses primarily on prosthetic walking. Although an older age alone does 
not prevent prosthetic walking, 1 1-14 the comorbidities described previously can 
impede against the higher energy, strength, and cognitive demands required for 
prosthetic walking.4•6 Older age is associated with less use of a prosthesis and with 
lower rates of prosthetic prescription.9•10•14-18 After discharge from rehabilitation, it 
is reported that elderly people use their prosthesis infrequently or not at all,9•19•20 
and there may be times when problems with the residual limb or prosthesis will 
prevent prosthetic walking. Therefore, rehabilitation programmes also include 
training in nonprosthetic mobility skills, for example, use of a wheelchair and 
training in transfers. These mobility skills can enable continued independence in 
personal and household care, or provide greater opportunities to be active in the 
community. 
Despite the assumed importance of both prosthetic and non prosthetic means 
of mobility, particularly for elderly amputees, previous systematic reviews have 
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prognosis for mobility in elderly persons with LLA is unclear. Options and goals 
for rehabilitation are subsequently based largely on empirical knowledge. Stronger 
evidence is needed to facilitate discussion, enable informed rehabilitation choices, 
and help in formulating case-specific goals for long term care. 12 The aim of this 
systematic review was to summarise publications reporting an established (long 
term) prosthetic or nonprosthetic mobility outcomes in elderly people with LLA, 
and to determine whether a prognosis for mobility can be made. 
Methods 
Search Strategy 
A systematic literature search of MEDLINE (Ovid), EMBASE, and CINAHL was 
performed using database specific keywords, medical subject headings, and free 
text synonyms for (lower limb) amputation, aged, rehabilitation and mobility . All 
publications were included; no restrictions to date were applied, and initially no 
restrictions to language were applied. 
Two investigators independently assessed all publications at each stage of 
the review according to predefined inclusion and exclusion criteria. Only titles 
that were excluded by both investigators were removed; where one or both 
investigators included a title, the publication was reviewed further. Where results 
differed on the exclusion of an abstract or full-text publication, the investigators 
reached agreement through discussion or, if disagreement remained, a third 
person was consulted for a final decision. A measure of agreement between the 
2 investigators (Cohen's K) was calculated at each stage of the review for those 
publications dated before November 2008. 
The search was first performed in November 2008, and updated in May 2010; 
in the updated search, the investigators were no longer considered as independent 
assessors and a measure of agreement could not be calculated. The reference lists 
of all fulltext publications were examined for additional studies with the same 
inclusion and exclusion criteria applied to the titles, abstracts, and full text of 
relevant publications accordingly. 
Inclusion and Exclusion Criteria 
Publications were first screened by title to include those with a focus on 
rehabilitation outcomes after LLA. Excluded were studies with a surgical, 
pathology or technical focus, expert reviews, case reports, letters and opinions, 
and studies that were clearly not undertaken in a population of elderly persons 
with LLA, for example, where the title stated upper limb or pediatric subjects. 
Abstracts and full-text publications were assessed to include those reporting a 
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long term mobility outcome, in an elderly population consisting of 10 or more 
subjects with major LLA. Major LLA was considered as being at or proximal to the 
transtibial level and included unilateral and bilateral amputations. 
Elderly persons were defined as being 60 years and older. Abstracts were 
included where the mean age was older than 60 years and the full text was 
reviewed for detailed information on the age range of included subjects. Where 
a mobility outcome was reported in a clearly defined (sub)group older than 
60 years, the publication was included. Mobility was defined as independent 
movement from point A to point B, with or without a prosthesis, gait aids, or 
wheelchair. Mobility included transfers from one point to another (for example, 
wheelchair to car) and standing up from sitting or lying, but did not include 
small changes in position, such as shifting position within a bed or chair. Global 
measures that include many outcomes, such as functional tasks or activities of 
daily living, were included only if a score for a mobility subscale was reported 
separately. Prosthetic prescription, prosthetic use versus nonuse, and reporting 
of time spent wearing a prosthesis, were not considered as measures of mobility. 
Mobility was to have been measured at a minimum of 6 months after amputation 
or 3 months after discharge from a rehabilitation programme. If the timing of the 
measurement was not clearly stated, the publication was excluded. 
Publication Assessment 
Two investigators independently assessed all included studies. No existing 
quality assessment checklist was applicable to the included study designs and 
our aim. Taking into account items from the Downs and Black criteria21  and 
items that the authors agreed were important for the description of mobility in 
elderly people with LLA, an assessment strategy was developed (Table 1). The 
items were assessed as yes, no, or unclear for the entire reported study population, 
irrespective of whether separate data were given for an elderly subgroup. A score 
with a maximum of 8 was given. 
Description of assessment criteria 
1 .  The aim, research question and/or hypotheses was clearly reported 
2. Eligibility criteria (inclusion and/or exclusion of subjects) were reported 
3. The population and/or setting from which subjects were drawn was reported 
4. Descriptive data* for sex were reported 
5. Descriptive data* for cause of amputation were reported 
6. Descriptive data* for level of amputation were reported 
7. Descriptive data* for unilateral/bilateral amputations were reported 
8. A statement concerning reliability of the mobility measure was reported 
* number, percentage or ratio. 




Summary Data Extraction 
Summary data were extracted for subject characteristics, study design, and 
mobility outcomes for the older subgroups only. If separate data were not 
available, the table result was left blank. 
The studies were grouped by the type of outcome measure: (1) objectively 
measured, for example, the time taken to perform a test or an actual distance 
walked; or (2) assigned by a researcher, for example allocating a patient to a 
mobility grade. All results were presented as a total of the original included 
population who were older than 60 years. 
For the mobility grades, a level was selected that most closely represented: 
(1) household prosthetic walking, with or without a gait aid; and (2) independent 
mobility through any means, for example, by using a wheelchair or gait aids. 
Results for elderly subjects scoring at or above the corresponding level were 
summed; the result presented is the number achieving at least that level of 
mobility. The mobility grade descriptions were summarised from each authors 
own wording. 
Resu lts 
A total of 936 unique publications were identified after removal of duplicates and 
triplicates (Figure 1 ). Screening by title and abstract excluded 736 publications 
and a further 186 were excluded after full-text revision. Cohen's kappa was 0.58 
(title), 0.36 (abstract), and 0.53 (full text) . One publication was included after 
thoroughly searching the reference lists of all 200 included full-text publications. 
Fifteen studies, dating from 1967 to 2005, met all inclusion criteria. Data relating 
to the population characteristics and mobility outcomes for the elderly (sub) 
groups were summarised (Table 2) . Two studies reported 2 different mobility 
measures; these studies are presented twice in Table 2 accordingly.22 •23 One 
study referred to previously published data; this was combined and presented 
together. 24•25 
Assessment of prosthetic mobility was the primary aim in 5 
publications.24•26 29 In others, mobility was reported alongside a range of different 
outcomes including survival, wound healing, and activities of daily living23 •30-33 
or a mobility outcome ensued from assessment of the clinimetric properties 
of a measurement tool.22•34•35 From the setting and population, patients could 
be divided into ( 1) those who were "selected;' referring to people admitted to 
a rehabilitation or prosthetic centre, who were prosthetic walkers and/ or had 
a prosthesis prescribed and (2) those who were "unselected;' referring to the 
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Figure 1 :  Publication selection 
Medline 
(5 1 4) 
1 publication Included 
from references 
1 339 publications 
936 titles / abstracts 
Embase 
(652) 
736 publications excluded: 1------- Mean age < 60years 
200full text 
Not major lower limb amputation 
Surgical, pathology or technical focus 
Case report, letter, or review 
1 86 publications excluded: 
Unpublished thesis 
>------- < lO subjects 
1 5  publications 
Timing < 6 months after amputation 
or<  3 months after rehabilitation 
or not clearly stated 
Mobility not in (sub)group >60 years 
Not English, Dutch, French or German 
inclusion of all patients who underwent a lower limb amputation. Table 2 shows 
that most studies performed a cross-sectional mobility measure, with 4 studies 
reporting a longitudinal mobility measure for the older population.27•28•34•35 Five 
studies scored a maximum of 8 for reporting of all assessment criteria. 22•23•26•27•34 
Objective measures were used to record the time taken to walk a distance, 
the actual distance walked, or the number of steps taken in a day. All objective 
measures were applicable only for prosthetic walkers with a sample size between 
14 and 53. One study included all patients undergoing amputation, with 18 (39%) 
of 46 able to perform the objective test.23 Timed walk tests, incorporating a chair 
stand, short walk, and 180° turn, were used in 2 studies, with a walking distance 
of 3m23 or Sm22 covered. Poorer performance by people with a transfemoral 








'° Table 2: Summary data for long term mobility outcomes for elderly people with lower limb amputation co 
MOBILITY GRADES 
Author, Criteria N Men n Vase n Mobility measure (no.of 
Year Aim met =!= Pop (%) Age (%) (%) Level n (%) grades) [Reliabil ity] [Type of Results 
Davies, Prosthetic 8 s 1 27 8K=97 (49) AK=l 00 (51 )  Harold-Wood-Stanmore scale H: 1 07 (54%): gait aids indoors, minimal outdoor walking 
2003 mobility (281 ) (65-95) [8=4 (2)] (1 -6) [VJ [Cl M: 1 1 4 (58%): transfers, walks with therapist or carer 
Schoppen, General 8 u 46 74 ±8 32 46 8K=33 (72) AK= 1 3  (28) Adapted Narang/ Pohjolainen H: 1 8  (39%): indoor prosthetic walking with gait aids 
2003* outcomes (46) (�60) (70) (1 00) scale (1 -8) [NJ [Cl M: 26 (57%): non-ambulatory mobil ity, w/c users 
Hermodsson, Mobility tool 8 u so 79 +7 26 so 8K=52 (1 00) Functional rating scale for H: 8 (1 6%) discharge; 1 1  (22%) 6 mo: with gait aids 
1 998 assessment (50) (61 -92) (52) (1 00) amputees (1 -8) [Y] [L] M:1 9 (38%) discharge;1 8 (36%) 6 mo: w/c, ind. transfers 
Datta, Mobility tool 8 s 53 70 36 43 8K=26 (49) AK=27 (51 )  Volpicel l i scale (0-6) H: 50% (median): walking < 30m, w/c used outdoors 
1 996* assessment (53) (60-80) (68) (81 ) [NJ [Cl 
Valentine, General 7 u 75 67 ±0.6 66 75 8K=46 (61 )  AK=29 (39) Modified Volpicelli scale (1 -4) H: 21 (28%): indoors, negotiates carpets, stairs with rails 
1 996 outcomes (1 25) (60-80) (88) (1 00) [8=21 (28)] [NJ [Cl M:  61 (81 %): w/c ambulators, independent transfers 
McWhinnie, General 7 u 31  31 8K=20 (65) AK=1 1 (35) Self developed scale ( 1 -3) [NJ [Cl H: 7 (23%): walking in the home 
1 994 outcomes (96) (80-95) (1 00) M: 19 (61 %): prosthetic walking or use of w/c 
Campbell, General 7 u - Self developed scale (1 -6) [NJ [C] -
1 994 outcomes (21 0) (80-96) 
Wong, General 6 u - Volpicelli scale (0-6) H: of 53 successful community ambulators 
2005 outcomes (1 84) (80-93) [N] [C] 1 8.9% were > 80 years 
Steinberg, Prosthetic 6 s 1 1 6  73 71  8K=66 (57) AK=30 (26) Self developed scale (1 -3) [NJ [Cl H: 81 (70%): prosthetic walking, w/c for trips 
1 985 mobility (1 1 6) (65-86) (61 )  ?=2(2),8=1 8(1 6) 
Lam, 6 s 58 Self developed scale (1 -3) [NJ [Cl H: 33 (57%): walking with gait aids, w/c used outdoors 
1 981 (1 1 5) (61 -85) 
Nehler, 5 u 1 1  1 1  Self developed scale (1 -3) [NJ [Cl H :  2 (1 8%): ambulatory indoors 
2003 (1 54) (�75) (1 00) 
Siriwardena, Mobility tool 5 s 8K=1 96 (49) AK=220(5 1 )  Self developed, Walking Abil ity 
1 991 assessment (598) (�60) (1 00) 8= - Index (1 -6) [NJ [L] 
Anderson, Prosthetic 5 s 81 70 46 81 8K=44 (54) AK=23 (28) Russek scale (1 -6) H: 46 (57%): enabling complete self care 
1 967t mobil ity (92) (60-87) (57) (1 00) 8=1 4 (1 7)11 [NJ [Cl 
'° '° 
OBJECTIVE MEASURES 
Author, Criteria N Men n Vasc n Mobility measure 
Year Aim met * Pop (%) Age (%) (%) Level n (%) [Reliabil ity] [Type of measure] Results 
Schoppen, General 8 u 46 74 ±8 32 46 BK=33 (72) AK=l 3 (28) 3m Timed up & go 18 (39%) performed test. Mean (SD) = 23.9s (1 3.2) 
2003* outcomes (46) (�60) (70) (1 00) [Y] [C] median = 2 1 .3s Age not associated with up & go score 
Datta, Mobi l ity tool 8 s 53 70 36 43 BK=26 (49) AK=27 (5 1 )  S m  Timed walking test Mean (SD, range) = 36.9s (25.0, 1 3- 140) 
1 996* assessment (53) (60-80) (68) (81 )  [Y] [C] 
Devlin, Prosthetic 8 s 1 4  70 ±6 1 1  1 4  A K =  1 4 (1 00) 2min walk test Mean (SD) distance with articulating knee=44.9 +28.9m 
2002 mobil ity ( 14) (61 -80) (79) (1 00) [Y] [L] with locked knee=54.4+35 (p=0.001 ) 
Holden, Prosthetic 7 s 36 BK=22 (61 )  AK= 1 4  (39) Electronic step count Mean (SD): discharge=570 (337); l st year=l 3 1 4 (1 1 35) 
1 987 mobility (-) (65-90) (steps/day) [-] [L] 2nd year=l 356 (1 309) TF 1 st year = 686 (-) 
Pop, population described as U (unselected) or 5 (selected); N, number of elderly amputees (total number of subjects in study). Age, Mean age + SD and (range for elderly subgroup); Men, number of men in population; Vase, amputations 
due to peripheral vascular disease or related causes; BK, below-knee amputation (includes transtibial); AK, above-knee amputation (includes knee disarticulation, transfemoral and hip disarticulation); B=n, bilateral amputees contributing 
independently to the total of all amputation levels; [B=n], bilateral amputees are counted within the total of all other amputations; ?, data reported as unknown in study; Reliability, there is a statement concerning reliability of the mobility 
measure Y (yes) or N (no); Type of measure, the mobility outcome was a C: cross-sectional measurement or L: Longitudinal measurement; m, meters; min, minutes; H, n(%) with household mobility or higher level; M, n(%) mobilizes 
independently or higher level; mo, months; w/c, wheelchair; s, seconds; IQR, interquartile range; TT, transtibial; TF, transfemoral. 
* Publication appears twice in table, as it reports more than one type of mobility measure. 
t Data extracted from Table 1 Anderson et al 1 967 and Table 2 Cummings et al 1963. 
:t: Criteria based on Table 1, for all included patients, maximum score of 8. 
II Percentages do not add to 100 due to rounding. 
15 .8 seconds slower in the Sm walk test22 and fewer steps taken per day 1 year 
after amputation, transfemoral taking 686 steps compared with 13 14 steps for 
transfemoral and transtibial levels combined.28 One year after discharge, people 
with transfemoral or transtibial amputations increased the number of steps taken 
per day from 570 steps at discharge to 1314 steps. They maintained this in the 
second year with 1356 steps.28 Finally, people with transfemoral amputation who 
used a locked knee compared with when they used an articulating knee were able 
to walk 9.Sm further in 2 minutes.27 
Thirteen studies assigned patients to a mobility grade with data ascertained 
from clinical records or by clinical assessment. The mobility scales defined 3 to 
8 levels of mobility according to skill, environment, independence, and/or use 
of gait aids. Six scales were self-developed.29-3 1,35-37 Three studies used a scale 
originally described by Volpicelli.38 However, results were summarised and 
presented differently. 22•32•33 A mobility level equivalent to independent household 
prosthetic walking with or without gait aids, or higher, was achieved by 18%37 
to 39%23 of unselected patients and by 50%24 to 70%29 of selected patients. A 
minimum mobility level equivalent to being independent through prosthetic 
or nonprosthetic means, was achieved by 36%34 to 81 %32 of unselected patients. 
One study of selected patients reported 58% of people achieving at least a level 
of independent mobility, using a prosthesis for transfers and walking only with a 
therapist or carer.26 
Discussion 
In this systematic review, we aimed to summarise the prosthetic and 
nonprosthetic mobility outcomes achieved by elderly people with LLA. Evidence 
of mobility outcomes is needed to assist planning of rehabilitation and long term 
care needs. Elderly people with LLA have long been the subject of expert reviews 
and "current best practice" articles. They are recognised as a unique population 
owing to the combination of physical, psychological, and social comorbidity they 
often present with. The potential bias from the inclusion of younger patients into 
a study with an elderly population with LLA supports the need for independent 
investigation. 12 Despite this, there were relatively few high-quality scientific 
studies of mobility that looked at the population independently of younger 
patients. Considered together with a Cochrane Review into patients older than 
60 years with transfemoral amputation, which found only 1 trial concerning the 
preferred weight of a prosthesis, 16 it is clear that there is a need for more research 
focussed on this population. 
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Elderly patients and mobility outcomes were not the primary focus of all 
included studies; instead, a mobility outcome was reported in a subgroup of 
elderly patients, alongside amputation healing, mortality, and other general 
functional outcomes. Most studies were descriptive, cross-sectional studies of 
a case series. The application of existing quality assessment tools proved too 
extensive with a substantial number of items inapplicable. Therefore, assessment 
of methodological quality was based on items addressing internal and external 
validity, which the authors agreed were important in describing mobility in 
people with LLA. The bias inherent in selected populations of prosthetic walkers, 
compared with unselected populations inclusive of all patients, must be taken 
into account when describing mobility after LLA. 12 Few studies met all assessment 
criteria, which limits generalisation of the results. 
A mobility outcome should be reliable and valid for patients with LLA 
and responsive to change. 39 The assessment of these aspects in this review 
was minimal, simply "Is there a statement anywhere in the article concerning 
reliability of the mobility outcome measure?" Only 5 studies included this 
information. 22•23•26•27•34 Limitations in comparing results between studies have also 
been described in previous systematic reviews of prosthetic walking and mobility 
scales. 17•18•40 Improvements, such as standardisation in reporting of outcome 
measures (with the inclusion of a statement about reliability of the measure), as 
well as population characteristics (including the level of amputation, cause of 
amputation, and so forth), is essential for improving the overall methodological 
quality of future studies. 
Fifteen different measurement tools were used to assess mobility in elderly 
people with LLA. These were presented in 2 categories: objective measures and 
assigned measures of mobility. The objective measures included 3 walk tests. 
The 2-minute walk test measures the distance walked in 2 minutes and the up­
and-go test measures how quickly a person can stand from a chair, walk a short 
distance, turn 180°, and return to a seated position; 2 variations of this test were 
conducted over different distances (3m and Sm), so unfortunately could not be 
compared. 22•23 For prosthetic walkers, including the elderly population specifically, 
the timed up-and-go test is recommended for use in assessing mobility. It has 
demonstrated reliability, validity, responsiveness, ease of use in a clinical setting, 
and it replicates the type of mobility needed for a household situation.22,4 1-43 Use 
of the detailed procedure described by Schoppen et al43 is recommended to allow 
the results of future studies to be compared. 
A second objective measure identified was the electronic step-count 







prostheses, have been more extensively developed in recent years, but not as yet 
studied in an elderly population. 44•45 Accuracy with use of the devices may be 
limited in people who walk at a slow velocity or with a nonsymmetrical gait.46 
An important first step is selection and testing of reliability and validity of these 
devices in the elderly population. 
The second group of outcome measures were those that saw subjects 
assigned to a mobility grade, either by direct observation or by review of clinical 
records. In general, scales are simple for routine clinical use, giving descriptive 
information not only on achievement of prosthetic walking, but also on use of 
gait aids, use of a wheelchair, and ability to transfer. From the included studies, 
explicit and identifiable differences in mobility were lost owing to the great 
diversity of scales and definitions used; some described just 3 levels of mobility 
and others provided detail of up to 8 levels. Many scales were self-developed by 
the authors of each study. Only 2 of the studies gave consideration to reliability 
of the scale: the Functional Rating Scale for Amputees and the Harold- Wood­
Stanmore scale.26• 34 The latter was previously found as the most frequently used 
scale in literature40 and was later developed into the Special Interest Group 
in Amputee Medicine (sIGAM) scale.47 The SIGAM scale is recommended for 
use to describe basic, clinically useful functional levels, with demonstrated 
reliability." 1 •42•47 However, the SIGAM scale was not identified in this review as 
having been used in an elderly population; it is limited to prosthetic mobility only 
and whereas the Harold-Wood- Stanmore scale is a therapist-assigned measure, 
the SIGAM scale is based on results from a questionnaire.47 The Functional Rating 
Scale for Amputees incorporates prosthetic and nonprosthetic mobility including 
(in)dependence with a wheelchair and use of assistive devices but has not been 
used extensively. Three studies22 •32•33 used a scale originally described by Volpicelli 
but the clinimetric properties of this scale have not been reported. 42 Consensus 
on the use and application of mobility scales that include prosthetic and 
nonprosthetic mobility, as well as a preferred option for the elderly population, is 
required to enable more accurate comparison of results between studies. 
Results from the included studies confirmed that when looking at selected 
populations of elderly patients, mobility can be achieved by a high proportion of 
patients. From the mobility grading scales, up to 70% of people from a selected 
population maintained a household level of prosthetic walking for at least 6 
months post amputation or 3 months post rehabilitation. 29 Studies inclusive of 
all patients undergoing amputation reported up to 39% maintained prosthetic 
walking.23 Taking into account that a proportion of the population will not 
survive the acute post amputation phase, the potential for surviving patients to 
achieve prosthetic walking appears quite high. In contrast, however, 3 studies 
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reported that only about 20% of people maintained household prosthetic walking 
long term. 3 1•34•37 From a broader view, incorporating measures of both prosthetic 
and nonprosthetic mobility, between 36% to 81 % of people were reported as 
being independently mobile. 32•34 With such great discrepancy in the results, a 
clinically useful prognosis for mobility in the elderly person with LLA cannot be 
made. 
Amputation, patient characteristics and population selection are presented 
in Table 2. Additional variables addressed in the included studies were physical 
abilities ( 1-leg standing balance, pre-amputation mobility, physical comorbidity 
( cardiovascular disease, diabetes, stroke, chronic obstructive pulmonary 
disease), psychological comorbidity (depression, cognitive decline), cognitive 
traits (motivation, confidence), and social situation (marital status) . Further 
investigation of these variables was prevented from the limitations imposed 
by the included studies, which were described earlier. Within the limitations 
of this review, the 1-leg balance test seems an important factor with potential 
for predicting prosthetic mobility. Missing from the included literature is the 
influence of rehabilitation setting, which may also affect mobility outcomes of 
elderly people with LLA. The variables described should be further investigated 
for their influence on mobility in this population. Provision of a prosthesis 
and gait training is a costly and time-consuming process. Being able to better 
select patients by their mobility potential, for example, those who will achieve 
and maintain prosthetic walking or those who could better focus on regaining 
nonprosthetic mobility, is an important goal for future research to aim toward. 
Limitations of the review 
A cautious approach was taken for the exclusion of articles, with 2 investigators 
independently reviewing all publications at each stage of the search and 
exclusions made only where both reviewers had agreed. Nevertheless, titles 
are inherently limited in the information that they can convey and we cannot 
rule out having excluded relevant studies if the focus appeared otherwise. A 
thorough reference check of all 200 full-text articles found only 1 additional 
publication, published in 1967, that lends support to the comprehensiveness of 
the original search strategy. Although agreement between reviewers during each 
stage of the original search was only moderate, as measured through Cohen's K, 
no publication was excluded before discussion and agreement from at least 2 
reviewers. A further limitation was that no measure of agreement could be 
calculated for the updated search, as the reviewers were no longer independent, 
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Isolating studies concerning elderly patients with LLA was problematic 
because of varied definitions. There were publications that, although they 
described "older" or "elderly" patients in the title, included patients younger 
than 50 years, 45-51 reported only a mean age, 52 or did not report the age at all. 53 
There were also studies where nothing was immediately indicative that an elderly 
population had been studied.23•30•34 To minimise the risk of missing a relevant 
publication, all abstracts were included where the mean or median age was older 
than 60 years, and then the full text was reviewed for detailed data concerning 
mobility in a subgroup older than 60 years. Age is frequently used in statistical 
models to predict mobility outcomes, with an increased age associated with a 
poorer mobility outcome. In general, these studies did not meet our inclusion 
criteria, as they presented no detail on the outcome for the elderly patient other 
than having a poorer outcome compared with their younger counterparts, and 
the publications were therefore excluded. Analysis within elderly-only groups 
would be of value to determine the effects of ageing within the elderly population. 
There are many varied and important aspects to be addressed in 
rehabilitation of the elderly person with LLA, including psychological health, 
social support, care of the residual limb, and other physical functioning skills, 
such as activities of daily living.  This article considered only mobility outcomes. 
Presently, there is no consensus on what constitutes a successful mobility 
outcome. Our criteria provided a strict time frame for measurement of mobility 
that would inform on established outcomes; that is, mobility was to be assessed 6 
months after the amputation or 3 months after rehabilitation. Many publications 
were excluded because they gave no specific detail on timing or gave only the 
mean follow-up, with no standard deviation or range. Our criteria excluded 
reports of prosthetic use versus nonuse, prescription of a prosthesis, or duration 
of wearing a prosthesis, such as hours per day, although these measures may 
provide information on a preference for prosthetic walking. Studies considering 
balance only were also excluded, as the patient was not moving from one point 
to another, although balance may be a prerequisite for mobility. 1 7•1 8•23 Possibly, 
outcomes related to nonprosthetic mobility are studied through secondary 
measures such as general daily functioning or activities; for example, mobility 
may be implicit in a functional measure of performing a task such as independent 
meal preparation. The relationship between nonprosthetic mobility and 
functional independence could be investigated in future studies. 
Many mobility grades have similarities with more general scales of daily 
function and independence. Publications were included where there was a 
focus on mobility but this was difficult to judge in some cases. Results from 
the mobility grades were summarised into (1) household prosthetic walking 
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with or without a gait aid and (2) independent mobility through any means, for 
example, by using a wheelchair or gait aids. Given the variation in the number of 
mobility grades and scope of definitions within each grade, this categorisation 
was somewhat subjective. However, it did provide clarity and consistency in 
presentation of the studies, which would otherwise have not been evident. 
Summarising also allowed consistency in reporting of the results, with all 
reported as a proportion of the study's total included population. 
Conclusions 
The lack of strong findings drawn from this systematic review does not reflect 
the importance that mobility can afford in enabling independence for the 
elderly person with LLA. Evidence to support a prognosis for prosthetic and 
nonprosthetic mobility is not available in current literature. The unique 
requirements that elderly people face in their rehabilitation, arising from multiple 
comorbid conditions and a short life expectancy, support a need for further 
investigation of mobility in this population. 
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Abstract 
Background: For research findings to be generalised, a sample must be 
representative of the actual population of interest. Lower l imb amputation 
is most frequently performed in older patients with vascular disease, a 
population that is often under-represented in research. 
Aim/methods: The aim of th is study was to explore the impact of selection bias 
by comparing characteristics from a sample included in a prospective study 
of phantom pain with the actual population who underwent amputation. 
Results: Only 27% of all potential patients were referred during the first 
year of the prospective study. The referred patients were 8 years younger 
(p<0.00 1 )  and less likely to have had amputation because of a vascular 
condition, diabetes or in fection (p=0.003) than those not referred. There was 
also a significant difference in one year survival between the groups; 67% of 
referred patients survived compared with just 40% of non-referred patients 
(p=0.004). 
Conclusions: The biased population in the phantom pain study may have 
resulted in an underestimation of phantom pain in the original study and 
subsequent protective factors should be considered within the context of 
the younger population reported. Selection bias is common in amputation 
research, and research methods to minimise its impact must be given greater 
attention. 
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I ntroduction 
After a lower limb amputation (LLA), people face a number of challenges 
including loss of mobility, altered body image and phantom pain. Research 
to better understand these consequences allows planning for rehabilitation 
and long term care and builds an evidence base from which we can more 
accurately inform patients on their expected outcomes. However, difficulties with 
population sampling are frequent in amputation research and this impacts our 
ability to draw accurate conclusions. 
LLA is most frequently performed in older patients with vascular disease, a 
population that is, for the most part, under-represented in research. 1 Multiple 
comorbidities and cognitive decline can prevent this sub-population from 
meeting required inclusion criteria. The issue of bias in studies of elderly people 
is well recognised.1 -4 The same is true of amputation research, with authors' 
invariably describing selection bias within their sample as a limitation of their 
study. 5-1 1  However, the impact of this bias is rarely described. 12 It is important to 
understand this research limitation in applying results to clinical practice and to 
better design future studies. 
In a prospective study of phantom limb pain, it was noted that the population 
characteristics of the included sample were considerably different from what 
would be expected in the LLA population.5 The aim of the current study is to 
explore the impact of this bias on the primary outcomes (factors associated with 




The study protocol was approved by the medical ethics committees of the 
University Medical Center Groningen. Patients participating in the phantom pain 
study provided their written informed consent. 
Setting 
Both studies were conducted in the 3 northern provinces of the Netherlands: 
Groningen, Friesland and Drenthe. Fourteen hospitals in the region performed 
lower limb amputations, generally under the care of a vascular surgeon. This 
study looks at patients who had a first ever unilateral transtibial amputation, 



















Phantom pain (PP) study 
A prospective study ran from 1 November 2003 to 30 April 2008. At a face-to-face 
meeting, and confirmed afterwards in writing, surgeons were informed about 
the study including the aims, inclusion and exclusion criteria, and recruitment 
procedures. 
The surgeons were requested to include all patients: [1] aged �18 years; [2] 
undergoing primary major amputation (at or proximal to metatarsophalangeal 
level); and [3] able to read and write in Dutch. The primary investigator discussed 
the study aims with the patient and they were asked to participate and give their 
written consent. 
Exclusion criteria were: [1] had a previous ipsilateral amputation; [2] were 
too unwell or showed signs of clinical dementia which prevented completion of 
the questionnaires; or [3] were recruited more than 5 days after the amputation. 
If the surgeons themselves decided to exclude a patient, they agreed to send the 
characteristics of the patient (age, sex) and amputation details (level, cause) to the 
primary investigator to ensure a complete census of patients was recorded. The 
primary investigator maintained regular contact with the study coordinator at 
each hospital. 
Population study 
In 2010, surgeons from each hospital were contacted about a new study on the 
incidence of LLA. Surgeons from all hospitals agreed to participate. They were 
requested to compile a list of patients who underwent major amputation in 2004. 
The medical records of these patients were reviewed between August 2010 and 
July 2011 for patient data (age, sex), amputation details (level, cause), marital 
status, comorbidities and medical history including previous minor amputations 
or peripheral vascular procedures ( angioplasty, embolectomy or peripheral 
bypass) and survival or date of death. To ensure a complete survival dataset, 
general practitioners were contacted for patients whose status was not up to date 
in hospital records. 
Statistical analysis 
Characteristics of referred patients (irrespective of whether they were included 
or excluded from analyses in the original study) were compared with the non­
referred patients using x2 tests for categorical variables, Mann-Whitney U test for 
age distribution and log rank tests for survival. Significance was set at 0.05 and 
analyses were performed using PASW Statistics version 18.0. 
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Results 
Surgeons representing 12 of 14 hospitals attended the information meeting of the 
PP-study. Two hospitals were unable to participate because of restrictions from 
their local administration and medical ethics procedures. Surgeons from ten 
hospitals agreed to participate in recruitment of patients. From the current study, 
one hospital was unable to identify the relevant files because of changes in their 
database. This hospital was excluded and subsequently, one patient from this 
hospital who had been referred to the PP study was excluded. 
Thirty nine (27%) of a possible 146 patients were referred during the first 
full year of the study (table 1) . The referred population had a median age 8 
years younger (p< 0.001) and were less likely to have had amputation because 
of a vascular condition, diabetes or infection (p=0.003) than those who were 
not referred. More non-referred patients had bilateral amputation while more 
referred patients had a knee disarticulation (p=0.049). No differences in the 
number or type of major comorbidities were seen, although referred patients 
were more likely to have had undergone a previous vascular intervention 
(p=0.042) such as a peripheral bypass procedure or angioplasty. Referred patients 
were more frequently discharged home or to a rehabilitation centre with non­
referred patients more often discharged to a care centre (p=0.020). 
There was a significant difference in one year survival between the groups; 
67% of referred patients survived compared with 40% of non-referred patients 
(p=0.004). Overall survival time after amputation also differed significantly 
(figure 1): median (standard error) survival for referred group = 41.1 (7.9) 
months, non-referred = 13.6 (6.6) months, x2(1df) = 5.6; p=0.018. 
To verify whether or not the differences in the groups were linked to the 
significantly poorer survival of the non-referred population, characteristics of 
patients who survived to 12 months are presented in table 2. There remained 
a significantly younger median (p=0.016) and mean (p=0.007) age difference 
between the referred and non-referred group. Again, the referred group were 
more likely to have had a knee disarticulation, less likely to have had a transtibial 
amputation (p=0.041), and more frequently had amputation because of non­
vascular causes (0.012). There were no other significant differences between the 
referred and non-referred groups in 12 month survivors. Overall survival differed 
by 9 months (median (standard error) survival for referred group = 64.1 (14.7) 
months, non-referred = 55.6 (11.5) months, x2(1df) = 1.8; p=0.177) and non­
referred patients were more frequently discharged to a care centre while referred 
patients were more often discharged to a rehabilitation centre (p=0.130). 
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(PP stud ) p o u lation 
Total included 39 (27) 1 07 (73) 1 46 
Age, median (IQR) * 67.6 (50.8 ; 72.9) 75.5 (68.1 ; 83.3) <0.00l t 73.0 (65.2 ; 80.9) 
Age, mean (sd) 63.0 ( 1 3.9) 74.4 (1 2.0) <0.001 *  7 1 .4 ( 1 3.5) 
Men 24 (62) 63 (59) 0.463 87 (60) 
Cause of amputation 
vascular 31 (80) 1 01 (96) 0.003 1 32 (92) 
other 8 (2 1 )  4 (4) 1 2  (8) 
Level of amputation 
bi lateral 2 (5) 1 1  ( 1 0) 0.049§ 1 3  (9) 
transfemoral 1 2  (32) 32 (30) 44 (30) 
knee d isarticulation 7 ( 1 8) 5 (5) 1 2  (8) 
transtibial 1 7  (45) 59 (55) 76 (52) 
Admitted from 
home 24 (75) 58 (62) 0. 1 25 82 (65) 
care 8 (25) 36 (38) 44 (35) 
Marita l status 
married/partnership 21  (64) 42 (49) 0. 1 1 8  6 3  (53) 
single/widow/ divorced 1 2  (36) 43 (5 1 )  55 (47) 
Number of comorbidities 
0 7 (23) 9 ( 1 0) 0.1 71  1 6  (1 3) 
1 -2 15 (48) 56 (63) 73 (59) 
� 3  9 (29) 24 (27) 33 (28) 
Comorbidities 
peripheral vase disease 21  (57) 54 (5 1 )  0.320 75 (52) 
hypertension 1 6  (42) 39 (36) 0.334 55 (38) 
diabetes 1 4  (37) 45 (42) 0.358 59 (41 ) 
congestive heart fai l ure 6 ( 16) 26 (24) 0.2 1 7 32 (22) 
myocardial infarct 5 ( 1 3) 1 4  ( 1 3) 0.593 1 9  ( 1 3) 
cerebrovascular disease 3 (8) 1 7  (1 6) 0. 1 85 20 ( 14) 
chronic l ung disease 8 (22) 1 8  ( 1 7) 0.335 26 ( 18) 
kidney disease 9 (24) 2 1  (20) 0.376 30 (21 )  
Peripheral vase. procedure 23 (59) 44 (41 ) 0.042 67 (46) 
Discharged to 
home 1 0  (26) 1 6  ( 1 6) 0.020 26 ( 1 8) 
rehabil itation centre 9 (23) 8 (8) 1 7  ( 1 2) 
care 15 (39) 53 (52) 68 (48) 
d ied before discharge 5 ( 1 3) 25 (25) 30 (2 1 )  
1 2  month survival 26 (67) 43 (40) 0.004 69 (47) 
Hospital 
> 1 0  amputations 29 (27) 80 (73) 0.960 1 09 (75) 
s 1 0  amputations 1 0  (27) 27 (73) 37  (25) 
p is difference between referred and non-referred groups; *Median age presented because data were not 
normally distributed, and mean age also presented to enable comparison to original PP-study; t Mann Whitney 
U Test; :j: Independent sample t-test; all others are x-square test; §Exact method used as cell count assumptions 
not met;**Comparison of hospitals with > 10 (n=6) amputations to s;10 amputations (n=7); Actual population 
is presented to enable comparison of characteristics, no statistical analysis was performed; not all percentages 
add up to 100 because of rounding. 
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Table 2: Characteristics of referred and non-referred patients who survived 
� 1 2  months after am utation. 
n (%) Referred (PP study) Not referred p Actual population 
Total included 26 (38) 43 (62) 69 
Age, median (IQR) * 65.4 (50.1 ; 75.3) 72. 1 (65.2 ; 8 1 .2) 0.01 6t 70.2 (61 .8 ; 77.9) 
Age, mean (sd) 62.2 (1 5. 1 )  7 1 .3 ( 1 2.0) 0.007* 67.9 (1 3 .9) 
Men 14  (54) 28 (65) 0.249 42 (61 )  
Cause of amputation 
vascular 1 9  (73) 41 (95) 0.01 2 60 (87) 
other 7 (27) 2 (5) 9 ( 1 3) 
Level of amputation 
bilateral 0 (O) 3 (7) 0.041 § 3 (4) 
transfemoral 8 (3 1 )  8 (1 0) 1 8  (26) 
knee disarticulation 6 (23) 2 (5) 8 ( 1 2) 
transtibial 1 2  (46) 28 (65) 40 (58) 
Peripheral vase. procedure 1 5  (58) 20 (47) 0.258 35 (5 1 )  
Discharged to 
home 8 (3 1 )  1 0  (24) 0.1 30 1 8  (27) 
rehabilitation centre 8 (3 1 )  6 ( 1 4) 1 4  (21 )  
care 1 0  (39) 26 (62) 36 (53) 
p is difference between referred and non-referred groups; *Median age presented because data were not normally 
distributed, and mean age also presented to enable comparison to original PP-Study; t Mann Whitney U Test; * 
Independent sample t-test; all others are x-square test; §Exact method used as cell count assumptions not met; 
Actual population is presented to enable comparison of characteristics, no statistical analysis was performed; not all 
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Figure 1 :  
Survival of patients 
referred and not referred 
to study after lower limb 
amputation. 
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Discussion 
A prospective study of phantom pain aimed to report all patients undergoing 
primary major lower limb amputation yet more than 70% of potential 
participants were not referred in the first year. This resulted in a sample that was 
younger, less likely to have had vascular related amputation and differed in both 
pre and post care setting than the actual population who underwent LLA. 5 
The PP-study described a prevalence rate for phantom pain of 32% measured 
6 months after amputation. 5 Other literature measuring occurrence at 6 months 
has reported more than double this amount, with 65-79% of people having 
phantom pain. 13•14 Occurrence rates at 6 months in trials to treat phantom pain 
range from 0-38% (0/10 in intervention; 5/13 in control group) 15  to 9-73% (1/11 
in intervention; 8/11 in control). 16 The PP-study has a lower rate of phantom 
pain than expected which raises some uncertainty in generalisation and clinical 
application of the protective factors identified. These protective factors should be 
considered within the context of the biased population. 
Three protective factors against the development of phantom pain were 
described: being male, having a lower limb amputation (versus an upper limb 
amputation) and time since amputation.5 In the current study, there were no 
differences in sex between referred and non-referred patients (upper limb 
amputations were not included and only one year of the PP-study was analysed). 
Other factors in the PP-study were also investigated but not found to be 
significant, including level of amputation, cause of amputation and age at time 
of amputation. None of these factors were accurately represented by the sample 
referred to the PP-study and it is not possible to draw a valid conclusion over their 
influence based only on this data. 
The factors identified in the PP-study were largely in disagreement to other 
literature. In addition to prevalence rates being much higher than the PP-study, 
sex is reported as being unrelated to occurrence of phantom pain13•17 although 
males and females may deal with the pain differently. 18 Increasing age is shown as 
having a higher risk of phantom pain 19 while others have reported no relation 17 or 
not included age in their analysis. 13 More proximal amputation levels and having 
bilateral amputation, may increase a person's risk of phantom pain19 although 
again, others have found no association between the two. 13•20 
The contradictory findings surrounding phantom pain in these different 
populations are, at least in part, also partly attributable to differences in 
definitions and study design. Cut off points for what constitutes phantom pain 
can include people with almost constant pain or people who experience only 
occasional pain. 5 Most previous studies of phantom pain are cross sectional and 
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direct cause and effect cannot be stated. Studies include people with differing 
lengths of time since amputation, from a few months to many years, 18•19•2 1  yet 
time since amputation is another factor potentially linked to phantom pain. Poor 
physical condition from comorbidities and cognitive deficit leads to difficulties 
in patient inclusion and sample sizes are generally small. As amputation research 
is also characterised by a high mortality rate, follow up rates are often low. In 
this study almost 50% of the total population had died within 12 months of 
their first major amputation, including 33% of the referred group. The PP-study 
is the largest longitudinal study of phantom pain performed ( total included at 
first follow up was 85 from 120 included) and followed patients for up to 3 .5 
years.5 Unfortunately, the substantial bias seen in the population presents a major 
limitation and there remains limited evidence around risk factors associated with 
phantom pain. Reviews looking at mechanisms and treatment of phantom limb 
pain reveal similar shortcomings in methodology. 22-26 
A major difficulty with amputation outcome research is obtaining large and 
representative samples. The reasons for having an amputation make it difficult 
for many cases to be included in research as elderly people with systemic disease 
tend not to be considered for participation and have a higher rate of drop out 
or death. 1 This appeared to be a key element of (non)recruitment to the PP­
study, with patients who were older and with amputation due to vascular disease 
least likely to be referred. Data, or at least their estimates, on non-participants 
(including people who did not give consent, patients who are excluded, deaths 
and drop outs) should be communicated by authors. In the PP-study, all referral 
sources were requested to provide this information, but unfortunately it did 
not occur. Minimal data presented in amputation research should include the 
number of participants and non-participants, age, sex, level of amputation and 
cause of amputation. 
Our data were split to look at 12 month non-survivors compared to 
survivors. With outcomes of interest for the frailer group likely differing from 
the survivors, it is reasonable that they are not included in longitudinal outcome 
research. Unfortunately, our results showed that a substantial number of this 
healthier group, the 12-month survivors, also failed to be included in the PP­
study. In designing any study, gaining strong interest and support from relevant 
stakeholders and referral sources is vital. In the case of the PP-study, referral 
sources (surgeons and staff) were informed of the aims and methodology at 
a regional meeting, with verbal agreements given for participation (referral 
of patients) . The high referral rate (>85% of all within hospital, contributing 
>69% of all referred) from the study's operating/base hospital, suggests either 
the physical presence of the investigator and/ or simply being the study's main 
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location are the most effective strategies for recruitment. Across the entire 
regional network of hospitals, a physical presence was not possible. Attempts 
to counter this limitation through regular phone and newsletter contact were 
unsuccessful, with 6 hospitals not referring patients in the first year despite 
their agreement. Improving recruitment via clinicians is a difficult task; even 
large randomised controlled trials have great difficulty identifying successful 
strategies.27 Adding to this are strict timeframes of the inclusion criteria of the PP­
study with referral set for within 5 days. This meant that surgeons (and their staff) 
were primarily responsible for identifying cases, at a time when other factors, 
such as pre-operative assessment, can naturally be of a greater priority. It is not 
routine practice for the rehabilitation physician to be involved pre-surgically 
so this additional referral source was not utilised. Other alternatives were not 
considered as clinically relevant options, such as extending the inclusion period 
to > 5 days, as this would have introduced problems with recall. 
Limitations 
The population study used data from a retrospective review of medical files and 
as such, information was limited to what is included in these. The data were 
collected for a concurrent study on incidence and as such, they are considered 
to be complete. However, we acknowledge that cases may have been missed. If 
anything, the sample is an underestimation, although we do not expect that this 
would have any large affect on our main findings. Another limitation from the 
study design (review of medical records) is not having access to information on 
disease severity or duration of disease. Further, unless it is of a very severe nature, 
cognitive status is infrequently noted in the medical files. However, this is likely 
to be a major source of selection bias in LLA research given that vascular disease 
affects the body systemically. Finally, there was no information on survival status 
available for 27 patients and our results are likely to be an underestimate of 
survival time. 
In the current study, all patients referred to the PP-study were considered 
as one group. However, 16 ( 41 % ) of these patients were not part of the analyses 
as they did not meet the criteria for inclusion. These excluded patients were 
older and more likely to have had amputation because of vascular disease 
than included patients.5 The findings of this current study should therefore be 
considered as a conservative estimate of the impact of selection bias as these 
excluded older patients with vascular disease remained within the 'referred' 
group. 
1 1 8 
Conclusion 
Selection bias is common, and perhaps inherent, in amputation research. Over 
70% of patients were missed in a study of phantom pain, resulting in a younger 
population who were less likely to have had vascular related amputation and 
differed in respect to their pre- and post-care setting. As a result, phantom pain 
was possibly underestimated and the resultant protective factors identified 
should be considered only within the context of the biased population. Two 
important elements for improving research into amputation outcomes were 
identified: [ l ]  failure to refer relevant cases (recruitment bias); and [2] failure to 
communicate 'reasonable' non-inclusions. Potential bias should be more clearly 
presented by authors and subsequent conclusions and clinical decisions made 
with greater caution. In addition, maximum efforts should be directed to research 
methodology which minimises the influence of bias. 
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N THIS THESIS, research on how, and how well, the elderly person with lower 
limb amputation (LLA) is enabled through rehabilitation and long term care 
(LTc) was presented. In chapters two and three, we saw the vulnerability of the 
population, arising from a combination of older age and comorbidities. This 
population presents unique challenges in amputation rehabilitation and research, 
some of which were described in chapters four to eight. The discussion following 
summarises the key findings and current literature. The clinical implications of 
amputation in this population are considered under three areas: determining 
when to amputate and at which level; rehabilitation setting; and mobility. Research 
suggestions are presented within each of these discussion points. Finally, the 
strengths and limitations of this research, as well as amputation research more 
broadly, are presented. 
Summary of main results 
The incidence of LLA resulting from vascular disease, infection and/ or diabetes in 
2003-2004 was 24 per 100,000 person-years (chapter two) . This was unchanged 
from an earlier cohort from 1991-1992, confirming that around 150 people 
each year have a first amputation in the northern provinces of the Netherlands. 
There was no change in the mean age (74.0 years) and there remained slightly 
more men than women (60% versus 40%) in both cohorts. In 2003-2004, 50% 
of the population undergoing LLA had a diagnosis of diabetes. The relative risk 
of amputation in people with diabetes was 12 times higher than that of people 
without diabetes. 
From this population, 22% of people died within 30 days of their surgery 
(chapter three) . A history of cerebrovascular disease doubled the risk of death 
within 30 days. After one year, 44% of the population had died and after 5 
years, this was 76%. Renal disease was associated with higher mortality risk at 
these time points. No significant differences in survival time were seen by any 
of the subgroups analysed, including different age groups and sex, the level of 
amputation, or by diagnosis of diabetes. 
Of those patients who survived the acute admission period, 55% were 
discharged to long term care for their rehabilitation (chapter four) . The only 
factor associated with this outcome was older age. Although the overall number 
of people with LLA admitted to LTC is substantial, patients are spread across a 
number of facilities. In 2008-2009, there were between 0-19 admissions with 
LLA, representing a maximum of 3.6% of all patients. Due to the relatively small 
numbers seen in each centre, the ability of clinicians working in LTC to obtain and 






Results of the qualitative study ( chapter five) confirmed the difficulty 
that professionals working in LTC face in obtaining skills and knowledge for 
treating people with LLA. From interviews with 9 elderly care physicians (ECPs) 
and 9 physiotherapists (PTs), three main issues were presented: difficulty 
implementing and using guidelines; a lack of involvement and specialisation of 
the multidiscplinary team; and a lack of people admitted with amputation to each 
center. There was a lot of overlap with these weak points, summarised by a PT: 
"The best thing really would be if you could have a little section where the care is 
very specialised, because every time (there is an amputation admission) we spend 
quite a lot of time teaching others how to care for those (patients) in the right 
way. It costs a Jot of energy, but there are just too few people with amputation 
admitted here." 
In chapters six and seven, two important outcomes after LLA, HRQOL and 
mobility, were considered in respect to the elderly population. Eighteen months 
after amputation, significant improvements were seen in 5 of 7 domains 
investigated - physical function, social function, pain, vitality and perceived 
change in health. Most change occurred in the first 6 months. The pattern of 
change over time differed only for physical function for people aged over 65 
years compared to those younger. As this may have been related to the very small 
sample size, we also compared older and younger groups to population normal 
values of their respective age categories. These results also supported the idea of 
age-specific differences in the domains affected by LLA. 
In a systematic review of mobility outcomes, we found advanced skills are 
achieved in selected populations of elderly people with LLA, including outdoor 
and community walking. However, when mobility is considered in unselected 
populations, inclusive of all people undergoing LLA, including those who die 
post-operatively, less than 50% of the elderly population were able to achieve 
a household level of prosthetic mobility. A range of different tools were used 
to assess mobility, and combined with poor reporting of included populations, 
it was difficult to compare the outcomes from the included studies. Measures 
of non-prosthetic mobility were limited to non-validated mobility scales that 
categorise people as being bed-bound or wheelchair dependent. 
Issues of population inclusion and selection bias were noted throughout the 
research presented in this thesis. In chapter eight, the extent of this problem was 
described in reference to a previously published prospective study on phantom 
pain. By comparing to the actual population who had LLA ( derived from chapter 
two), we identified that more than 70% of potential inclusions had not been 
1 26 
referred to the study. The missing population was 8 years older, more likely to 
have had LLA because of a vascular-related cause and there was a significant 
difference in one year survival between the groups ( 40% not referred versus 
67% referred). When comparing the included and missing populations without 
'reasonable non-inclusions' (i.e. we excluded all of the population who did not 
survive 12 months, who were most likely not referred to the study because of the 
severity of their condition), important differences in the age and amputation level 
remained. 
Determining when to amputate and at which level 
Looking from the focus of how we can best enable the elderly person with 
LLA, the idea of being more aggressive needs due focus, by operating sooner 
and/or at a more proximal level or by choosing not to amputate at all. Two 
findings from this thesis lend additional support to this idea: [ 1] a very high 
rate of post-operative mortality and [2] the improvement seen in HRQOL and 
mobility for those who survive. Although at first the idea of amputation is highly 
confronting, it might in fact be a disservice to some patients to continue attempts 
at limb salvage, through ( endo-) vascular procedures, medications or prolonged 
hospitalisation and immobility. 
This line of thought has been termed "choosing life or limb" 1 to describe 
the reasoning that a person at risk needs to make an informed decision, ideally 
before the limb has reached a critical stage. 
'Just as the functional status of the patients is often a contra-indication to 
other disease treatments, chemotherapy for some cancers, for example, then 
we should be considering carefully whether we should be removing limbs from 
patients whose functional and medical status will not improve significantly as a 
result. Equally, there may be patients who may benefit from an early amputation 
and ambulation with a prosthesis." l : Game, 2012, P 97 
Put simply, 'choose life' and the patient will undergo amputation, enabling 
them to get out of hospital and get moving again. Also referred to as "positive, 
early amputation;' the amputation can be performed before the limb reaches a 
critical level, in which the patient's life is at risk. So far, this early intervention 
approach has mainly been reported in respect to younger patients with diabetes,2 
or in the population with trauma who are considering limb salvage versus 
amputation. 3-5 For the elderly population, early intervention might reduce an 
otherwise lengthy period of immobility and hospitalisation while attempts to heal 













that a substantial decrease in physical condition and function can occur, leading 
to poorer potential for good rehabilitation outcomes;6 pre-operative function 
being an important element for achieving a better outcome from rehabilitation in 
LTC.
7 Alternatively, a patient and their team may choose a more palliative pathway 
for care. This choice will effectively reduce their life expectancy. The decision on 
'life or limb' is, of course, never straightforward and it is often complicated by the 
urgency with which people must be treated, when patients' do not seek timely 
care.8 A case description highlights the myriad issues involved (see text box "Late 
in life, an agonizing choice over surgery"). 
A high incidence of LLA and poor mortality are often considered a failure 
of care. However, these rates must be viewed in the context of many additional 
influences, such as the population at risk, access to foot clinics, skills and 
knowledge of the surgical team, systems of recording hospital episodes. In 
short, incidence and mortality rates should not be considered as representative 
of the quality of care provided.9 Instead these rates must be placed into context 
of individual and institutional preferences in determining a medical or surgical 
pathway. It is now more accepted that LLA should not always be viewed as a 
negative outcome as it can represent healing and the end of pain. Previously 
maximising limb length was the overriding aim, whereas now, choosing to 
amputate at a proximal level, in some cases, is preferable if it provides the patient 
or carer a more functional outcome. 10 Following a similar approach, and keeping 
focus on what the patient sees as important, high incidence and poor mortality 
rates should also not always be viewed as a negative outcome. 
Research suggestions 
Continued surveillance of incidence of LLA and population characteristics can 
give insight into the need for preventative, rehabilitation and LTC services. Our 
results were suggestive that a small decrease in incidence was apparent, but 
without statistical confirmation. To gain a more confident answer to the question, 
a repeat study with a recent cohort is suggested. This would aim to evaluate if 
the lack of change in incidence in the northern provinces was due to chance 
or if we need to seriously consider the preventative services currently being 
provided. A repeat of the study presented in chapter two, would also enable the 
evaluation of changes in LLA performed as a complication of diabetes, data that 
was unfortunately not available in the 1991-1992 cohort studied. 
The reasons for high and varied rates of mortality also need to be explored. In 
chapter three over 20% of the population died within 30 days of their amputation. 
A similar rate has been reported, 1 1-14 while others have found it to be substantially 
less at around 8-10%. 15-20 The population included in a study has a direct effect on 
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Late i n  Life, an  Agon izing  Choice Over Su rgery 
FORGOING A POTENTIALLY LIFE-SAVING medical procedure may be easier at age 94 
than age 54, but for my patient George Pollack 
it was a wrenching decision anyway. Suffering 
from a severe foot ulcer that would not heal, he 
was told his only chance of a cure was a partial 
amputation of his leg. Even then, there were no 
guarantees. 
George was a savvy medical customer. He had 
been a lawyer in New York for more than 60 
years - among other things, serving as executor 
for the estate of Lou Gehrig's widow, Eleanor, and 
making sure that any payments from the use of 
Gehrig's image went toward A.L.S. research at 
Columbia University Medical Center. I originally 
met George when I was doing research on Lou 
Gehrig's illness. 
George was suffering from peripheral vascular 
disease, or obstruction of the arteries that feed 
the limbs. Early on, it is possible to reopen 
clogged blood vessels with a balloon. But when 
the disease worsens, blood-starved areas, usually 
the feet, may develop life-threatening ulcers. By 
the time I met George, in 2002, he was already 
prone to ulcers - a result of flat feet and decades 
of poor circulation - and he required a complex 
combination of antibiotics, ointments and 
dressings. I gave what advice I could, referring 
him to an infectious-disease specialist who 
helped cure one of the largest ulcers. 
By April 2009, things were worse. George had a 
large ulcer that would not heal on his left foot and 
was requiring hospitalizations and intravenous 
antibiotics. One surgeon strongly advised a 
below-the-knee amputation of the left leg. 
George got a second opinion from Dr. Alan I. 
Benvenisty, a surgeon and director of the vascular 
laboratory at St. Luke's Hospital. In August, 
hoping to try a balloon procedure, Dr. Benvenisty 
sent him for an angiogram, a dye study that 
generates images of the arteries. But the test 
showed that a balloon was out of the question. 
Amputation was the only surgical option. So Dr. 
Benvenisty did what any doctor should: he laid 
out the options, pro and con. He told George 
that surgery was very risky and that the wounds 
did not heal properly in roughly 30 percent of 
below-the-knee amputations. A study of 704 
such operations, published in The Archives of 
Surgery in 2004, found that patients were at 
risk for "significant morbidity and mortality:' In 
George's case the odds were even longer: he was 
94 and had suffered a mild heart attack during 
his angiogram. And then there was rehabilitation. 
At the very least, George would require two 
taxing months of aggressive physical therapy in 
a nursing facility. 
What was the other option? Without surgery, 
Dr. Benvenisty told George, the vascular disease 
would probably kill him in a matter of months. 
I was among the many people to whom George 
spoke. Part of him clearly wanted to try surgery. 
After all, he told me, who does not want to live? 
But he spent even more time telling me why he 
thought surgery was too risky - and how even 
if it succeeded, he couldn't bear to be away from 
his frail 90-year-old wife, Dorothy, during his 
rehabilitation. ''A few months is a long time when 
you get to be our age;' he said. George's daughter, 
Ruth Pappas, recalls hearing mixed signals from 
him at first: "I don't want to go on;' but "I haven't 
given up:' 
Ultimately, though, George chose hospice care 
over surgery. Ruth's husband, Tony Pappas, says 
George told him that even if the operation went 
well, he thought there would be complications 
and his life would not be prolonged. George 
chose home hospice. The hospice worker helped 
him go to the bathroom, keep clean and get in 
and out of bed. But he was not in hospice for long. 
He had already developed a fever, and after a few 
days he was worse, probably from a foot infection 
that had spread into his bloodstream. When the 
hospice physician proposed an antibiotic, George 
declined, saying, "I don't want to feel better:' Ruth 
believes this was her father's way of saying he was 
ready to die. He did so later that night, quietly, in 
his sleep. 
Dr. Benvenisty told me that in his experience, 
George was the exception to the rule. Most 
patients forge ahead - even those who swore 
never to have an amputation and those at high 
risk of dying from the procedure. I think George 
did the right thing, and perhaps I should have 
guided him even more in that direction. In the 
end, however, I was glad he made his own choice. 
Written by Barron H Lerner "From The New York Times, 16 Nov C 
2010 The New York Times. All rights reserved. Used by permission 
and protected by the Copyright Laws of the United States. 
The printing, copying, redistribution, or retransmission of this 
Content without express written permission is prohibited." 
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mortality outcomes, such as the inclusion of different causes of amputation, but 
there are additional factors to be considered, such as whether only people with 
a first amputation were included or also people with subsequent amputations. A 
review of mortality rates presented in literature is needed with the aim to look for 
any existing links between mortality outcomes and variables such as age at time 
of LLA. Special focus should be given to the population who survive 30 days but 
not longer than 12 months, and why the 30-day mortality rate differs so greatly 
from one population to another. 
The decision process for people presenting with critical limb ischemia or life 
threatening infection is mostly approached from a surgical perspective, often 
with a focus on limb salvage. Outcomes of amputation surgery have also been 
considered mainly from a surgical/ medical perspective, for example healing time 
and survival rates, and only recently have patient factors, such as quality of life, 
come to be seen as important.2 •10•2 1 •22 Rehabilitation and elderly care professionals 
could add important knowledge on rehabilitation prognosis and mobility 
potential and open further dialogue on quality of life and issues of importance 
to the elderly population. The current search for evidence-based decisions and 
discussion on when to amputate and at which level 1 •23•2" would benefit from this 
wider team approach. 
Amputation rehabilitation in the long term care setting 
Amputation rehabilitation in the Dutch LTC setting is gaining increasing interest 
and it appears to offer a lot of positive opportunities. The focus on this setting 
will likely continue as a change to the funding of rehabilitation services is being 
implemented, taking effect in 2013. One of the benefits of rehabilitation in LTC 
is having access to clinicians with specialist skills for the elderly population. 
An interdisciplinary team approach to rehabilitation after LLA is vital with 
each member having an important role in maximising outcomes.25•26 In the 
Dutch LTC setting, the team approach does not appear to have fully translated 
into care. The physiotherapist was largely responsible for all amputation 
related aspects, in consult with the rehabilitation physician and prosthetist. 
The occupational therapist in particular, was not involved in amputation 
rehabilitation with exception of arranging wheelchair prescriptions and a home 
visit before discharge (chapter five). This problem is not confined to our LTC 
setting or to the Netherlands, with a recent systematic review identifying just 2 
studies considering rehabilitation of amputation for the older person from this 
professions perspective.27 The studies included in that review were limited by 
methodological problems, however, there was some support that an increased 
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frequency of occupational therapy sessions relates to increased use of a prosthesis. 
Occupational therapists are widely considered as integral or core members28 to 
the functional outcomes achieved in amputation rehabilitation.25•26 Despite these 
endorsements, there is little practical application or documented evidence, at 
least within the LTC setting. 
Rehabilitation setting after LLA has mainly been looked at from the 
perspective of traditional rehabilitation center inpatient care. This setting yields 
best outcomes in terms of survival, a receipt of a prosthesis and better mobility, 
being more likely to return to independent living, greater medical stability, a 
lower number of subsequent amputations and a higher quality of life.29-33 For the 
elderly population, more interest has been given to larger populations, namely 
people with stroke or orthopaedic disorders. Two recent studies on amputation 
rehabilitation in the LTC setting reported 57-65% of people returning home 
within one year, with pre-operative functional ability the main factor associated 
with this outcome. 7•34 
The conclusion of the qualitative study ( chapter five) was that despite 
positive outcomes for patients with LLA, to a large extent, their care extends 
from a process of continuous problem solving, along with the energy and 
empathy of the clinicians involved. There is relative inexperience in treating the 
amputation population. Flexibility and informal communication styles between 
team members enables these patients to still achieve fairly good outcomes.7•35•36 
Unfortunately, this approach to care of people with LLA is largely unsustainable, 
when considered in the context of increasing demand for evidence in decision­
making and a need for greater efficiency. 
Research suggestions 
A major limitation with research in the LTC setting to date is both the lack and 
choice of outcome measures used. For example, in the research mentioned earlier, 
a successful outcome of rehabilitation was defined as 'return to home:7·34 However, 
this does not necessarily equate to better outcomes of mobility, function or 
HRQOL, with return to home for this population also highly reliant on additional 
resources such as the availability of family / carers and accessibility to the home 
or it could even reflect a choice for palliative end-stage care. Outcome measures 
in the LTC setting for people with LLA are infrequently used (chapter five). 
Determining which measures are of importance for evaluating rehabilitation of 
the elderly person with LLA, and actually implementing these measures in the LTC 
setting, will add much needed support for continuing this service. 
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(Prosthetic) mobility 
Following LLA, there is often a focus on prosthetic mobility. Chapter seven 
presented the numerous ways in which outcomes of prosthetic mobility have 
been defined in terms of prescription of a prosthesis, length of time worn or 
hours of use, an ability to perform certain skills or measuring the time to walk a 
determined distance and vice versa. More personalised definitions of a successful 
outcome are sought, but have not as yet been agreed upon. For example, 
Norvell et al. propose that mobility success after LLA needs to be considered 
"relative to the impairment necessitating the surgical procedure, but also relative 
to the additional impairments that affect mobility at baseline. "37: P412 Prosthetic 
mobility for the elderly population is a difficult task and of all elderly people 
undergoing LLA, less than half manage this skill (chapter seven) . Not only does 
prosthetic training require substantial effort from the patient themselves, but 
the rehabilitation team and prosthetist also invest a great deal of their time and 
energy. To see this effort reflected in a poor outcome is not only disappointing 
for the patient and clinicians,38 but is also an inefficient use of rehabilitation 
resources. 
Barriers to prosthetic mobility were desrcibed in publications from as early as 
the 1950's, which listed the clinical contra-indications for prosthetic ambulation: 
"There are few absolute contraindications to prescription of a prosthesis: these are 
severe cardiovascular disease, inadequate motor coordination, and senile mental 
changes."39: Grynbaum, 1956, p295 
"Basic requirements for satisfactory limb fitting in the aged: 
1. An adequate stump. 
2. Good general health - particularly in reference to cerebral, cardiac, pulmonary 
and renal function. 
3. Opposite leg in good condition. 
4. Amputee capable of unassisted crutch walking on the remaining leg. 
5. Considerable initiative and perseverance."40:McGoey, 7954, P471 
While preferred terminology has changed, the underlying principles of 
prosthetic prescription have not advanced much further and remain very much 
reliant on clinical experience.41 High levels of intrinsic motivation, transtibial 
level amputation (as opposed to more proximal levels), greater preoperative 
function and better cognitive abilities are presented as important predictors for 
prosthetic mobility in the elderly population.7•34•36•42 The 1-leg standing balance 
remains one of the best predictors for prosthetic walking ability. 7Ai.43 
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Research suggestions 
Rather than looking at who should pursue prosthetic mobility, the problem could 
be approached from the opposite angle: which patients would be better enabled 
if directed toward learning other skills during their rehabilitation stay. A geriatric 
focus in the LTC setting could provide important differences compared to 
inpatient rehabilitation. In enabling the elderly person, non-prosthetic mobility 
also relates back to the level of amputation chosen with knee disarticulation or 
transfemoral levels prefered in cases where poor healing or knee contracture are 
considered a risk factor. 44 
There are few studies investigating non-prosthetic mobility (transfers and 
wheelchair skills) or functional outcomes in elderly people with LLA. This is an 
important gap with skills in non-prosthetic mobility essential for both prosthetic 
users and non-users alike. Existing instruments that cover the full spectrum 
of mobility (from 'bed bound' to 'no restrictions') are mostly unstandardised 
or sporadically used scales (chapter seven). Current wheelchair skills test are 
not amputee-specific and there may be important differences in sitting balance 
that could affect results when applying these tests. Falls related to wheelchair 
use are high even in younger amputation populations.45 Energy requirements 
for wheelchair mobility are less than prosthetic ambulation in this population.46 
More effort to understand non-prosthetic mobility outcomes should be made, 
particularly in respect to enabling the elderly population. 
Strengths and l im itations 
The research presented in this thesis made use of several types of study designs, 
each with its own strengths and limitations for answering our research questions. 
The elements specific to each design have been discussed as part of the individual 
chapters. Limitations and strengths of this thesis more generally are reported in 
this section. 
Among the several study designs, different angles of the research problem 
were considered, including: what is currently known in literature (chapter seven); 
what clinicians' working in the field experience (chapter five); and how patients' 
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themselves experience amputation and the months following (chapter six). 
However, a limitation of the research, as well as the focus of this discussion, is 
that we consider the research problem from one perspective only, the outcomes 
for the consumer. The cost-effectiveness of providing care needs to be considered 
in parallel. Many areas lend themselves to an economic-focussed discussion, for 
example: amputating earlier or not at all; funding of rehabilitation services in LTC; 













Despite the many aspects of rehabilitation and LTC for the elderly person with 
LLA that were addressed in this research, there are, of course, many additional 
factors of importance which were only briefly mentioned, in particular the 
availability of family/carers, functional outcomes and falls. These issues, common 
to all areas of elderly care and rehabilitation, should be kept in mind for their 
influence on the outcomes described. 
We aimed to look in detail at the elderly population with LLA. However, 
it is clear that selection bias is a common theme through this work. While 
statistical methods such as those used in chapter six offer some advantages 
for the inevitable attrition in this population, nothing can replace good study 
designs, comprehensive reporting of populations and outcomes and improved 
coordination and collaboration from participating centres. Bias in research of 
elderly people is not unique to amputation research. The problem was recently 
highlighted in an important consensus statement on care of older people with 
diabetes by the American Diabetes Association and the American Geriatrics 
Society.47 They push for the inclusion of older age groups in research, including 
randomised control trials, in order to fill the large gaps in understanding the 
unique needs of this population.47 Bias is also described as characteristic of 
research conducted in the LTC setting.48 As the global population continues to 
experience an increase in age, methods that include the elderly population with 
LLA are of growing importance.49 
Noted throughout this thesis and highlighted in the systematic review, was 
the problem of inadequate reporting of included populations. We suggested in 
chapter seven that the minimal criteria to make a relatively informed conclusion 
from outcome studies are cause of amputation, level of amputation, sex and age 
of the participants/ population, with additional information dependent on the 
outcome of interest. For example, when looking at mortality rates, timing of the 
amputation is important. Specifically, does the population include only people 
undergoing their first amputation, or does it also include people undergoing a 
second or third amputation? 
The problem of missing information was also described in chapters two to 
four. The study design, a retrospective review of medical records, was chosen 
as important details cannot be obtained from most national databases, which 
are fraught with limitations.9•50•51 For example, the national database in the 
Netherlands is currently unable to differentiate between side of amputation. 
Therefore, when someone undergoes a transtibial level amputation followed by 
a transfemoral level amputation, it is not clear if the individual has a unilateral 
transfemoral amputation or a bilateral transtibial/transfemoral amputation, yet 
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the difference in their potential outcomes and care can be substantial. Identifying 
cases that were incorrectly recorded in the national database offered another 
advantage. This occurred where a patient had been coded with 'transtibial 
amputation' when in fact the surgical record showed they had undergone 
amputation at a different level or the operation had been cancelled. Unfortunately, 
these omissions and errors could not be quantified due to different procedures for 
obtaining cases by each hospital. 
Of course, a retrospective review of the medical files also introduced 
inevitable limitations. Most obvious was that for certain variables a substantial 
number of patients had missing information. This mostly concerned insight to 
additional factors we were interested in analysing. For example, smoking status 
was infrequently recorded despite it having a major role in both the need for 
amputation and healing rates after amputation.19•52 Similarly, patients' weight was 
infrequently recorded preventing investigation, for example, of the impact of 
being over- or under- weight on mortality outcomes, and despite the importance 
of weight when considering prescription of prosthetic componentry. Another 
limitation of the information presented in the medical records, was that we were 
unable to differentiate between cause of amputation and this remained simply 
'vascular, infection or diabetes related: The underlying disease processes of these 
diagnoses differ and may have an influence on the choice of treatment and long 
term care. As we focussed on the 'elderly only' population, we felt this was a 
reasonable compromise to make. 
Other authors have also questioned how to group or sample people with 
lower limb amputation.53•54 Separating by age groups, but not cause of amputation, 
in the research in chapter seven, suggested that more information specific for 
the elderly population is needed irrespective of the underlying reason. There 
are advantages and disadvantages with any method chosen and the research 
question should be kept in mind when determining these criteria. What this 
again highlights is the importance of clearly reporting the included ( and 
excluded) population characteristics. The International Society of Prosthetics and 
Orthotics have recently drafted recommendations for reporting populations with 
amputation and these should be considered when preparing research reports. 55 
Conclusions 
The research presented in this thesis has looked at the elderly person with LLA, 
specifically how, and how well, the population is enabled through rehabilitation 
and LTC. It is clear that older age does not prevent someone achieving good 












proved difficult. Some of these reasons are harder to avoid (high rates of death 
and drop out), while others were highlighted as needing improvement (reporting 
of included populations). A key finding was that, to a great extent, care is 
provided through the surgeons' and clinicians' best judgment and experience 
and remains a limitation to consistent decision-making. This includes decisions 
by the surgeon at the time of amputation through to rehabilitation decisions in 
LTC. The pre- and early- amputation research is highly surgically focussed and 
may benefit from increased input of the rehabilitation clinicians. Amputation 
rehabilitation for the elderly person must extend beyond replacement of the 
limb, encompassing psycho-social elements and alternative options for mobility. 
Currently, measures of non-prosthetic mobility are lacking and treatment 
from a wider group of the multidisciplinary team available in LTC (beyond the 
physiotherapist) should be implemented. 
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N THE NETHERLANDS, most people undergoing a lower limb amputation 
(LLA) are over 65 years of age. Chronic peripheral vascular disease or 
diabetes mellitus has led to irreversible ischemia or a life threatening infection. 
Despite advances in preventative care, medical treatment and (peripheral) 
revascularisation procedures, in some cases, an amputation remains the best 
option for ending ongoing pain, hospitalisation and infection/ischaemia, and 
ultimately, enabling a person to live. It is the enabling a person to live that 
the research presented in this thesis focusses on. How, and how well, is the 
elderly population enabled from the decision to amputate and their subsequent 
rehabilitation and long term care (LTc)? We begin in chapters two and three with 
an investigation of incidence and mortality rates in the Northern Netherlands. 
The provision of rehabilitation for people with LLA in the LTC setting is then 
explored in chapters four and five. Two important outcomes for the elderly 
person with amputation - mobility and health related quality of life - are the 
focus of chapters six and seven. Chapter eight looks at the problem of bias in 
research of this population. The general discussion in chapter nine summarises 
the clinical implications of the findings of these chapters, from surgical decisions, 
rehabilitation setting, mobility and the importance of improving research and 
reporting of amputation populations. 
The first chapters of this thesis present results from a historical cohort 
study of amputations performed in the Northern Netherlands in 2003 or 2004. 
Investigating population changes gives insight to the effectiveness of prevention 
programmes and need for rehabilitation services. Chapter two focussed on the 
incidence rates of amputation. Included were people who underwent a first 
major LLA (above the ankle) which was necessitated because of vascular disease 
or infection. The incidence of amputation was 8.8 (all-age) and 23.6 (�45 years) 
per 100,000 person-years. When comparing to data from a matched study 
(setting, inclusion and methods) of the years 1991 and 1992, this incidence rate 
was found to be unchanged. For the cases in 2003-2004, a diagnosis of diabetes 
was recorded in 50% of the population. The incidence rate within the diabetic 
population was 151 per 100,000 person-years, giving a relative risk of amputation 
12 times greater than people without diabetes. Reports from other Western 
economies have tended towards a decreasing rate of major amputation over time 
and a substantially lower relative risk in people with diabetes than seen in our 
setting. We propose that a follow up study with a recent cohort be performed 
to confirm the pattern of change in our region. Finding methods for reducing 
these incidence rates is of continued importance as diabetes prevalence increases 
and the global population ages. Consideration should be given to the provision 
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of services from a range of areas including vascular surgery, diabetes care and 
multidisciplinary foot clinics. 
Mortality rates after amputation are known to be high. This is attributed to 
both the older age of the population undergoing the procedure and the presence 
of multiple (cardiovascular) comorbidities. Looking at mortality rates in 
different (sub) populations can help in providing a prognosis to patients, as well 
as gaining insight into preventative and long term care needs. In chapter three 
we report 22% of all people died within 30 days of their first amputation, with 
cerebrovascular disease doubling the risk of death in this time frame. Longer 
term, mortality rates are more positive with 56% of people surviving at least one 
year and 24% surviving to 5 years, with odds of death within these time frames 
highest for people with renal disease. Mortality rates were not only investigated at 
different time points, but also by different combinations of important population 
characteristics including age, sex, the level of amputation and diagnosis of 
diabetes. With the exception of the oldest age group (85+ years), we found 
no substantial differences in the long term mortality rates. Conflicting results 
between our rates and other research may be due to population differences, such 
as inclusion of non-vascular amputations or people undergoing (partial) foot 
amputation. These procedures are more likely performed in people who are 
younger and in better general health than people who are at the point of needing 
amputation above the ankle. The variability in mortality rates emphasises the 
need for outcomes to be delineated by both the underlying cause and level of 
amputation (in addition to diabetes status), to avoid the bias resultant from 
populations with different causes and levels included. 
After LLA, rehabilitation should be initiated as soon as possible. This is 
particularly important for the elderly population who can experience a rapid 
decline in their physical conditioning, which in turns leads to poorer outcomes 
in rehabilitation. Previous research has shown that being older, female, living 
alone and having LLA at a more proximal level increased the chance of discharge 
to LTC. In chapter four we report that in the Dutch setting, of all patients who 
survived the acute admission period, 55% were discharged to a LTC facility 
(Dutch: verpleeghuis) for their rehabilitation and the only factor associated with 
this outcome was older age. Although the overall number of people with LLA 
admitted to LTC was substantial, patients are spread across 34 different facilities 
in the 3 provinces. This dispersion of patients led to questions over the ability of 
clinicians to obtain and maintain amputation specific knowledge and skills. 
To look further at this issue, we interviewed clinicians working in LTC facilities. 











potential for amputation rehabilitation in this setting. The findings, presented 
in chapter five, confirmed that the lack of people admitted with LLA led to 
subsequent difficulties in providing efficient or evidence-based rehabilitation. 
Most of the amputation aspects of rehabilitation lay with the physiotherapist with 
the wider multi-disciplinary team largely unutilised. Although other studies have 
reported positive rehabilitation outcomes for people with amputation in this 
setting, we suggest that the current set-up is largely unsustainable. A designated 
LTC facility for amputation rehabilitation in each region is presented as a solution 
but also smaller clinical changes are suggested, including improvements in 
communication and training. 
Mobility in people with LLA is thought to be the key to independence and 
the basis of a higher quality of life (HRQOL). These outcomes are the focus of 
chapters six and seven. Change in health related quality of life over 18 months was 
analysed in a cohort of people with first LLA. The influence of age and walking 
ability on different HRQOL domains were investigated, along with a comparison 
to population norm values. Eighteen months after amputation, quality of life had 
improved significantly in 5 of 7 domains investigated - physical function, social 
function, pain, vitality and perceived change in health. Most change occurred 
in the first 6 months. The pattern of change over time differed only for physical 
function for people aged over 65 years compared to those younger. As this may 
have been related to the very small sample size, we also compared older and 
younger groups to population norm values of their respective age categories. 
These results supported the idea that there are age-specific differences in the 
domains affected by amputation, which should be explored further. 
In a systematic review of mobility outcomes (chapter seven), we found 
advanced skills are achieved in selected populations of elderly people with 
LLA, including outdoor and community walking. However, when mobility is 
considered in unselected populations, inclusive of all people undergoing LLA, 
including those who die post-operatively, less than 50% of the elderly population 
were able to achieve a household level of prosthetic mobility. A range of different 
tools were used to assess mobility, and combined with poor reporting of included 
populations, it was difficult to compare the outcomes from the included studies. 
Measures of non-prosthetic mobility were limited to non-validated mobility 
scales that categorise people as being bed-bound or wheelchair dependent. The 
unique requirements that elderly people face in their rehabilitation, arising from 
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multiple comorbid conditions and a short life expectancy, support a need for 
further investigation of mobility in this population. 
Issues of population inclusion and selection bias were noted throughout the 
research presented in this thesis. In chapter eight, the extent of this problem was 
described in reference to a previously published prospective study on phantom 
pain. By comparing with the actual population who had LLA ( derived from 
chapter two), we identified that more than 70% of potential inclusions to the 
phantom pain study had not been referred for inclusion. The missing population 
were, on average, 8 years older, more likely to have had LLA because of a 
vascular-related cause and there was a significant difference in one year survival 
between the groups (40% not referred versus 67% referred). When comparing 
the included and missing populations without 'reasonable non-inclusions' (i.e. 
we excluded all of the population who did not survive 12 months, who were 
most likely not referred to the study because of the severity of their condition), 
important differences in the age and level remained. 
In chapter nine, the clinical implications of our findings are discussed. It is 
clear that older age does not prevent someone achieving good outcomes after 
amputation. However, studying this population in isolation proved difficult. Some 
of these reasons are hard to avoid (high rates of death and drop out), while others 
were highlighted as needing improvement (reporting of included populations). 
Many aspects of rehabilitation and LTC for the elderly person with LLA were 
addressed in this research but there are additional important factors which were 
only briefly mentioned, in particular the availability of family/ carers, functional 
outcomes and falls and balance. Further, among the several study designs used in 
this research, we focussed on one perspective only, the 'consumer: An economic 
perspective could add additional information for decisions. A key finding was 
that, to a great extent, care is provided through the surgeons' and clinicians' best 
judgment and experience and there are limitations to consistent decision-making. 
This includes decisions by the surgeon at the time of amputation through to 
rehabilitation decisions in LTC. The pre- and early- amputation research is mostly 
surgically focussed and may benefit from increased input of the rehabilitation 
team. Amputation rehabilitation for the elderly person extends beyond 
replacement of the limb, encompassing psycho-social elements and alternative 
options for mobility. Currently, measures and research of non-prosthetic mobility 
outcomes are lacking and treatment from a wider group of the multidisciplinary 













Met dank aan Jaap van Netten en Maerian de Jong 
voor de vertaling van deze samenvatting 
I
N NEDERLAND zijn de meeste mensen die een beenamputatie ondergaan 
ouder dan 65 jaar. Chronisch vaatlijden of diabetes mellitus heeft bij 
hen geleid tot onomkeerbare ischemie of een levensbedreigende infectie. 
Ondanks vooruitgang in preventieve zorg, medische behandeling en (perifere) 
revascularisatiemogelijkheden, is een amputatie in sommige gevallen de beste 
optie om langdurige pijn, ziekenhuisopnames en infectie/ischemie te beeindigen 
en daarmee leven mogelijk te maken. Het is <lat 'mogelijk maken om te leven' 
waar het onderzoek <lat in <lit proefschrift wordt gepresenteerd op focust. Hoe, 
en in welke mate, wordt het de oudere met een amputatie mogelijk gemaakt 
om te leven, vanaf het moment <lat de beslissing valt om te amputeren, de 
daaropvolgende revalidatie, en tenslotte de verpleeghuiszorg? 
We beginnen in hoofdstukken twee en drie met een onderzoek naar de 
incidentie en de mortaliteit in Noord-Nederland. De revalidatievoorziening voor 
amputatiepatienten in de verpleeghuiszorg wordt vervolgens onderzocht in de 
hoofdstukken vier en vijf Twee belangrijke uitkomsten voor ouderen met een 
amputatie - mobiliteit en gezondheidsgerelateerde kwaliteit van leven - zijn de 
focus van hoofdstukken zes en zeven. Hoofdstuk acht bekijkt het probleem van 
'bias' in het onderzoek van deze populatie. De discussie (hoofdstuk negen) vat de 
klinische implicaties van alle bevindingen samen, daarbij worden de chirurgische 
beslissingen, de revalidatiesetting, mobiliteit, het belang van beter onderzoek en 
het rapporteren van de populatie besproken. 
In de hoofdstukken twee en drie van <lit proefschrift worden resultaten 
gepresenteerd van een historische cohort-studie naar amputaties, uitgevoerd 
in Noord-Nederland in 2003 en 2004. Onderzoek naar veranderingen in de 
populaties geeft inzicht in de effectiviteit van preventieprogramma's en de 
behoefte aan revalidatie. Hoof dstuk twee focust op de incidentie van amputatie. 
Daarvoor werden personen gei:ncludeerd die voor het eerst een beenamputatie 
(boven de enkel) ondergingen vanwege vasculaire redenen of infecties. De 
incidentie van amputatie was 8,8 (alle leeftijden) en 23,6 (� 45 jaar) per 100.000 
persoon-jaren. In vergelijking met de data van een gelijke studie (setting, inclusie 
en methoden) van de jaren 1991 en 1992 was de incidentie niet veranderd. In de 
jaren 2003 en 2004 had 50% van de populatie diabetes mellitus. De amputatie 
incidentie was 151 per 100.000 persoon-jaren, leidend tot een relatief risico op 
amputatie <lat 12 keer hoger is dan in personen zonder diabetes. Onderzoek in 
andere westerse economieen laten een afnemende incidentie van amputaties 
zien en een substantieel lager relatief risico voor patienten met diabetes dan in 
onze setting wordt gevonden. We stellen voor dat een follow-up onderzoek in 
een recent cohort gedaan wordt om het patroon van (gebrek aan) verandering in 
onze regio te bevestigen. Het blijft van belang methoden te vinden om het aantal 
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amputaties te verminderen, nu diabetes vaker voorkomt en de gebele bevolking 
ouder wordt. Daarbij staat aandacbt voor zorg in meerdere disciplines, waaronder 
vaatgeneeskunde, diabeteszorg en multidisciplinaire voetklinieken, voorop. 
Het is bekend dat de mortaliteit na een amputatie boog is. Mortaliteit wordt 
toegescbreven aan zowel de bogere leeftijd van de patienten als aan multipele 
(cardiovasculaire) comorbiditeit. Op basis van mortaliteit bij verscbillende (sub) 
populaties kan patienten een prognose gegeven worden over de noodzaak van 
preventieve en zorg op de lange termijn. In hoof dstuk drie rapporteren we dat 
22% van de patienten binnen 30 dagen na bun eerste amputatie is overleden, 
waarbij cerebrovasculaire ziekten bet risico op overlijden in deze periode 
verdubbelen. Op de langere termijn zijn de cijfers betreffende de mortaliteit 
positiever; 56% van de patienten overleeft bet eerste jaar en 24% overleeft vijf jaar. 
De kans op overleven in deze tijdsperioden is bet laagst voor mensen met een 
nierziekte. De mortaliteit werd niet alleen onderzocbt op verscbillende punten 
in de tijd, maar voor verscbillende combinaties van populatiekarakteristieken, 
waaronder leeftijd, geslacht, amputatieniveau en de diagnose diabetes. Met 
uitzondering van de oudste leeftijdsgroep (85+) die een slechtere overlevingskans 
heeft, vonden we geen substantiele verschillen in de mortaliteit op lange 
termijn. Tegenstrijdige resultaten tussen onze en andere studies kunnen 
mogelijk verklaard worden door verschillen in populatie, zoals de inclusie van 
niet-vasculair gerelateerde amputaties of mensen die partiele voetamputaties 
ondergaan. Deze procedures worden vaker uitgevoerd bij mensen die jonger 
zijn en een betere algemene gezondheid hebben dan mensen die een amputatie 
boven de enkel ondergaan. De variatie in mortaliteit benadrukt het belang van 
gedifferentieerd rapporteren over de onderliggende oorzaak en amputatieniveau 
(naast het apart rapporteren van de diabetespopulatie), om 'bias' als gevolg van 
niet-vasculaire amputaties of verschillende amputatieniveaus te voorkomen. 
Met revalidatie moet zo snel mogelijk na een amputatie worden begonnen. Dit 
is vooral belangrijk voor oudere patienten die anders een snelle achteruitgang 
in bun fysieke conditie kunnen ervaren, wat vervolgens weer leidt tot slechtere 
revalidatieresultaten. Eerder onderzoek heeft aangetoond dat een hoge leeftijd, 
vrouwelijk geslacbt, alleen wonen en een amputatie op een meer proximaal 
niveau de kansen op het ontslag naar een verpleeghuis voor revalidatie verhogen. 
In hoofdstuk vier rapporteren we dat van alle patienten die de acute fase overleefd 
hebben, 55% naar een verpleeghuis ging voor revalidatie. De enige factor 
die hiermee samenhing was een oudere leeftijd. Ook al was het totale aantal 
patienten dat naar een verpleeghuis ging hoog, in de drie noordelijke provincies 


















leidt tot de vraag hoe clinici amputatiespecifieke kennis en vaardigheden 
verkrijgen en behouden. 
Om dit verder te onderzoeken hebben we clinici in de verpleeghuizen 
gefoterviewd met als doel vanuit hun perspectief de setting, de barrieres en 
het revalidatiepotentieel voor amputatiepatienten in de verpleeghuizen te 
beschrijven. De resultaten, gepresenteerd in hoofdstuk vijf, bevestigen <lat het 
kleine aantal amputatiepatienten in ieder verpleeghuis leidt tot problemen in 
het geven van effi.ciente en evidence based revalidatie. De meeste aspecten van 
de amputatierevalidatie liggen op het bord van de fysiotherapeut, waarbij de 
grotere mogelijkheden van het multidisciplinaire behandeling niet benut worden. 
Ondanks <lat andere studies positieve resultaten van amputatierevalidatie 
in verpleeghuizen laten zien, stellen wij voor <lat de huidige organisatie niet 
duurzaam te handhaven is. In iedere regio een verpleeghuis <lat zich specialiseert 
in amputatierevalidatie is een oplossing. Ook kleinere veranderingen worden 
voorgesteld, waaronder verbeteringen in de communicatie en de training van 
clinici. 
Mobiliteit van mensen met een amputatie wordt verondersteld de sleutel te 
zijn voor onafhankelijkheid en de basis voor een hogere kwaliteit van leven. 
Deze uitkomsten zijn de focus van hoofdstukken zes en zeven. Verandering in 
gezondheidsgerelateerde kwaliteit van leven na 18 maanden werd geanalyseerd 
in een cohort van mensen met een eerste beenamputatie. De invloed van leeftijd 
en loopmogelijkheden op verschillende gezondheidsgerelateerde aspecten van 
kwaliteit van leven werden onderzocht, samen met een vergelijking naar de 
normaalwaarden van de populatie. Achttien maanden na een amputatie was de 
kwaliteit van leven significant verbeterd in 5 van de 7 domeinen die onderzocht 
werden - fysieke functies, sociale functies, pijn, vitaliteit en ervaren verandering 
in gezondheid. De grootste verandering vond plaats in de eerste 6 maanden. Het 
patroon van verandering over de tijd verschilde alleen voor fysieke functie voor 
mensen ouder dan 65, in vergelijking met de mensen jonger dan 65. Omdat 
<lit verschil mogelijk werd veroorzaakt door de zeer kleine onderzoeksgroep, 
vergeleken we ook oudere en jongere groepen met de populatie normaalwaarden. 
De resultaten ondersteunen het idee <lat er leeftijdspecifieke verschillen zijn in de 
domeinen van kwaliteit van leven die befovloed worden door de amputatie. Deze 
verschillen zouden verder onderzocht moeten worden. 
In een systematische review (hoofdstuk zeven) naar de uitkomsten op het 
gebied van mobiliteit vonden we <lat geavanceerde vaardigheden bereikt werden 
in geselecteerde groepen van oudere mensen met een amputatie, waaronder het 
wandelen buitenshuis. Echter, als mobiliteit bekeken werd in niet geselecteerde 
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populaties, inclusief alle mensen die een beenamputatie ondergaan en inclusief 
alle mensen die post-operatief overlijden, dan is slechts 50% van de oudere 
populatie in staat het niveau van mobiliteit binnen het huishouden te bereiken. 
Veel verschillende meetinstrumenten werd gebruikt om mobiliteit te meten, en 
in combinatie met het slechte rapporteren van de gei:ncludeerde populatie zorgde 
ervoor dat de uitkomsten van verschillende studies moeilijk te vergelijken waren. 
Meetinstrumenten van niet-prothese gerelateerde mobiliteit waren beperkt tot 
niet gevalideerde mobiliteit schalen die patienten categoriseren als 'gebonden aan 
bed' of 'rolstoel afhankelijk: De unieke behoeften die oudere mensen tijdens hun 
revalidatie hebben, als gevolg van de comorbiditeit en de korte levensverwachting, 
ondersteunen de noodzaak van verder onderzoek naar de mobiliteit van deze 
populatie. 
Zaken als het includeren van de populatie en selectie bias werden beschreven 
in al het onderzoek gepresenteerd in dit proefschrift. In hoof dstuk acht wordt 
de grootte van dit probleem onderzocht, op basis van een eerder gepubliceerde 
prospectieve studie naar fantoompijn. Door de actuele populatie die geamputeerd 
werd (beschreven in hoofdstuk twee), ontdekten we dat meer dan 70% van de 
potentiele te includeren patienten niet doorverwezen was. De ontbrekende 
populatie was gemiddeld 8 jaar ouder, had een grotere kans op een amputatie 
ten gevolge van een vasculair probleem. Bovendien was er een significant 
verschil in de overleving na een jaar tussen beide groepen (40% in de niet­
verwezen groep versus 67% in de verwezen groep) . Ook nadat we alle 'terechte 
niet-verwezen patienten' (alle patienten die binnen twaalf maanden overleden 
en die zeer waarschijnlijk niet verwezen werden vanwege hun slechte conditie) 
hadden geexcludeerd, bleven er relevante verschillen bestaan op het gebied van 
populatiekarakteristieken tussen de gei:ncludeerde en de niet-gei:ncludeerde 
populatie. 
In hoofdstuk negen worden de klinische implicaties van alle bevindingen 
besproken. Het is duidelijk dat een oudere leeftijd alleen het bereiken van 
goede uitkomsten van een amputatie niet in de weg hoeft te staan. Echter, het 
onderzoeken van deze gei:soleerde groep patienten is moeilijk gebleken. Sommige 
redenen zijn moeilijk te vermijden (hoge percentages van overlijden en uitval), 
terwijl andere redenen in dit proefschrift zijn beschreven als belangrijke 
gebieden die verbetering behoeven (het rapporteren van de gei:ncludeerde 
populatie) . Veel aspecten van revalidatie en verpleeghuiszorg voor de oudere 
amputatiepatient zijn in dit proefschrift aan bod gekomen, maar er zijn meer 
belangrijke factoren die in dit onderzoek slechts kort genoemd zijn. Vooral de 
beschikbaarheid van familie/verzorgenden, functionele uitkomsten, vallen en 
balans. Verder, de verschillende onderzoeksdesigns die in dit onderzoek gebruikt 












zijn, badden allemaal een focus op slecbts een perspectief, dat van de 'gebruiker'. 
Een economiscb perspectief zou waardevolle informatie kunnen opleveren 
voor de beslissingen die genomen worden. Een belangrijke bevinding was dat 
de zorg voor bet grootste deel geleverd wordt op basis van de best mogelijke 
inscbattingen en ervaring van de cbirurg en andere clinici, en dat er beperkingen 
zijn in bet consistent nemen van dergelijke beslissingen. Dit bevat de beslissingen 
van de cbirurg op bet moment van amputatie tot de beslissingen tijdens de 
revalidatie in bet verpleegbuis. Het onderzoek naar de fases voorafgaand en 
direct volgend op amputatie is sterk cbirurgiscb georienteerd en kan profiteren 
van input van bet revalidatie team. Amputatierevalidatie voor de oudere patient 
is meer dan bet vervangen van een ledemaat, er moet ook rekening opbouden 
met psycbosociale elementen en alternatieve opties voor mobiliteit. Op dit 
moment ontbreken meetmetboden en onderzoek naar niet-protbese gerelateerde 
mobiliteit. Ook de bebandeling door een bredere groep van bet multidisciplinaire 
team die in de verpleegbuizen bescbikbaar is (i.e. meer dan alleen de 
fysiotberapeut) zou gei:mplementeerd moeten worden. 
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